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QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
Noninvasive Evaluation of the Carotid Circulation
Pasteur died of a stroke. So did Lenin, 
von Hindenburg and Franklin D. 
Roosevelt. Through most of medical 
history it was thought that strokes were 
cataclysmal intracranial vascular acci­
dents, unpredictable and without satis­
factory treatment or possibility of pre- 
morbid diagnosis. The recently appre­
ciated fact that most patients with 
ischemic strokes have potentially oper­
able extracranial carotid lesions has 
provoked interest in their early recog­
nition and localization. Although ar­
teriograms are necessary to define the 
anatomy of carotid bifurcation lesions 
prior to operation, it is desirable to 
be able to screen patients without the 
inconvenience, expense and small risk 
associated with arteriography, particu­
larly when serial examinations are 
required. Patients with asymptomatic 
bruits, atypical neurologic symptoms 
and previous strokes are of special 
interest.
The noninvasive methods that have 
been developed have elucidated several 
clinical observations. As a stenosis in­
creases the associated bruit becomes 
longer and of higher pitch, and as the 
occlusion becomes nearly complete, the 
bruit may no longer be audible. Caro­
tid phonoangiography provides photo­
graphic representation of the wave­
forms produced by such bruits and al­
lows their differentiation from trans­
mitted cardiac murmurs or more prox­
imal bruits. By comparing the wave­
forms with the arteriogram one can de­
duce the degree of stenosis represented 
on the former. A pansystolic bruit 
represents a 40% to 50% stenosis and 
a bruit extending into diastole indicates 
an even greater stenosis and a more
marked pressure gradient.1 The carotid 
vessels can also be studied with a di­
rectional Doppler flow probe to gen­
erate a flow map on the storage oscil­
loscope and thus provide a graphic 
projection of blood flow velocities, al­
lowing localization of a stenotic lesion 
and an estimate of the amount of nar­
rowing. At the same time, recordings 
can be made of the audiosignal for 
subsequent study and interpretation, 
and a tracing generated of the analog 
blood flow signals.2,3
The ophthalmic artery is a direct 
continuation of the intracerebral por­
tion of the internal carotid artery and 
can be studied with a Doppler flow 
probe, as can its supraorbital branch. 
A hemodynamically significant internal 
carotid artery stenosis may be reflected 
by a reversal of ophthalmic or supra­
orbital artery flow.4 Since the collateral 
circulation through the ipsilateral ex­
ternal carotid or the opposite internal 
carotid artery across the circle of 
Willis is quite variable, it may or may 
not allow normal or near normal pres­
sure in the internal carotid artery dis­
tal to the middle cerebral artery to 
generate antegrade signals. Bone and 
Barnes3 have added refinements such 
as carotid compression to the technique 
of Doppler ophthalmic examination and 
report a higher degree of accuracy; 
yet these additions add small but 
definite risks to an already complex 
technique and make its application as 
a simple screening test performed by a 
technician more difficult. Those nonin­
vasive techniques that depend solely 
on evaluation of ophthalmic or supra­
orbital artery flow have been found 
to overlook a sizeable number of sig­
nificant stenoses, and many give pc i- 
tive results only with near or total 
occlusion of the internal carotid ar­
tery.6'8 The results of such determina­
tions are helpful if positive but not of 
much value if they are negative.
Oculoplethysmography is performed 
by applying small suction cups to the 
cornea to record the volume changes 
in each globe produced by pulsatile 
arterial flow. At the same time record­
ings are made of ear lobe pulses to 
detect any delays between the internal 
and external carotid pulses which are 
indicative of an internal carotid steno­
sis. Such pulse delays are often 
minimal and the study may over­
look patients with bilateral disease. In 
experienced hands an accuracy rate of 
90% can be attained by combining 
oculoplethysmography with carotid 
phonoangiography, permitting greater 
discrimination in recommending arte­
riography and increasing the yield of 
those arteriograms performed.1’8
Prospective clinical studies6,8 have 
compared the accuracy of several non­
invasive studies. The clinical diagnosis 
of cerebrovascular disease was not al­
ways accurate, nor was the correlation 
between lesions and the presence of a 
bruit. None of the methods detected ste­
noses of less than 50%. With greater de­
grees of stenosis the methods were of 
varying accuracy and those studies that 
used more than one means of evalua­
tion achieved maximum accuracy. Our 
own preference has been for the com­
bined carotid Echo Doppler scan con­
sisting of four parts: carotid bifurcation 
imaging, recording of carotid Doppler 
audiosignals, strip chart recording of 
analog blood flow signals and deter-
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minations of ophthalmic artery flow 
direction. Using this combination, an 
accuracy of 93% of that attainable 
with arteriography has been possible, 
and lesser degrees of stenosis have been 
recognized.9
What are the uses and abuses of 
noninvasive studies? Patients with 
asymptomatic bruits, nonhemispheric 
neurologic symptoms, prior strokes, or 
known risk factors for cerebrovascular 
disease can be studied noninvasively in 
an attempt to identify those at parti­
cular risk of stroke and to improve the 
selection of patients for arteriography. 
Patients who require repeated examina­
tions to follow the progression of 
asymptomatic bruits or nonhemody- 
namically significant stenoses obvious­
ly cannot be subjected to repeat arteri­
ography at regular intervals, but can 
be studied noninvasively with no risk 
and minimal expense and inconve­
nience. The major limitation of non­
invasive studies has been their inability 
to detect ulcerated plaques, particu­
larly if they are nonstenotic. The most 
common cause of transient ischemic 
attacks (TIAs) is emboli, most of which 
originate from ulcerated plaques at the 
carotid bifurcation. Single or multiple 
TIAs represent a considerable stroke 
risk and are a bona fide  indication for 
arteriography. If noninvasive techniques 
are used instead of arteriography in pa­
tients who present with TIAs a con­
siderable number of patients who might 
benefit from carotid endarterectomy 
will be overlooked.
F rederic Jarrett, md, frcs[c]
Department of surgery,
University of Wisconsin Hospitals,
1300 University Ave.,
Madison, WI 53706
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Nerve Entrapment Syndromes
In this issue (page 354) Wiens and Lau 
draw attention to a particular type of 
peripheral nerve entrapment syndrome 
affecting the anterior interosseous nerve 
of the forearm. Although the article 
deals exclusively with a relatively rare 
form, it is well to  be reminded of 
the existence of nerve entrapment syn­
dromes.
The subject merits periodic emphasis 
in the literature because entrapment 
syndromes in general are not rare. The 
symptoms develop insidiously, are 
somewhat bizarre and frequently mimic 
those caused by other pathologic en­
tities. An example of this mimicry is 
the resemblance between “spinal claudi­
cation”, due to entrapment of the cauda 
equina and the lumbar nerve roots in 
spondylitic spinal stenosis, and vascular 
claudication. Only a careful and com­
plete history and physical examination 
will make the distinction between them 
apparent. The symptoms of entrap­
ment of the lateral femoral cutaneous 
nerve near the anterior superior iliac 
spine (meralgia paresthetica) can be 
confused with those of “atypical” vas­
cular claudication. I have encountered 
many patients with this form of entrap­
ment syndrome who have needlessly 
been shunted back and forth between a 
variety of health care professionals in 
the search for relief of their symptoms.
Awareness and recognition of nerve 
entrapment syndromes should there­
fore be of interest to surgeons as well 
as to primary care physicians. An ex­
cellent monograph1 is available to those 
wishing to extend their knowledge of 
the subject.
R.U. Repo, md, frcs[c]
Assistant professor of orthopedic surgery, 
McMaster University,
Hamilton, Ont.
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REVIEW ARTICLES
Parathyroid Hormone and Hyperparathyroidism:
Current Concepts
David Goltzman, md, frcp [c]
Our expanding knowledge of the 
physiologic and biochemical factors 
governing calcium homeostasis has 
improved our capacity to evaluate 
hypercalcemia, of which an increased 
incidence is being discovered through 
the widespread use of multiphasic 
screening. Consequently, we are 
diagnosing mild forms of hyperpara­
thyroidism more often than formerly.
The enhanced recognition of virtually 
symptom-free hyperparathyroidism pre­
sents a problem in patient management 
because the natural history of this 
form of hyperparathyroidism is unknown 
and the pathologic lesion underlying 
the condition may be ambiguous, 
resulting in difficult decisions in 
surgical management. Further study is 
required to resolve this issue in order 
to provide optimal care for the 
affected individual.
Notre connaissance croissante des 
facteurs physiologiques et biochimiques 
qui gouvernent I'homeostase du cal­
cium a ameliore notre capacite 
d'evaluer I’hypercalcemie que Ton 
decouvre maintenant avec une frequence 
accrue grace a I'emploi repandu des 
epreuves de depistage. En consequence, 
on diagnostique de plus en plus 
souvent les formes benignes d’hyper- 
thyroidie. La reconnaissance plus 
frequente d'un hyperthyroidie virtuelle- 
ment asymptomatique pose un probleme 
de traitement puisque devolution 
naturelle de cette forme d'hyper- 
thyroidie est inconnue et que la lesion 
pathologique sous-jacente peut etre 
ambigue, entrainant de difficiles 
decisions de traitement chirurgical. 
D'autres etudes sont requises pour 
resoudre cette question de facon a 
assurer des soins optimums aux 
personnes qui en sont atteintes.
From the department of medicine, 
McGill University and Royal Victoria 
Hospital, Montreal, PQ
Reprint requests to: Dr. D. Goltzman, 
Rm. A-417, Royal Victoria Hospital, 
687 Pine Ave. W, Montreal, PQ 
H3A 1A1
The increase in our knowledge of 
parathyroid physiology and chemistry 
coupled with the widespread use of 
biochemistry to assess patients has 
greatly altered our understanding of 
the pathogenesis of hyperparathyroid­
ism and our concepts regarding its 
management.
Calcium Homeostasis
The calcium of the extracellular 
fluid appears to be maintained in tight 
control by the net result of calcium 
fluxes across the intestine, kidney and 
bone (Fig. 1). The mechanisms influ­
encing calcium transport in these tis­
sues have come under intensive scrutiny 
in recent years, and considerable new 
insight has been gained into the actions 
of vitamin D and parathyroid hormone 
(PTH), the two major humoral factors 
controlling calcium homeostasis. Vita­
min D has been shown to undergo 
metabolic transformation from a pre­
cursor of low potency to a highly 
active entity.1 It is known that this 
sterol, ingested in food or converted 
by ultraviolet irradiation from an inert 
precursor, 7-dehydrocholesterol, is 
transported by a plasma protein to the
KIDN EY
FIG. 1—Sites of known (-») and po­
tential (- - ►) action of vitamin D (D) 
and parathyroid hormone (PTH) as me­
chanisms influencing calcium transport 
across gut, bone and kidney in maintenance, 
of calcium of extracellular fluid (ECF).
liver where it is hydroxylated at the 
25 position. This 25-hydroxy vitamin 
D derivative is then carried in the cir­
culation as a protein-bound entity to 
the kidney (mainly), where one of at 
least two additional hydroxylations 
may occur. In association with states 
of hypocalcemia, phosphate depletion 
and PTH excess, the activity of a 
renal hydroxylase enzyme is aug­
mented and a 1,25-dihydroxy vitamin 
D derivative is formed.1,2 This is the 
most potent metabolite of vitamin D 
yet discovered. It acts chiefly on the 
intestine to enhance calcium absorption 
and restore normocalcemia; at least in 
pharmacologic concentrations it is 
capable of producing bone resorption 
as well. Additionally, perhaps by an 
indirect mechanism, the vitamin seems 
necessary for the full resorptive action 
of PTH on bone. In calcium-replete 
states, the major circulating dihydroxy 
metabolite is believed to be 24,25-di­
hydroxy vitamin D, the primary func­
tion of which is currently being evalu­
ated. The major role of PTH in 
influencing absorption of calcium from 
the gut is therefore indirect through 
its “activation” of 25-hydroxy vitamin 
D to its potent, 1,25-hydroxy meta­
bolite.
In physiologic circumstances the 
major direct role of PTH in maintain­
ing calcium homeostasis may be to en­
hance calcium absorption from the 
(distal) renal tubule and thereby to 
diminish calcium loss through the kid­
ney.3 In contrast, by interfering with 
phosphate reabsorption in the (prox­
imal) tubule, PTH enhances phosphate 
loss through the kidney, so that in 
states of PTH excess the result is a 
well-recognized hypophosphatemia. A 
number of other influences of PTH 
excess on the nephron have also been 
observed, such as interference with 
bicarbonate reabsorption with resultant 
renal tubular acidosis.4 These metabolic 
alterations induced by the hormone 
are all seen in accentuated form in 
clinical states of augmented PTH pro­
duction.
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The most notable effect of increased 
circulating PTH is enhanced bone re­
sorption.3 Although this is unquestioned 
in the elevated concentrations of the 
hormone seen in hyperparathyroidism, 
it has been observed that in much 
lower concentrations, such as occur 
in physiologic states, the hormone 
may be anabolic in bone.5 Other 
agents inducing bone resorption, such 
as prostaglandins, have been identified 
and have occasionally been implicated 
(especially in association with neopla­
sia) in states of hypercalcemia and 
bone resorption simulating hyperpara­
thyroidism.6
PTH Biosynthesis and Metabolism
Parathyroid hormone is an 84- 
amino acid single-chain polypeptide3 
synthesized in the parathyroid cell (Fig. 
2).7 The peptide product of the para­
thyroid ribosomes appears to have a 
31-amino acid extension at the NH2 
terminus of the molecule and this 
elongated precursor is known as 
pre-proparathyroid hormone (pre-pro 
PTH).8 The greater part (25 amino 
acids) of this precursor extension is 
most likely removed from the nascent 
chain by an enzyme as the newly-syn­
thesized peptide passes into the cister- 
nae of the endoplasmic reticulum, 
leaving a smaller precursor, extended 
by only 6 amino acids (pro PTH).9 
This peptide is converted to the hor­
mone by a tryptic-like cleavage11’ 
probably within the Golgi complex, 
and the 84-amino acid hormone is then 
packaged into secretory granules and 
released in response to hypocalcemia. 
The biologic activity of pre-pro PTH 
and its fate (i.e., whether this entity is 
released into the circulation) are cur­
rently unknown. Pro PTH appears to 
have little if any intrinsic biologic 
activity until it is converted to the 
hormone,11 and it is unlikely, although 
this has not been proved, that this 
precursor ever enters the circulation.
The extent to which further intra- 
glandular metabolism of the 84-amino 
acid form of the hormone occurs is 
currently under intensive investigation. 
However, it is generally accepted that 
further metabolism in peripheral tis­
sues, mainly liver12 and kidney,13 does 
occur. The consequence of the meta­
bolism of the hormone is the produc­
tion of hormonal fragments,1417 most 
notably an inert middle and carboxyl 
terminal fragment which, by virtue of 
its long half-life, is the form of para­
thyroid hormone generally circulating 
in highest concentration in the blood. 
The fate of the amino-terminal portion 
of the molecule is uncertain, yet is 
most important since the entire biolo­
gic activity of the hormone appears to 
reside in the amino-terminal-34 resi­
dues.18 One group of workers19 has 
reported the existence of a biologically 
active amino-terminal fragment (in 
addition to the intact hormone) in the 
circulation of man. This has raised the 
possibility that the 84-amino acid form 
of the hormone itself may be an inert 
precursor requiring conversion to an 
active amino-terminal fragment for 
hormonal action. However, recent 
evidence has indicated that cleavage of 
the 84-amino acid form of the hormone 
may not be required for at least some 
forms of biologic activity.20 Conse­
quently the apparently specific meta­
bolism undergone by the 84-amino acid 
species may limit the quantities of 
biologically active circulating moiety 
or generate an amino fragment with a 
site or duration of activity different 
from what is possessed by the intact 
molecule.
Etiology and Pathogenesis of
Hyperparathyroidism
The most common cause of hyper­
parathyroidism is still a solitary para­
thyroid adenoma in which the under­
lying disturbance appears to be a 
defect in cell growth localized to one 
gland whose proliferating cells main­
tain their biosynthetic function. How­
ever, the generalized abnormality re­
sulting in hyperplasia of all four glands 
is now being recognized more often,21 
and appears to be inceasing in fre­
quency as a cause of hyperparathyroid­
ism recurring postoperatively.22
FIG. 2—Biosynthesis and metabolism 
of parathyroid hormone. Schematic repre­
sentation of different portions of PTH 
molecule are as follows: »**»» , 25-amino 
acid NH2-terminal extension of pre-pro 
PTH; -v\ , 6-amino acid NH2-terminal
extension of pro PTH; i/w/i, N H 2-terminal 
portion of major species of PTH contain­
ing biologic activity; lull , inactive mid­
dle and carboxyl-terminal portion of major 
species of PTH. Both well-established 
pathways (-») and potential pathways 
( - - - ►)  of metabolism are noted.
Although one might suspect an ex­
ternal stimulus to be causative in at 
least some of these cases of hyperpla­
sia, no such stimulus has yet been 
identified. Consequent upon the investi­
gation of factors other than the calcium 
ion, such as /^-adrenergic agents23 and 
vitamin D metabolites,24 which may 
influence glandular release of hor­
mone (perhaps by modulating the ef­
fect of calcium), a subset of cases of 
parathyroid hyperplasia with a disor­
dered external drive to parathyroid 
gland secretion may eventually be dis­
covered.
An unknown controlling ionic or 
humoral factor need not be implicated 
if a defect in the “sensing” mechanism 
in glandular tissue is identified, where­
by normal concentrations of ambient 
calcium are interpreted as low by the 
defective cells and consequently induce 
inappropriate glandular secretion of 
hormone. Such a mechanism has been 
postulated in certain cases of familial 
hyperparathyroidism.25 Finally, those 
cases of four-gland enlargement asso­
ciated with the multiple endocrine neo­
plasia (MEN) syndromes are believed 
to emanate from defects in embryo- 
genesis, which subsequently manifest 
as disorders of cell growth in a number 
of endocrine glands (including all four 
parathyroid glands) to which the 
daughter cells with common defective 
ancestry migrate.
The identification on histologic 
grounds of the underlying lesion of 
hyperparathyroidism, that is, the dis­
tinction between adenoma and hyper­
plasia, is extremely difficult and is 
made considerably more so when the 
hyperplasia is asymmetrical so that 
only one or two of the four glands may 
appear enlarged on gross examination. 
Nevertheless a means of making this 
distinction is of the utmost importance 
in deciding on an appropriate surgical 
approach to therapy. The recognition 
of distinguishing characteristics may 
have to await further insight into the 
mechanisms causing adenomas and 
hyperplasias.
Clinical Aspects and
Differential Diagnosis
The widespread use of multiphasic 
screening has markedly altered the 
mode of presentation of primary hy­
perparathyroidism so that asymptomatic 
hypercalcemia appears to constitute a 
large proportion of the clinical in­
stances of the disorder.26,27 Renal mani­
festations, notably those of nephroli­
thiasis, are currently the most common 
form of symptomatic disease, while 
osseous abnormalities are detected 
relatively infrequently.27 Gastrointes­
tinal symptoms, including those of 
pancreatitis and dyspepsia, may quite
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frequently accompany the hypercalce­
mia. However, proved peptic ul­
ceration should alert the physician to 
the possibility of an accompanying 
Zollinger-Ellison syndrome,28 and there­
fore of the MEN syndrome, type I. 
Other components of this syndrome, 
including other pancreatic islet-cell 
neoplasms and pituitary tumours, 
should then be considered (Fig. 3).
Alternatively, the association of hy­
perparathyroidism with thyromegaly 
and hypertension should raise the pos­
sibility of medullary carcinoma of the 
thyroid and pheochromocytoma(s) con­
stituting the MEN syndrome, type II.2" 
Although both syndromes are inherited 
as autosomal dominant entities, the on­
ly endocrinopathy shared by the two 
appears to be hyperparathyroidism. 
More recently patients with MEN syn­
drome, type II together with mucosal 
neuromas have been designated MEN, 
type III, partly in view of a reported 
lower frequency of hyperparathyroid­
ism in the latter entity.30 The impor­
tance of recognizing other endocrino- 
pathies in association with primary 
hyperparathyroidism is not only of con­
sequence to the affected patient, but 
obviously is of importance in the man­
agement of family members as well.
Causes of hypercalcemia that must 
be considered in the differential diag­
nosis of hyperparathyroidism can gen­
erally be grouped, on a pathogenetic 
basis, into those due primarily to ex­
cessive bone resorption, those due to 
excess absorption from the gut and 
those due to reduced renal excretion 
(Table I). Yet in view of our increased 
knowledge concerning the interaction 
of factors controlling calcium home­
ostasis, it is obvious that several patho­
genetic mechanisms are generally in­
volved in any single disorder; for 
example, in hyperparathyroidism, the
FIG. 3—Interrelation of endocrino- 
pathies constituting multiple endocrine 
neoplasia (MEN) syndromes types I and 
II. Individual endocrinopathies depicted 
have been reported as occurring on occa­
sion as familial diseases without other 
associated components of MEN I and 
MEN II. Triad of medullary thyroid car­
cinoma, mucosal neuromas and pheo- 
chromocytomas has occasionally been 
designated MEN III.
increased bone resorption due to PTH 
excess may be accompanied by en­
hanced absorption of calcium from 
the gut owing to augmented concentra­
tions of 1,25-dihydroxy vitamin D as­
sociated with increased PTH produc­
tion. Similarly the hypercalcemia of 
vitamin D intoxication may result 
primarily from enhanced absorption of 
calcium from the gut, and also from 
increased bone resorption. Neverthe­
less a pathogenetic classification should 
provide a more rational basis for 
reaching the diagnosis in a given pa­
tient.
Establishing the diagnosis of hyper­
parathyroidism in the patient with 
hypercalcemia may not be exceedingly 
difficult if an adequate history is taken 
and physical examination is performed, 
inasmuch as many diseases associated 
with hypercalcemia may be thereby 
excluded. The absence from the his­
tory and physical examination of an 
adequate explanation for the presence 
of mild hypercalcemia (especially if 
this hypercalcemia can be documented 
as of long standing and is accompanied 
by few signs and symptoms) makes the 
diagnosis of hyperparathyroidism more 
probable. In contrast the investigation 
of severe hypercalcemia of recent on­
set should include consideration of 
neoplasia as a highly likely underlying 
cause.
Laboratory investigation should then 
permit the distinction of PTH-asso- 
ciated from non-PTH-associated hyper­
calcemia and also of excess PTH pro­
duction from glandular as opposed to 
ectopic sites.
Laboratory Investigation
In view of the well-defined metabolic 
disturbances of hypophosphatemia and 
mild hyperchloremic acidosis induced 
by PTH excess, various combinations 
of serum phosphorus, chloride and bi­
carbonate concentrations have been 
advocated as indices to distinguish 
PTH-induced from non-PTH-induced 
hypercalcemia.31 Their accessibility
Table I—Etiology of Hypercalcemia
Excess bone resorption 
Hyperparathyroidism 
Malignant condition 
Producing PTH
Producing other hormonal agents 
Immobilization 
Thyrotoxicosis
Excess absorption from gut
Sarcoidosis (other granulomas) 
Vitamin D intoxication 
? milk-alkali syndrome 
? adrenal insufficiency 
? idiopathic hypercalcemia of infancy
Excess renal reabsorption 
? thiazide diuretics
makes these values useful but they are 
not highly specific. Similarly the renal 
tubular reabsorption of phosphate, 
known to be diminished by PTH, 
suffers from lack of specificity, espe­
cially in view of the finding that hyper­
calcemia, in the absence of PTH, may 
induce phosphaturia.32 The radiologic 
or pathologic demonstration, or both, 
of the pathognomonic skeletal lesion of 
hyperparathyroidism, osteitis fibrosa 
cystica (and especially subperiosteal re­
sorption, a relatively early sign), is ob­
viously helpful when present. However, 
because of the relatively low frequency 
of bone involvement in patients cur­
rently presenting with the disease, these 
signs are often not reliable. The use 
of a 10-day course of corticosteroids33 
in an attempt to suppress hypercalcemia 
has occasionally been useful in dis­
tinguishing PTH-related causes of the 
derangement (in which suppression 
does not occur) from non-PTH-related 
causes (in which suppression of hyper­
calcemia is often observed).
Several newer tests have been intro­
duced as diagnostic aids in distinguish­
ing PTH-related from non-PTH-related 
hypercalcemia. These include measure­
ment of urinary cyclic AMP and the 
radioimmunoassay for PTH. However, 
such measurements are rather difficult 
to obtain partly because special ex­
pertise is required to perform the tests 
and interpret the measurements. The 
measurement of urinary cyclic AMP 
is based upon the identification of this 
nucleotide as an intermediary in the 
mechanism of action of PTH, particu­
larly at the level of the kidney.34 Ex­
cess circulating PTH has been asso­
ciated with increased concentrations 
of urinary cyclic AMP (relative to 
urinary creatinine excretion). However, 
amounts excreted by patients with 
hyperparathyroidism and by normal 
individuals may overlap.35’37 The dis­
crimination of this test might be en­
hanced by measuring specifically uri­
nary cyclic AMP of nephrogenous 
origin (presumably related primarily to 
the action of PTH on the kidney), but 
this would demand associated assay of 
plasma cyclic AMP, an even more 
complex and meticulous process.
The radioimmunoassay for PTH pro­
vides the most specific means of estab­
lishing the diagnosis of hyperparathy­
roidism, yet problems of technique and 
of interpretation persist. Because the 
human hormone for development of 
antisera and use as reagent in the assay 
is not widely available, heterologous 
assays (usually employing antisera to 
bovine PTH) are generally used with 
a consequent lack of maximal sensi­
tivity. A second problem, that of hor­
monal heterogeneity6,17 (Fig. 2), relates 
to the several circulating forms of PTH 
(at least an 84-amino acid form and a
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middle and carboxyl fragment). Be­
cause of this heterogeneity, species of 
the hormone recognized by antisera 
developed in one laboratory may not 
be recognized by those developed in 
another, and consequently different 
“levels” of hormone may be measured 
in the same blood specimen.
PTH concentrations are best inter­
preted in conjunction with simultane­
ous measurement of serum calcium18 
since detectable values of PTH that 
fall within the normal range would be 
considered inappropriately high if the 
serum calcium concentration was 
elevated. Such “normal” concentrations 
of PTH found concomitantly with in­
creased concentrations of serum cal­
cium are indicative of insufficient 
suppression of glandular secretion, con­
sistent with the diagnosis of hyper­
parathyroidism. In contrast with other 
endocrinopathies, formal stimulation or 
suppression tests with measurement of 
hormonal response by radioimmunoas­
say have not generally been helpful. 
In some degree this is owing to the 
continued partial responsiveness of 
many parathyroid adenomas to the 
calcium stimulus. 38,39 Induced hypercal­
cemia (by infusion of calcium) in a pa­
tient with hyperparathyroidism may 
substantially suppress the abnormal 
gland and diminish radioimmunoassay- 
able PTH. On the other hand, induced 
hypocalcemia (by infusion of ethylene- 
diamine tetra-acetic acid) may stimu­
late the gland and augment radioimmu- 
noassayable PTH. Sufficient data are 
not yet available to provide limits for 
normal as opposed to abnormal stimu­
lation or suppression of radioimmuno- 
assayable PTH in formal testing and 
this difficulty is compounded by the 
lack of interlaboratory uniformity of 
PTH radioimmunoassay methods and 
results. Consequently we depend on 
several basal values of PTH in con­
junction with calcium determinations 
to provide sufficient information.
The usefulness of the assay has been 
extended by employing it in conjunc­
tion with selective venous catheteriza­
tion for preoperative localization of 
the site of excess PTH production. 40 
Several other techniques introduced for 
preoperative location of abnormal 
parathyroid tissue, including selenome­
thionine scanning and arteriography, 
have in general been less helpful. The 
technique of selective venous catheteriz­
ation is arduous, requiring the interest 
and experience of a cooperative veno- 
grapher. Catheterization of at least the 
inferior thyroid veins on both sides is 
required, 41 since excessive dilutional 
effects occur when larger veins are 
sampled.
In several centres this technique is 
now reserved for problem cases in 
which hypercalcemia has recurred after
neck exploration and reintervention is 
required. Although most useful in 
these situations, the technique is also 
susceptible to failure because of the 
distorted venous architecture follow­
ing surgery and requires close correla­
tion of the site of sampling with the 
venogram. It should prove particularly 
useful for distinguishing glandular 
from ectopic sites of PTH production.
Therapy
If the underlying cause of the PTH 
excess is an intrinsic defect within 
parathyroid tissue, as may be true in 
the majority of cases of adenoma and 
hyperplasia, then the preferred treat­
ment (in the absence of available me­
dical therapy to diminish “uncon­
trolled” cell growth) is to diminish the 
quantity of hypersecreting tissue by 
excising it. On the other hand, if the 
underlying cause of PTH excess is a 
defect extrinisic to the parathyroid 
cells, as it may be in some cases of 
hyperplasia, then the rational solution 
would be to eliminate the external de­
fect stimulating thei gland; inasmuch 
as no such defect has yet been iden­
tified, the approach here also has been 
to excise excess tissue, although with a 
lower rate of cure. How much tissue 
to excise may be a hard decision in 
view of the difficulties in distinguishing 
modest glandular enlargement from 
normal glands17 and parathyroid ade­
nomas from asymmetrical hyperplasia.
Medical therapy for hyperparathy­
roidism is of limited value. One might 
expect three categories of agents to be 
helpful: those that interfere with hor­
mone release, those that antagonize 
the action of the hormone and those 
that counteract the metabolic disturb­
ances induced by the hormone. To 
date only agents in the last category 
are available, most notably the phos­
phate anion. However, with long-term 
oral phosphate therapy, although hyper­
calcemia may be reduced, PTH secre­
tion continues unabated or even ac­
celerated with the possibility of con­
tinued bone resorption and the danger 
of metastatic calcium deposition. This 
form of therapy therefore is less than 
ideal and is generally employed only 
when the degree of hypercalcemia it­
self represents a threat to the patient’s 
well-being and surgical therapy for 
hyperparathyroidism is absolutely con­
traindicated.
The difficult decision in therapy 
arises in the patients discovered to have 
asymptomatic hypercalcemia as the 
only manifestation of hyperparathy­
roidism. Although prospective studies 
have conclusively demonstrated the 
hazards of other untreated conditions 
not initially recognized by the patients 
and considered to be asymptomatic
(such as prolonged untreated hyperten­
sion), no such studies are currently 
available for patients found to have 
mild elevations of serum calcium. 
Furthermore, it is not certain whether 
hyperparathyroidism with asympto­
matic hypercalcemia represents the 
same disease state as hyperparathyroid­
ism with obvious osseous or renal 
manifestations. Nevertheless where 
such mild hyperparathyroidism has 
been reversed by parathyroid surgery, 
sensitive biochemical and morphologic 
indicators of calcium and skeletal 
homeostasis have been found to im­
prove42 and clinical well-being may be 
enhanced as well, indicating the ben­
efit of the surgery.
The somewhat exacting technical 
requirements of parathyroid surgery 
leave open the question of whether 
or not to intervene in what may be 
a relatively benign disorder.
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SESAP II Question
20. A 42-year-old man had a Billroth II subtotal gastrectomy for duodenal ulcer two years ago. He is now asymp­
tomatic. Laboratory studies disclose the following values: hemoglobin 10.0 gm/100 ml, hematocrit 30 per cent, 
normal leukocyte count and differential. Which of the following studies would be most useful in further evalu­
ating this patient?
(A) Examination of the stool for occult blood
(B) Gastric analysis with test for occult blood
(C) Measurement of prothrombin time
(D) Determination of mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and mean 
corpuscular hemoglobin concentration (MCHC)
(E) Erythrocyte fragility test
For this question select the one answer that is BEST from those noted above.
For the critique of Item 20 see page 329 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus: Surgical Education 
and Self-assessment Program No. 2. For enrolment in the Surgical Education and Self-assessment Program No. 2 
please apply to the American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Surgical Considerations in Hyperparathyroidism:
Current Concepts
M arvin  J. W e x l e r , m d , f r c s [c ], facs
The pathologic and histologic alterations 
seen in the parathyroid glands removed 
at operation have changed drama­
tically in recent years as a result of 
early diagnosis and treatment, often 
in asymptomatic patients. This situation 
has resulted in considerable disagree­
ment over optimal surgical therapy 
and the number of parathyroid glands 
the surgeon should remove. These 
areas of controversy are analysed and 
current concepts critically reviewed.
Les alterations pathologiques et histo- 
logiques retrouvees sur les glandes 
parathyroi'des a la chirurgie ont change 
dramatiquement au cours des dernieres 
annees, resultat d’un diagnostic et 
d'un traitement precoces, souvent 
chez des patients asymptomatiques. 
Cette situation a entraine de serieux 
disaccords en ce qui concerne le 
traitement chirurgical optimal et le 
nombre de glandes parathyroi'des devant 
etre enlevees par le chirurgien. Ces 
sujets controversy sont analyses et 
les notions actuelles sont revues de 
fapon critique.
Surgical interest in the parathyroid 
glands has grown phenomenally since 
1925 when Mandl1 first removed a 
parathyroid tumour from a patient 
with generalized bone disease and hy- 
percalciuria. Once considered rare, 
primary hyperparathyroidism is now 
being diagnosed with greater frequency 
and at an earlier stage as clinicians 
become increasingly aware of its exist­
ence and varied symptomatology, and 
as use of the multichannel autoanalyser 
has become routine in the general 
medical investigation of most patients.2 
The advanced stages of this disease, 
characterized by extensive renal dam­
age or widespread skeletal involvement 
with osteitis fibrosa cystica, multiple 
cysts and brown tumours, are rarely 
seen today. Patients now present with
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minimal or no bone changes and 
it is the discovery of renal calculi that 
generally initiates an investigation for 
hyperparathyroidism. Less commonly, 
patients present with symptoms re­
lating to the gastrointestinal tract, the 
pancreas, or the cardiovascular or ner­
vous systems.3 Accordingly, the histo­
pathologic features of the lesions in 
the parathyroid glands removed at 
operation have also changed notably. 
This situation has given rise to altera­
tion in our pathologic and surgical 
concepts and, more recently, to con­
siderable controversy over the basic 
clinical question: How many parathy­
roid glands should the surgeon remove?
Incidence of Multiglandular Disease
The history of parathyroid surgery 
has followed closely the evolutionary 
pattern of other surgical endocrino- 
pathies such as Cushing’s syndrome, 
pituitary and thyroid disease and hy­
peraldosteronism. The pathologic con­
dition initially suspected was either an 
adenoma or a carcinoma. Later, with 
increased knowledge and earlier diag­
nosis, surgeons recognized that these 
entities were possibly the later phases 
of an initial hyperplasia, so that they 
might expect to find a simple diffuse 
hyperplasia early in the course of the 
disease. Although the water-clear cell 
type of primary hyperplasia of the 
parathyroid was identified by Albright 
and associates in 1934,4 chief cell hy­
perplasia of all four parathyroid glands 
was not described until 1958,5 yet ac­
counted for 25 of the subsequent 100
cases dealt with at the Massachusetts 
General Hospital.3
In the case of a neoplasm, the deci­
sion is simple—one removes the 
tumour, leaving the normal undiseased 
tissue behind. The hyperplasias demand 
more of the surgeon because he has to 
decide how much tissue to resect and 
how much to leave. Complete expo­
sure and identification of each and 
every gland become crucial. The gen­
eral practice in the past has been to 
remove 3 Vi glands in the belief that 
hyperplasia is always a diffuse process 
involving all four glands. Part of the 
most accessible and best vascularized 
gland was left behind to prevent the 
development of hypoparathyroidism.
As can be seen in Table I, the re­
ported frequency of multiglandular 
disease varies considerably, ranging 
from 10% to 65%.6-15 Clearly this is 
a reflection of the inconsistent criteria 
used for distinguishing between nor­
mal tissue, hyperplasia and adenoma. 
Authors who report a 10% to 20% 
frequency of multiglandular disease 
base their diagnoses on gross appear­
ance, size and weight of the glands; 
those who claim rates from 40% to 
65% rely on histologic distinctions 
that at best are less than pathogno­
monic and far from universally ac­
cepted.
Essentially three surgical “philoso­
phies” have evolved and enjoy current 
popularity. All have as their objective 
the removal of abnormal and potential­
ly abnormal tissue without creating 
hypoparathyroidism yet obviating the
Table I—Incidence of Multiglandular Disease in Selected Series
Author
Total 
no. of 
patients
No. with 
multiglandular 
disease, %
Paloyan, Paloyan and Pickleman0 98 65
Muller7 352 50
Haff and Ballinger8 38 50
Esselstyn and colleagues9 100 49
Bruining10 267 45
Block and colleagues11 182 20
Palmer and colleagues12 250 15
Myers13 82 13
Clark, Way and Hunt14 295 12
Davies15 350 10
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necessity for future re-exploration with 
its inherent difficulties. Fundamental 
differences in theories of the patho­
genesis of hyperparathyroidism and 
conflicting data regarding success in 
achieving the stated objectives underlie 
these alternative approaches. These are 
best summarized as follows:
The “Right” Approach
The conservative approach advocates 
that at first only one side of the neck 
should be explored. If one enlarged and 
one normal gland are found on gross 
examination, the “adenoma” is excised 
and the operation terminated. Roth, 
Wang and Potts,16 the principal pro­
ponents of this mode of surgical treat­
ment, offer evidence that: over 80% 
of primary hyperparathyroidism is due 
to a solitary adenoma, excision of 
which results in a very low recurrence 
rate. These workers claim that double 
adenomas, if they ever exist, are very 
rare.17 The coexistence of a grossly en­
larged and a normal-sized gland is 
assumed to refute the diagnosis of 
hyperplasia. In the uncommon event 
of a recurrence in such a circumstance, 
one side of the neck remains for easy 
exploration and a healthy, functioning, 
normal gland remains undisturbed on 
the side originally operated on. Un­
necessary trauma to normal glands is 
avoided and the very real danger of 
permanent hypoparathyroidism asso­
ciated with re-exploration is eliminated. 
If it is necessary to explore both sides, 
clinically enlarged glands can be re­
moved without the need for biopsy of 
apparently normal glands.18
The “Left” Approach
The radical approach, first urged 
and still championed by Paloyan,6'19 
Haff and Ballinger8 and others,20 is 
based upon these workers’ own data, 
which indicate that recurrence of dis­
ease after simple excision of an ade­
noma is frequent, and on the premise 
that hyperparathyroidism is a second­
ary manifestation of chronic extrinsic 
stimulation. Accordingly, prophylactic 
near-total removal of the end organs 
is necessary. In all patients 3 Vi glands 
are excised, leaving 75 to 100 mg of 
well-vascularized glandular tissue. If a 
gland cannot be located, ipsilateral 
thyroid lobectomy and thymectomy are 
performed.
According to proponents of this ap­
proach, gross inspection is unreliable in 
distinguishing normal from abnormal 
tissue and they suggest that the true 
incidence of multiglandular disease is 
high. The pathologist must be supplied 
with sufficient material to permit a 
comparison of the changes in the 
various glands. Finally, this technique 
provides irrefutable proof that the sur­
geon has visualized all glands.
The “Middle” Way
Advocates of a moderate, middle-of- 
the-road, selective approach as repre­
sented by Palmer and associates,12 
Myers13 and Clark, Way and Hunt,14 
argue that persistence rates due to tech­
nically inadequate primary exploration 
are unacceptably high. True recurrence 
rates, due to misinterpretation of dif­
fuse hyperplasia, are low. Therefore, 
an uncompromising effort is made to 
identify all parathyroid tissue, includ­
ing exploration of the common sites of 
ectopic or supernumerary glands as 
Palmer and Sutton advocate in this is­
sue (page 350). Only grossly enlarged 
glands are excised and biopsy of one 
or more seemingly normal glands is 
done for positive identification, but 
routine biopsy of all glands is not per­
formed. This approach, like the more 
conservative one, is also based on the 
belief that one can tell by its appear­
ance whether a gland is abnormal, that 
a gland of normal size does not and 
will not have abnormal secretory func­
tion. This selective surgery is associated 
with a low rate of postoperative hypo­
calcemia.
Four important questions must be 
answered to reconcile these conflicting 
approaches:
•  What is hyperplasia?
•  Is histologic evidence of hyper­
plasia in a normal-sized gland of clinical 
importance?
•  What is the true incidence of 
polyglandular disease and is all multi­
glandular disease hyperplasia?
•  Can the surgeon distinguish be­
tween normal and abnormal glands by 
their gross appearance at operation?
Adenoma versus Hyperplasia
Prior to the general recognition in 
the 1960s of chief cell hyperplasia of 
all four parathyroid glands as a clinical 
entity, most surgeons were content to 
seek and remove only one enlarged 
gland and made little or no attempt 
to determine the status of the remain­
ing normal-appearing glands, or even 
to identify them at all. According to 
some,21 this practice accounted for the 
popular figure of 80% for adenomas 
reported in most series of that time.22 
In an attempt to solve this problem 
Esselstyn and colleagues9 routinely did 
biopsies of all four glands in 100 pa­
tients with primary hyperparathyroid­
ism and subjected the tissue to histo­
logic study. They reported hyperplasia 
in 49% of this group. They rigidly 
defined an adenoma as a “discrete, 
usually diffuse lesion” of a single para­
thyroid gland; the presence of a definite 
rim of normal capsule tended to con­
firm the diagnosis but was not absolute­
ly essential to it. Nonadenomatous 
glands could show no morphologic
evidence of hyperfunction and in cases 
where the cells of two or more glands 
showed evidence of hyperfunction, the 
diagnosis of adenoma was not applied. 
Paloyan, Paloyan and Pickleman6 de­
fined cases of hyperplasia as those in 
which there is either gravimetric and 
histologic evidence of cellular over­
activity in more than one gland, hyper­
plasia alone, an adenoma coexisting 
with hyperplasia, or multiple parathy­
roid adenomas. The mere existence of 
the latter entity is now disputed by 
some.17’23 Clearly, arguments for sur­
gical management based on reported 
rates of multiglandular disease or hy­
perplasia are factitious. It is now rec­
ognized by pathologists that the entire 
spectrum of adenoma, hyperplasia, 
transitional cells and normal histology 
may be present not only in a single pa­
tient, but in some instances in a single 
gland.21
Most pathologists experienced in 
parathyroid histology concede that 
there are few, if any, reliable histologic 
criteria that permit consistent and pre­
cise differentiation between normal 
parathyroid tissue and hyperplasia and 
between hyperplasia and adenoma.11,24’2-> 
Furthermore, the surgeon cannot rely 
on frozen sections of biopsy specimens 
in making the diagnosis; the pathologist 
can do little more than confirm the 
presence of parathyroid tissue.
The concept of an abnormal external 
stimulus bringing about early hyper­
plasia of all parathyroid glands, with 
the later development of an autonomous 
adenoma in one that causes suppres­
sion of the remainder, is undoubtedly 
too simplistic. Primary hyperparathy­
roidism probably represents a collec­
tion of diseases of varied etiology and 
pathogenesis. Abnormal stimuli may 
originate from without and perhaps 
also within a single gland and hyper­
plasia need not be a process affecting 
all four glands (Fig. 1). Whether the 
surgeon can distinguish between nor­
mal and abnormal glands at operation 
is a question difficult to answer. This 
does appear possible from a clinical 
and functional aspect, but cannot be 
done on histologic grounds. Evidence
GLANDS RESPOND
OR MULTIPLE GLANDS
ADENOMAS + FOCAL HYPERPLASIA
FIG. 1—Pathogenesis of hyperparathy­
roidism. Possible interrelation between 
adenoma and hyperplasia.
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continues to mount that microscopic 
hyperplasia in a normal-sized or even 
a suppressed gland is common but of 
no functional importance and of no 
clinical consequence.23,26 Alternatively, 
diagnosing hyperplasia in slightly en­
larged glands without histologic sup­
port can also lead to error owing to 
varying amounts of surrounding fatty 
tissue.
Persistent versus Recurrent
Hyperparathyroidism
From a clinical standpoint, the 
answer to the dispute over how much 
and how many glands to remove lies in 
the outcomes of the various surgical 
approaches. Unfortunately the relevant 
data are imprecise because of the fail­
ure of most surgeons to distinguish 
clearly between persistent disease and 
true recurrence following surgical treat­
ment. This accounts for reported 
“recurrence” rates ranging from 0.4%14 
to 19%.20
Persistent disease is considered by 
most surgeons to represent overlooked 
disease. Recurrent disease, defined as 
return of hypercalcemia at least 6 
months after a period of normocalce- 
mia, implies newly developed patholo­
gic change. Clark, Way and Hunt14 re­
cently summarized all reports in the 
English literature of surgically treated 
hyperparathyroidism since Paloyan and 
colleagues19 first advocated routine pro­
phylactic subtotal parathyroidectomy in 
1969. In this collected series of 3204 
patients, treated by the selective ap­
proach described earlier in which only 
abnormally enlarged parathyroid glands 
were removed, recurrent hyperparathy­
roidism developed in only 24 (0.7%). 
This low figure suggests that true re­
currence is rare, even with a selective 
approach, but persistence may be com­
mon owing to an inadequate primary 
operation. It must be recognized, how­
ever, that most reported series consist 
of retrospective reviews in which fol­
low-up data are incomplete and are 
often based upon an isolated serum 
calcium determination. In reports of 
follow-up studies as long as 15 to 40 
years after operation,12,14,15 patients lost 
to follow-up are infrequently acknowl­
edged and the majority of patients have 
usually been under observation for less 
than 5 years. Even in a recent prospec­
tive study of 198 patients with hyper­
parathyroidism from whom a single 
enlarged gland was removed between 
1968 and 1970 and who were kept un­
der surveillance to the end of 1975, 
25% either died or were lost to follow­
up within 5 years and a further 25% 
were under observation for less than 5 
years.27 Reliable long-term and prospec­
tive follow-up studies with regular 
monitoring of serum calcium and para­
thyroid hormone (PTH) concentrations 
are needed. Recurrences reported 5 to 
15 years after the initial operation are 
not unusual. Monitoring on a regular 
basis, particularly if sensitive PTH as­
says are included, may provide earlier 
evidence for recurrence. It is still pos­
sible that recurrent disease is the result 
of a physiologically insignificant 
amount of hyperfunctioning tissue be­
ing left at the first operation and later 
proliferating to produce eventual re­
currence. As such it represents un­
recognized abnormal tissue and there­
fore persistent disease. However, as 
shown by the data currently available, 
true recurrent disease as distinct from 
persistent disease is relatively uncom­
mon even with the most conservative 
of selective approaches. On this basis, 
there is no support for routine prophy­
lactic subtotal parathyroidectomy ex­
cept in patients with multiple endocrine 
adenomatosis type I, familial hyper­
parathyroidism, or secondary hyper­
parathyroidism in which recurrence 
rates are reported as high as 33% with 
lesser surgery.14 The hypothetical pos­
sibility of producing delayed recur­
rence of hyperparathyroidism from 
eventual autonomy of an overstressed 
remnant remains if we elect routine 
subtotal parathyroidectomy. Total para­
thyroidectomy with auto-transplanta­
tion of tissue to the forearm as de­
scribed by Wells and colleagues28 may 
prove to be the ultimate solution in 
such cases. At present the indications 
for this procedure are unclear.29,30
Unfortunately a recent clinical and 
pathological study of 112 patients re­
quiring parathyroid reoperation17 did 
not distinguish between persistent and 
recurrent disease. Nevertheless, the 
findings supported the concept that 
persistence due to a technically inade­
quate operation and failure to find an 
adenoma is the major problem of post­
operative recurrence rather than mis­
interpretation of diffuse hyperplasia 
and failure to perform routine subtotal 
excision. Of the causes of unsuc­
cessful parathyroid exploration, the 
commonest was the failure of the sur­
geon to be familiar with the normal 
location of the parathyroid glands and 
the way a gland may be displaced when 
diseased. In this series 66 adenomas 
and 7 carcinomas were found. In only 
29 patients was the histology that of 
primary hyperplasia, which had con­
tinued despite excision of one or more 
diseased glands at the initial operation. 
It is also notable that in more than 
half the unsuccessful cases attributed 
to technical incompetence the initial 
diagnosis of parathyroid tissue was 
later revised when, at histologic ex­
amination, the tissue was found to be 
lymph node or fat or thyroid.
Assuming that the surgeon is com­
petent in this area, aberrant locations 
of glands and supernumerary glands 
(fifth or sixth) overlooked at the initial 
exploration are the principal causes of 
reoperation in patients treated accord­
ing to traditional surgical guidelines.30 
Recurrent hyperparathyroidism due to 
enlargement of a parathyroid gland 
previously observed to be normal is 
rarely documented.
Postoperative Hypocalcemia
The biggest argument against routine 
prophylactic subtotal parathyroidecto­
my is the high incidence of postoper­
ative hypocalcemia (13% to 30%) 
reported by some10,18,26,31 compared 
with a negligible incidence (1% to 
4%) when only glands that are en­
larged are removed.10,12,14,28,27 Close 
scrutiny reveals that the high figures 
usually include a group of patients in 
whom the hypocalcemia is transient 
and who are easily treated until suffi­
cient compensation is afforded by the 
remaining tissue. The greater the 
amount of residual tissue, the less the 
likelihood that hypocalcemia will oc­
cur and the faster the recovery if it 
does occur. It is important to caution 
against the overzealous administration 
of calcium during the early postoper­
ative period. This may suppress the re­
maining parathyroid function and 
eventually produce atrophy. Variations 
in the degree of treatment with calcium 
may also account for reported discre­
pancies in different series. Paloyan, 
Paloyan and Pickleman,6 while they 
reported only two instances of hypo­
parathyroidism in 100 patients who 
underwent subtotal parathyroidectomy, 
disregarded this group in which hypo­
calcemia is transient and considered 
only those with permanent hypopara­
thyroidism. In the evaluation of post­
operative calcium problems it is im­
portant to recognize that these are not 
necessarily the result of excision of ex­
cessive amounts of parathyroid tissue. 
They can occur after removal of only 
a single large adenoma, as a result of 
rapid bone absorption of calcium sub­
sequent to removal of the influences of 
excessive PTH. Calcium taken orally is 
usually sufficient to correct symptoms 
and is rarely required for more than 
a few weeks. In a recent study,28 12 
of 50 patients who were operated upon 
by a “radical” surgeon required treat­
ment for symptomatic postoperative 
hypocalcemia. However, only five had 
had a formal subtotal parathyroidec­
tomy; the others had had only one or 
two glands removed and biopsy of a 
varying number of the remaining 
glands. These results suggest that biop­
sy alone may induce postoperative 
hypocalcemia owing to manipulative 
damage, since the incidence was re-
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duced to 2% in a subsequent 50 pa­
tients in whom a conservative approach 
was used and only the enlarged 
gland(s) removed.
As clearly stated by Ballinger,20 the 
crucial question is whether the risk of 
hypocalcemia is greater than the risk 
of leaving hyperfunctioning parathyroid 
tissue in situ with development of in­
sidious nephrocalcinosis and the in­
creased danger of permanent hypocal­
cemia resulting from subsequent ex­
plorations. It would appear that, taken 
in proper context, the risk of either 
eventuality is extraordinarily small. The 
patients at highest risk for the develop­
ment of permanent hypocalcemia are 
those with either previous incomplete 
neck exploration for hyperparathyroid­
ism or previous or concomitant thyro­
idectomy. It is in this latter group that 
parathyroid autotransplantation may 
find its role.
Conclusion
“The success of parathyroid surgery 
must lie in the ability of the surgeon 
to know a parathyroid gland when he 
sees it, to know the distribution of the 
glands, where they hide, and also be 
delicate enough in technic to be able 
to use this knowledge.”3 Resolution of 
the controversy over the frequency of 
recurrent disease is, at least in part, 
dependent on clearly distinguishing it 
from what is actually persistent disease 
and on eliminating the latter as far as 
possible at the primary operation.
The question of whether surgeons, 
even those most experienced in para­
thyroid surgery, can identify a para­
thyroid gland without confirmation by 
biopsy is paramount. Frequently the 
answer must be in the negative.” It 
would therefore appear to be vital to 
visualize all four glands and to do a 
biopsy of all glands that appear normal 
to confirm their identification. This 
can be accomplished easily with iris 
scissors with little apparent damage to 
the residual tissue but with full knowl­
edge, as emphasized by the study of 
Edis and associates,26 that the fre­
quency of postoperative hypocalce­
mia will be increased although it will 
usually be temporary and easily man­
aged. Clearly the major problem is 
that of continued hyperparathyroidism 
where the risk at a subsequent opera­
tion far outweighs the morbidity of 
temporary postoperative hypocalcemia. 
All glands that appear abnormal should 
be removed and weighed by the pa­
thologist after removing extracapsular 
fat; there should be dialogue between 
pathologist and surgeon. Glands with 
a normal gross appearance do not re­
quire excision.
There does appear to be an increas­
ing proportion of patients with what
might be termed a mixed bag of one 
or two grossly enlarged glands sug­
gestive of adenoma, perhaps one nor­
mal-sized gland that is hypercellular 
on biopsy and one gland of normal 
histology.32 This combination is con­
sistent with the pathogenetic concepts 
proposed earlier (Fig. 1). The nature 
and course of these variants remain 
unclarified and it seems necessary to 
relate the gross and microscopic find­
ings of all four glands to a definitive 
approach to surgical treatment and then 
to a long-term follow-up over many 
years. Inclusion of electron microscopy 
may further aid this process.
More pressing problems are the 
course to be followed when one gland 
cannot be definitely located, perhaps 
even after hemithyroidectomy and 
transcervical thymectomy, and the ap­
proach to be taken for recurrent dis­
ease. The ultimate success in the man­
agement of the patient with continuing 
hyperparathyroidism depends upon the 
surgeon. He must know what the ab­
normality is and how to correct it. In 
the hands of an accomplished surgeon 
with detailed knowledge of the numer­
ous anatomical variations of the para­
thyroid glands,33 the success rate is 
high, even without sternotomy. As pre­
viously noted, persistent disease usual­
ly reflects some lack of competence on 
the part of the surgeon at the time of 
the primary operation rather than an 
inability to distinguish between ade­
noma and hyperplasia or to perform 
routine prophylactic subtotal resection. 
A density test recently described by 
Wang and Rieder34 may prove valu­
able in the intraoperative differentia­
tion of primary parathyroid hyperplasia 
from neoplasia and may call for further 
modification of surgical attitudes and 
approaches.
It is important to recognize that an 
adenoma may be located in an ectopic 
fifth parathyroid gland. It is note­
worthy that of 14 patients with medi­
astinal parathyroid tumours reported 
by Scholz and associates,35 5 had pre­
viously had four glands identified in 
the neck. Others612’14,17 have reported 
similar experiences. In such circum­
stances, while removal of a single 
“suspicious” enlarged gland or subtotal 
removal of the normal four may result 
in transient normocalcemia, the remain­
ing tumour will surely declare itself, 
perhaps to be misinterpreted as recur­
rent disease. The periodicity of hyper­
function must also be considered. Light 
may be shed on these concepts and 
controversies by more routine use of 
sensitive assays for PTH. Purnell, 
Scholz and Beahrs27 have measured 
serum PTH values after parathyroidec­
tomy and found that in some patients 
these remained elevated. The impor­
tance of the increased PTH concentra­
tion in the presence of normal serum 
calcium concentration is not certain. 
This subject has been more extensively 
reviewed in this issue of the Journal by 
Goltzman (page 285).
Subtotal parathyroidectomy is man­
datory in patients with multiple endo­
crine adenomatosis, familial hyperpara­
thyroidism, or secondary hyperpara­
thyroidism. If a question of viability or 
sufficiency of residual tissue arises, as 
is often encountered in patients re­
explored for recurrent disease, para­
thyroid tissue should be transplanted 
to the forearm where monitoring and 
subsequent removal can be performed 
if necessary.
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Glimpses of Surgical History: 
V for
Venesection
David A.E. Shephard
Blood has so profound a meaning 
for man that bleeding, both natural 
and accidental or induced (as with 
VENESECTION), early took on 
deep significance. Menstruation sug­
gested that blood could, maybe 
should, be shed periodically; and, 
in a strange twist of sexual be­
haviour, monkish males subjected 
themselves to a regular regimen of 
blood-letting to counter the sup­
posedly harmful effects of accumu­
lation of semen and to help them 
battle fleshly temptation. In other 
realms of Hygeia, the revulsive ef­
fects o f accidental hemorrhage were 
also recognized by primitive people. 
So blood-letting became one o f the 
earliest forms of therapy: as an old 
verse put it, “ It maketh cleane your 
braine, releeves your eie, /  It mends 
your appetite, restoreth sleepe” —  
and evidently much else besides.
We still practice venesection: 
transfusion and autotransfusion re­
quire venesection, and polycythemia, 
hemosiderosis, arterial hypertension 
and pulmonary congestion were 
treated by venesection until quite 
recently. Such treatment seems ra­
tional, very different from that o f 
the barbers o f two or three centuries 
ago who let blood flow freely (the 
red o f the barber’s pole reminds us of 
this) and from that of the owners 
o f "bleeding shops” that people, 
well or ill, visited regularly to be 
“ blooded” or to “ breathe a Vein” . 
To be bled— without medical ad­
vice— was for many an everyday 
custom.
What we consider rational vene­
section did not replace the maniacal 
approach until the mid-19th century. 
The practice o f barbers, bath-keep­
ers and sow-gelders collapsed into 
desuetude only with the rise o f ex­
perimental physiologists like Mag- 
endie and Bernard and with the 
scepticism o f therapeutic nihilists 
like Skoda. As today’s operators 
(and their head-of-the-table col­
leagues) watch for the ebb and flow  
o f blood in a patient “ etherized upon 
a table” , let thought be given to the 
many who laboriously laid the lore 
and learning o f blood over the cen­
turies, so that modern “Surgeons. . . 
trust to the Blooding” in rational 
care of their patients.
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CAGS PAPERS
Clinical Experience with the Newer Hepatobiliary
Radiopharmaceuticals
L. R o s e n t h a l l , m d
Technetium 99m-labelled hepatobiliary 
imaging agents provide high resolution 
images not previously possible with 
rose bengal labelled with iodine 131. 
This has prompted a re-examination of 
the utility of these radioactive phar­
maceuticals. We have found that the 
newer methodology provides a rapid, 
innocuous and accurate means of 
excluding acute cholecystitis from the 
diagnosis in patients with symptoms 
suggestive of this disease and of 
assessing surgically altered biliary 
anatomy. In the presence of moderate 
bilirubinemia, up to about 85.5 to 
103 pmol/L (5 to 6 mg/dL), a definitive 
distinction can be made between 
medical and surgical jaundice.
Les agents de contraste marques au 
technetium 99m servant a la mise en 
evidence des voies hepatobiliaires 
offrent des images a contraste marque 
qui n'etaient pas possibles avec le 
rose bengale marque a I'iode 131.
Ceci nous a incite a re-examiner I’utilite 
de ces produits pharmaceutiques 
radioactifs. Nous avons trouve que la 
nouvelle methodologie offre un moyen 
rapide, nonenvahissant et precis 
d’exclure du diagnostic la cholecystite 
aigue chez les patients ayant des 
symptomes suggerant cette maladie, 
et d’evaluer les modifications chirur- 
gicales de I'anatomie biliaire. En 
presence d’une bilirubinemie moderee 
allant jusqu'a 85.5 a 103 ^mol/L (5 a 6 
mg/dL), une distinction definitive 
peut etre faite entre I'ictere medical 
et I’ictere chirurgical.
From the division oj nuclear medicine, 
The Montreal General Hospital,
Montreal, PQ
Presented at the 1st annual meeting of 
the Canadian Association of General 
Surgeons, Vancouver, BC, Jan. 27, 1978
Reprint requests to: Dr. L. Rosenthall, 
Director, Division of nuclear medicine, 
The Montreal General Hospital,
1650 Cedar Ave., Montreal, PQ H3G 1A4
Rose bengal labelled with iodine 131 
was the standard hepatobiliary imaging 
agent after its introduction in mid- 
1950. The principal limitation of this 
agent is the radionuclide 131I which 
has an 8-day physical half-life, a high- 
energy photon emission that is ineffi­
cient for gamma camera imaging and a 
beta emission that does not contribute 
to the imaging process but rather adds 
unnecessarily to the body radiation- 
absorbed dose. To stay within accept­
able limits of radiation burden the ad­
ministered dose was kept low and this 
resulted in liver and biliary tract 
images of low information density and, 
consequently, poor detail. Technetium 
99m is a radionuclide with the desir­
able physical qualities of being a pure 
gamma emitter and possessing a short 
(6-hour) half-life which aid in delivering 
a low radiation-absorbed dose even 
when administered in millicurie 
amounts. Unfortunately, it has not 
been possible to label the hepatocyte- 
seeking rose bengal with 99mTc. An 
alternative radionuclide is 123I, which 
has physical properties somewhat akin 
to those of 99mTc, but is cyclotron-pro­
duced, expensive and inappropriate 
for general use in the form of a sim­
ple kit.1 A variety of radioactive phar­
maceuticals concentrated by hepato- 
cytes have therefore been developed 
employing the inexpensive and ubi­
quitous 99mTc as the label in millicurie 
doses to provide images of high in­
formation density in short imaging 
times.210 Two of these have undergone 
considerable clinical investigation, 
""Tc-pyridoxylideneglutamate11 and the 
99mTc-labelled N-substituted iminodi­
acetic acid (IDA) derivatives12'14 (Fig. 
1), but the others are still at the ex­
perimental stage. The IDA derivatives 
are believed to possess some advantages 
over pyridoxylideneglutamate,15 but 
both are rapidly concentrated by the 
hepatocytes, and subsequently excreted 
into the biliary tract, gallbladder and 
gut within an hour of intravenous ad­
ministration. The analogues of N-sub- 
stituted IDA vary in their transit time 
through the liver and in the degree of 
renal excretion. 99mTc-dimethyl-IDA 
("'"Tc-dm-IDA) has the most rapid 
transit through the liver, but about 
15 % is excreted by the kidneys; in 
contrast, 99mTc-parabutyl-IDA (99mTc- 
pb-IDA) has a slower hepatic transit 
time and a 2% renal excretion, not 
unlike 131I-rose bengal. The disparate 
properties of these two radioactive 
pharmaceuticals assume importance in 
the presence of hyperbilirubinemia as 
will be shown later.
This review relates our experience 
with 99mTc-dm-IDA, and to a lesser 
extent 99mTc-pb-IDA, in the diagnosis
o
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FIG. 1—Various acetanilide iminodr 
acetic acid (IDA) derivatives.
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of acute and chronic cholecystitis, the 
differential diagnosis of jaundice and 
the assessment of the postsurgical by­
pass pathways of the biliary system.
Technique
Gallbladder Assessment
Food is withheld for 2 hours prior 
to the examination. About 5 mCi of 
99n,Tc-dm-IDA or ""Tc-pb-IDA is in­
jected intravenously and radionuclide 
images are obtained at 15-minute in­
tervals for the first hour until the gall­
bladder is visualized. Nucleographs are 
procured at 30-minute intervals there­
after if necessary. The study is ter­
minated when most of the radiotracer 
is excreted into the gut if the gallblad­
der cannot be visualized.
In the presence of liver disease and 
jaundice the slower excretion of the 
radioactive pharmaceuticals will ex­
tend these temporal relations.
Differentiation of Jaundice and
Determination of Surgically
Altered Anatomy
No food restriction is necessary. 
After an intravenous dose of 5 mCi of 
""Tc-dm-IDA or ""Tc-pb-IDA nu­
cleographs are obtained every 30 min­
utes for the first 4 hours or less if the
diagnosis becomes apparent. In severe 
hepatobiliary disease a 24-hour image 
is obtained to determine whether ex­
cretion into the gut has taken place.
Results and Discussion
Normal Gallbladder
In normal subjects the gallbladder is 
visualized within 30 minutes of the 
intravenous injection of 99mTc-dmTDA 
provided food is withheld for 2 hours 
before the examination. With 99mTc-pb- 
IDA the time to visualization may be 
longer because of its slower transit 
time, but does not exceed 1 hour. En­
try into the gut can be appreciated 
about the same time as the gallbladder 
is visualized or soon after (Fig. 2).
In an earlier study all 43 patients 
with a normal gallbladder as demon­
strated by oral cholecystography and 
the results of routine liver function 
tests (total serum bilirubin, protein, 
transaminase and alkaline phosphatase 
values) showed gallbladder filling on 
the 99mTc-dm-IDA images.16 These pa­
tients did not require cholecystokinin, 
as advocated by others,17 to induce 
emptying of the gallbladder prior to 
administration of the radioactive phar-
FIG. 2— Normal gallbladder. 99mTc-pb-IDA images were obtained at 20, 30 and 
60 minutes. Gallbladder is identified as early as 20 minutes but is more clearly seen at 
30 and 60 minutes (single arrow). Filling of common bile duct (double arrows) and gut 
entry (open arrow) are evident at 60 minutes.
FIG. 3— Acute cholecystitis. Serial
M "Tc-pb-IDA images fail to identify gall­
bladder over 2-hour period of observation. 
Bowel entry is observed as early as 30 
minutes and common bile duct is seen at 
45 minutes and later (arrow).
FIG. 4— Serial 99mTc-dm-IDA images in case of partial extrahepatic biliary ob­
struction in patient with acute pancreatitis. Biliary system is dilated and can be seen 
extending into branches of right and left hepatic ducts. Bowel entry is delayed as it is 
only apparent at 3 hours. Gallbladder is visualized by 1V4 hours and enlarges progres­
sively (arrow), thereby excluding a diagnosis of acute cholecystitis, particularly the 
clinically suspected hydrops.
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maceuticals in order to facilitate vi­
sualization.
Abnormal Gallbladder
Failure to visualize the gallbladder 
in the presence of normal excretion 
into the gut indicates either acute or 
chronic cholecystitis (Fig. 3).
Fig. 5b
FIG. 5— Comparison between images 
obtained using 99l“Tc-dm-IDA and 99mTc- 
pb-IDA in patient with complete obstruc­
tion of common bile duct secondary to 
carcinoma of colon. Serum bilirubin value 
was 205 |emol/L (12 mg/dL). (a) Frontal 
and lateral 99mTc-dm-IDA images at 1.5 
and 24 hours, respectively. There is ex­
ceedingly low liver concentration at 1.5 
hours and complete absence at 24 hours. 
Most is excreted through kidneys. Of in­
cidental note is obstruction of right kidney 
at ureteropelvic junction (arrow), (b) 
Frontal 99mTc-pb-IDA images at 15 and 
75 minutes and at 5 and 24 hours. Much 
greater concentration is registered in liver 
at 15 minutes with less renal excretion 
than of " ”Tc-dm-IDA at 1.5 hours. At 
24 hours liver is well demonstrated and 
there is no appreciable gut entry; only 
kidneys are visualized (arrows). This is 
consistent with complete obstruction.
In one study16 of pathologically and 
surgically proved cases all nine patients 
with acute cholecystitis and seven pa­
tients with chronic cholecystitis and 
cystic duct obstruction failed to show 
concentration by the gallbladder of 
99mTc-dm-IDA. There were an addi­
tional 11 patients with chronic chole­
cystitis and patent cystic duct who did 
not exhibit gallbladder filling with 
99mTc-dm-IDA. The gallbladder in two 
of these patients actually did fill fol­
lowing a 5-minute 100-unit infusion 
of cholecystokinin and a second dose 
of 99n,Tc-dm-IDA. The presence of non­
obstructing stones in the gallbladder 
cannot generally be demonstrated by 
radionuclide imaging.
The conclusions to be drawn from 
our experience with the use of hepa­
tobiliary imaging in patients with sus­
pected disease of the gallbladder are:
(a) nonvisualization of the gallbladder 
after radionuclide injection signals 
either acute or chronic cholecystitis;
(b) radionuclide visualization of the 
gallbladder excludes the presence of 
an obstructed cystic duct. Therefore 
acute cholecystitis can confidently be 
ruled out in patients presenting with 
symptoms suggestive of the diagnosis 
if the gallbladder is visualized. The 
technique is innocuous, noninvasive 
and rapid.
Differentiation of Jaundice
Partial extrahepatic obstruction is 
characterized by a dilated tract and
delayed emptying of the system into 
the bowel (Fig. 4). Activity in the 
bowel without dilatation of the biliary 
tract identifies a jaundice of intra- 
hepatic origin. Failure to detect entry 
of the radionuclide into the bowel 
within a 24-hour period of observation 
establishes a diagnosis consistent with 
complete extrahepatic obstruction pro­
vided the serum bilirubin concentration 
is only moderately elevated. Flowever, 
when the degree of bilirubinemia is 
high, lack of excretion into the gut may 
also be associated with severe hepato­
cellular disease and intrahepatic cho­
lestatic jaundice and the result is no 
longer definitive.
Experience with 99mTc-dm-IDA has 
shown that for serum bilirubin con­
centrations of 85.5 jjlmol/L (5 mg/dL) 
or lower, serial imaging can consistent­
ly distinguish between medical and 
surgical jaundice; in the presence of 
higher concentrations the degree of 
liver uptake of the radioactive phar­
maceutical diminishes rapidly and the 
results are of only qualified value. The 
introduction of 99mTc-pb-IDA with its 
higher degree of liver concentration 
and lesser renal excretion than 99raTc- 
dm-IDA has improved the ability to 
differentiate between medical and sur­
gical jaundice at more elevated values 
of serum bilirubin (Fig. 5). Clinical 
trials with this radioactive pharma­
ceutical are still under way and the 
precise limitations have not been fully 
defined.
FIG. 6— Serial frontal and lateral 
" Tc-dm-IDA images in patient with he- 
patojejunostomy and bilirubinemia o f 34.2 
y.mol/1, (2 m g/dL). Good concentration is 
registered at 15 minutes and gut entry can 
be appreciated by 1 hour. There is no 
evidence of dilated biliary tree, which ex­
cludes obstruction as cause of jaundice. 
Single arrow =  normal transient renal ex­
cretion, double arrow=free end of jejunum.
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Ultrasonography generally plays a 
primary role in evaluating the status 
of the biliary tract. However, in a 
small proportion of cases ultrasono­
graphy does not clearly define the sta­
tus of the biliary tract and the disclo­
sure of dilatation by itself does not 
necessarily imply obstruction, particu­
larly if there has been previous surgical 
intervention. Radionuclide imaging 
helps by providing morphologic and 
dynamic information in these cases.
Determination of Surgically 
Altered Anatomy
The integrity of such operative pro­
cedures as choledochojejunostomy, 
cholecystojejunostomy and hepatojeju- 
nostomy (Fig. 6) can be assessed in 
the presence of moderate jaundice. In­
let and outlet obstructions of gastro­
enterostomies can be disclosed (Fig. 7) 
and intra-abdominal bile spills are 
easily detected (Fig. 8). Hepatobiliary 
imaging in the presence of these con­
ditions offers a unique and noninvasive 
method of investigating the altered and 
disordered anatomy proximal to the 
gastroenterostomy.
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Tantalum Angiography in the Study of Rejection 
of Pulmonary Transplants
M. Goldberg, md, frcs[c], A. Greenaway, b sc, M.I. Steinhardt, md, frcp[c],
S.C. Luk, md, frcp[c] and B. Pollock, b sc
The results obtained in dogs after 
the use of pulmonary allografts from 
donors pretreated with cyclophospha­
mide were compared with those 
obtained after the use of unmodified 
and immunosuppressed grafts.
Tantalum angiography demonstrates 
the pulmonary vasculature in detail to 
precapillary levels. In normal lungs 
a uniform narrowing of vessels occurs 
ending in a fine precapillary rete.
In rejected lungs the finer peripheral 
vessels are occluded by thrombi. 
Parenchymal spaces between medium­
sized vessels are enlarged owing to 
expansion by hemorrhage, congestion 
and mononuclear cell infiltration.
After pretreatment of the donor, the 
angiogram shows a normal appearance 
in the transplant up to 84 days after 
transplantation. The microvasculature 
demonstrates no vasoconstriction, 
thrombus formation or irregularities in 
vessel diameter.
Electron microscopy demonstrates 
persisting vessel integrity until late 
rejection when total disruption 
associated with thrombosis occurs. 
Immunosuppression markedly inhibits 
the early rejection response and donor 
pretreatment almost totally prevents 
it. Tissue disruption and thrombosis 
occur only at the stage of late 
rejection and terminal necrosis.
Les resultats obtenus chez le chien 
avec ('utilisation d’allogreffes pulmo- 
naires provenant de donneurs trades 
a la cyclophosphamide ont ete compares 
avec ceux obtenus avec des greffes 
nonmodifiees et traitees aux immuno- 
suppresseurs.
L'angiographie au tantale demontre 
en detail le systeme vasculaire jusqu’au
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niveau des precapillaires. Dans le 
poumon normal, un retrecissement 
uniforme des vaisseaux survient, se 
terminant en un fin reseau de 
precapillaires. Lorsqu'il y a reaction de 
rejet, les vaisseaux peripheriques les 
plus fins sont obstrues par des thrombi. 
Les espaces parenchymateux entre les 
vaisseaux de moyen calibre sont elargis 
a cause de I'expansion provoquee par 
I'hemorragie, la congestion et I’infil- 
tration de cellules mononuclees. Apres 
traitement du donneur, i'angiogramme 
montre l’apparence normale du greffon 
jusqu'a 84 jours apres la greffe. Les 
vaisseaux microscopiques ne presentent 
aucune vasoconstriction, formation de 
thrombi ou irregularite du diametre 
des vaisseaux.
L’examen au microscope electronique 
demontre la persistance de I’integrite 
vasculaire jusqu’au rejet retarde quand 
une separation des tissus accompagnee 
de thrombose survient. L'immuno- 
suppression inhibe fortement la reponse 
de rejet immediate et le traitement 
du donneur la previent presque totale- 
ment. Le detachement des tissus et la 
thrombose ne surviennent qu’au stade 
du rejet retarde et de la necrose 
terminate.
At present the outstanding problem in 
any transplantation program is ade­
quate abrogation of the induced rejec­
tion response of the allograft. Prolonged 
survival is dependent upon inherent 
histocompatibility, attenuation of re­
jection by selective immunosuppres­
sion, and anticipation and treatment of 
any postoperative complications related 
to technique. Guttman1-3 prolonged 
functional survival in animal and hu­
man renal allografts by pretreatment 
of the cadaver donor kidney with cy­
clophosphamide and methylpredniso- 
lone. Cytotoxic drugs decrease the 
immunogenicity of the graft by inactiv­
ating the donor’s nonparenchymal pas­
senger leukocytes. No agent or com­
bination of agents has consistently in­
hibited the rejection response, but 
donor pretreatment has prolonged his­
tologic integrity and functional sur­
vival as assessed by ventilation and 
perfusion scanning studies in canine 
pulmonary allografts.4
Tantalum angiography has been used 
specifically in experimental hyperacute 
rejection of renal xenografts.5 This new 
radiologic procedure, which uses intra­
arterial injections of tantalum particles, 
was compared with the standard re­
placement method of microphil injec­
tion. Tantalum angiograms vividly il­
lustrated the subtle changes of de­
creased glomerular perfusion. The 
radiologic demonstration of decreased 
numbers of visualized glomeruli corre­
lated with the physiologic, coagulation 
and pathologic studies and indicated 
localized obstruction of the microcir­
culation of the glomerulus by intra­
vascular coagulation. The microphil 
injections into hyperacutely rejected 
kidneys were inferior in demonstrating 
these changes because of their com­
plete filling of the postglomerular vas­
cular bed, including the renal veins. 
With the technique of tantalum angio­
graphy the progressive destruction of 
the glomerular microcirculation demon­
strated that this avascular bed was the 
prime target in the experimental model 
of hyperacute renal xenograft rejec­
tion. Arterial spasm was suggested by 
the segmental narrowing of the arteries 
early in the process of rejection, a fea­
ture that could not be demonstrated by 
microphil injections.
We attempted to correlate, in detail 
previously undescribed, the histologic 
features of abrogation with angio­
graphic changes in the central and 
peripheral vascular bed of a pulmonary 
allograft using the new method of 
tantalum angiography.
Material and Methods
Left lung transplantation was per­
formed in 41 dogs; 14 dogs underwent 
left autotransplantation and 27 under­
went left allotransplantation (7 without 
immunosuppression, 10 with postoper­
ative recipient immunosuppression and 
10 following donor pretreatment and 
with postoperative recipient immuno­
suppression). Immunosuppression was 
induced by postoperative administra­
tion of methylprednisolone (2 mg/kg 
body weight) and azathioprine (1.5 
mg/kg). Pretreated donors received a 
continuous infusion of cyclophospha-
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mide (0.75 g) and methylprednisolone 
(2.0 g) for at least 6 hours prior to 
transplantation.
Lung biopsy specimens were obtained 
either in vivo or after the animal’s 
death. Whole lung specimens were in­
flated with 10% buffered formalin by 
way of the bronchus at pressures rang­
ing from 20 to 30 cm HaO. After 24 
hours’ fixation tissues were dehydrated 
in graded alcohols, then embedded in 
paraffin and sectioned for micro­
scopic study. Sections were stained 
with hematoxylin and eosin. When cir­
cumstances warranted, special staining 
procedures were also employed includ­
ing trichrome, reticulin, periodic acid- 
Schiff and Gram’s staining.
Electron microscopy was performed 
when light microscopy demonstrated 
an entity that warranted further in­
vestigation. For fixation by immersion, 
the lung tissue was cut into 1-mm 
blocks and immersed in cold phos­
phate-buffered 1% osmium tetroxide 
for 1 hour. After dehydration in graded 
alcohols and propylene oxide accord­
ing to the method of Luft,6 the tissue 
blocks were embedded in a mixture of 
epon-araldite.7 Sections were cut with 
glass knives on an ultramicrotome 
(LKB Instruments, Rockville, MD); 
1-/A sections were stained with tolu- 
idine blue. Thin sections for electron 
microscopy were stained with uranyl 
acetate and examined and photographed 
in the Philips electron microscope 
(model EM-301, Philips Electronic, 
Mahwah, NJ).
Tantalum pulmonary angiography 
was used to define minute changes in 
the microvasculature not previously 
identified by other angiographic tech­
niques. The technique was applied to 
both normal and transplanted canine 
lungs. Fifteen grams of tantalum 
(size, 1 jx) was suspended in 30 mL of 
0.9% saline. An effective method of 
obtaining a uniform suspension was 
aggressive manual agitation just prior 
to injection. The animal was killed, 
the lung removed and inflated and the 
bronchus clamped. Experience demon­
strated that no matter how quickly the 
hilar structures were clamped after 
infusion of the pulmonary artery, tan­
talum was able to enter into either an 
alveolar or venous phase, thus destroy­
ing arterial definition. Therefore to 
ensure preferential back-up of tantalum 
in the arterial side of the lung the pul­
monary veins were ligated before in­
jection. The pulmonary artery was 
cannulated and the suspension slowly 
infused until greying became notice­
able over portions of the lung surface, 
at which time the infusion was ter­
minated and the pulmonary artery 
ligated. A water manometer was at­
tached to a T limb of the infusion cir­
cuit to quantify injection pressures and
to ensure that pulmonary artery pres­
sures of 20 mm Hg were not ex­
ceeded.
Two high resolution industrial films 
(Cronex NDT, E.I. DuPont De Ne­
mours Inc., Wilmington, DE), speeds 
65 and 45, offering complementing 
degrees of resolution and penetration 
were used. Lung tissue was placed in 
direct contact with the film and ex­
posed in a “Faxitron” unit. An ex­
posure of 30 kV for 1.5 minutes for 
the canine lung tissue was adequate. 
Films were then developed in the 
automatic processor for 7 minutes at 
31.7°C.
Results of Histologic Studies
A utotrcinsplaritation
Three hours after operation a “re­
implantation response” was identifiable. 
Focal areas of interstitial and alveolar 
edema and a moderate degree of con­
gestion were present. There was neither 
a granulocytic nor a lymphocytic re­
sponse and the bronchial wall distal to 
the anastomosis was intact with no 
ischemic change. Presumably the re­
implantation response is due to oper­
ative trauma, lung ischemia (increased 
pulmonary capillary permeability and 
pulmonary edema), or to a denervation- 
resistance response attributed to out­
flow obstruction of the small veins.810
At 21 days mild peribronchial edema 
was present and fibrin deposition was 
found both in alveoli and in bronchial 
lumina. In both sites the fibrin was ac­
companied by minimal infiltration by
nonspecific inflammatory cells. At 35 
days only patchy focal areas of edema 
in alveoli were present along with com­
pensatory emphysema. There was no 
perivascular or peribronchial lympho­
cytic aggregation.
Electron microscopy beyond 30 days 
demonstrated only a very few focal 
areas of interstitial edema and con­
gestion. Alveolar type I and type II 
pneumocytes and endothelial cells with 
adjacent basement membrane were all 
normal. The remaining portions of 
lung showed no abnormality.
Allotransplantation
Four days after unmodified allo­
transplantation, light microscopy show­
ed both perivascular and peribronchial 
infiltration with mononuclear cells, 
presumably T-lymphocytes (Fig. 1). At 
times the lymphocytic infiltrate was 
predominantly peribronchial with ede­
ma in the perivascular space. Occa­
sionally lymphocytic infiltrates were 
also seen in the alveoli, the bronchi 
and the interstitium. Submucosal edema, 
congestion and mild infiltration by 
mononuclear cells were found at the 
bronchial anastomosis, but no evidence 
of impaired viability or ischemic 
change was demonstrated.
At 7 days the perivascular lympho­
cytic infiltrate became more intense, 
as did the hemorrhage into the alveoli, 
bronchi and interstitium. A fibrinous 
exudate into the alveoli was seen in­
itially and became more pronounced 
with time. There was no desquamation
FIG. 1—Photomicrograph of canine lung 4 days after allotransplantation without 
immunosuppression. Bronchus (B) is cuffed by infiltrates of mononuclear cells (open 
black arrow) which extend through bronchial wall into submucosa. Medium-sized artery 
(A) is surrounded by edema (black arrow) and little cellular infiltrate. Mild congestion 
and edema are present in alveolar septa (S) (hematoxylin and eosin, reduced by 27% 
from X20).
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of any of the alveolar lining cells, nor 
was there evidence of arteritis or vas­
culitis. Thrombosis of vessels was a 
terminal event associated with necro­
sis and total disruption of lung archi­
tecture. In early rejection the leukocyte 
response was predominantly lympho­
cytic but during the necrotic stage at 
7 to 9 days cellular infiltrates were 
mainly polymorphonuclear.
Electron microscopy at 4 days re­
vealed lymphocytes containing active 
cytoplasmic organelle systems. No ab­
normalities were found in either the 
endothelial cells or the adjacent base­
ment membrane. Small lymphocytes 
were present in the interstitial and in­
travascular compartments. Occasional­
ly there was focal disruption of the 
endothelial basement membrane which 
allowed perivascular migration of lym­
phocytes with subsequent interstitial 
infiltration. Lymphoblastic transforma­
tion of T-lymphocytes was readily 
identified in capillaries adjacent to 
endothelial basement membranes. In 
all instances type I and type II pneu-
FIG. 2—Electron micrograph of lung 80 days after allotransplantation and post­
operative immunosuppression. Capillary (C) contains single erythrocyte (R) and is 
lined by normal endothelial cells (white arrow) interconnected by normal electron- 
dense junctions. Adjacent basement membrane (black arrow) and type I pneumocytes 
(open black arrow) lining alveoli (AA) are intact. Representative infiltrative T-lympho- 
cyte (LL) is positioned in mildly edematous interstitial compartment. Architectural 
integrity is present (reduced by 23% from X4500).
mocytes remained intact; there was no 
baring of the basement membranes 
and no generalized disruption of the 
endothelium (Fig. 2). Seven days after 
operation there were more extensive 
areas of intra-alveolar and interstitial 
hemorrhage, severe congestion and 
edema. At this stage there was dis­
ruption of basement membranes and 
lung architecture (hemorrhagic necro­
sis). The mononuclear cell infiltration 
became less conspicuous and was re­
placed by an infiltrate of polymorpho­
nuclear cells and macrophages that 
were actively consuming debris and 
erythrocytes.
In cases of allotransplantation with 
postoperative immunosuppression light 
microscopy suggested the entire spec­
trum of acute rejection described above 
but the period over which these changes 
occurred was greatly prolonged. The 
degree of response, as estimated by the 
absolute number or volume of lym­
phocytes, was depressed at any ar­
bitrary time postoperatively when com­
pared with the unabrogated response.
End-stage infections and sudden ter­
minal venous thrombosis were com­
monly seen in the immunosuppressed 
animals. The rejection response identi­
fied by electron microscopy was simi­
lar to the unabrogated response but 
the period over which these changes 
occurred was prolonged. When acute 
rejection was present the alveolar type 
I and type II pneumocytes, endothelial 
cells and basement membranes were all 
intact. It was only in the end stage of 
necrosis that changes in these and all 
other structures were present.
In allotransplantation with postoper­
ative immunosuppression and donor 
pretreatment light and electron micro­
scopy demonstrated an even greater 
abrogation of the rejection response 
than in the other two groups. Appear­
ances in light and electron photomicro­
graphs were entirely within normal 
limits in most long-term survivors. 
The findings of light and electron mi­
croscopy identify neither the lung’s 
antigenic stimulus, which elicits the cel­
lular response, nor the target organ or 
organelle to which the T-lymphocytes 
react.
Results of Angiographic Studies
A normal angiographic pattern was
FIG. 3—Tantalum angiogram of canine 
lung 68 days after allotransplantation and 
postoperative immunosuppression with pre- 
treatment of donor. Normal asymmetrical 
dichotomous arterial branching pattern is 
illustrated to sixth generation (precapil­
lary) levels with total patency and normal, 
uniform tapering. No attenuation of or en­
croachment upon peripheral precapillary 
branches and no intraluminal filling de­
fects are present.
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identified in autografts and allografts 
with abrogated rejection responses. An 
asymmetrical dichotomous arterial 
branching pattern was visualized to the 
sixth generation, with total patency 
and normal uniform tapering and 
branching patterns. No distortion of or 
encroachment on peripheral precapil­
lary branches and no intraluminal fill­
ing defects were present (Fig. 3).
With rejection the vasculature 
showed a loss of normal tapering of 
various arterial and arteriolar branches 
coupled with multiple filling defects 
representing thrombus formation. The 
absolute number of branches also 
diminished and there was visualization 
only to the fourth generation, produc­
ing the typical appearance of a 
“pruned tree”. These changes may be 
asymmetrical since various portions of 
the allograft may be rejected at dif­
ferent rates, thus producing a range 
of histologic and angiographic changes 
in any one allograft (Figs. 4 and 5).
When rejection was at its end stage, 
multiple filling defects representing 
thrombus formation occurred in all the 
visualized branches. There was filling 
to second generation arteries produc­
ing a complete pruned tree appearance. 
These branches showed irregular and 
ragged intimal surfaces and loss of 
normal tapering. The lung parenchyma 
demonstrated total consolidation with 
parenchymal infiltration encroaching 
on the smaller arteries and arterioles 
which, together with the intraluminal 
thrombus formation, prevented distal 
filling of the pulmonary vascular tree 
(Fig. 6).
Discussion
Most methods of graft immunosup­
pression inhibit the sensitization phases 
of the afferent arc, or the effector 
phases of the efferent arc, of the im­
mune response. Results depend upon 
depression or inactivation of sensitized 
lymphocytes and plasma cells. The 
exact mechanisms by which immuno­
suppressive therapy acts upon both the 
cellular and humoral phases of im­
munity have not yet been determined.
In canine pulmonary allotransplant­
ation, immunosuppression has been 
effected by methotrexate alone,11'12 
methotrexate in combination with 
other agents,13,14 azathioprine alone1518 
and azathioprine and methylpredniso- 
lone.14'19’20 Cyclophosphamide and acti- 
nomycin C can also markedly alter the 
immune response. Pretreatment of the 
donor with cyclophosphamide and 
methylprednisolone has prolonged his­
tologic integrity and functional survival 
in canine pulmonary allografts when 
compared with other immunosuppres­
sive regimens.4 This effect is caused 
by a reduction in graft immunogenicity
following the destruction of nonparen- 
chymal cells of hemopoietic origin 
(mobile passenger leukocytes), which 
are the stimulus of allograft immunity 
and possibly the targets for certain ef­
fector mechanisms.
The pathogenesis of allograft rejec­
tion of the canine lung remains con­
troversial and our results differ some­
what from those generally described. 
Three phases of rejection have been 
described: alveolar, vascular and ne­
crotic. The alveolar phase, occurring 
2 to 3 days postoperatively, is charac­
terized by a fibrinous exudate into al­
veoli, with swelling of type I pneumo- 
cytes followed promptly by their dis­
solution. The vascular or cellular phase, 
occurring 2 to 5 days postoperatively, 
is characterized by segmental peripheral 
arteriolar narrowing due to perivascular 
cuffing by mononuclear cells, endo­
thelial swelling and intimal hyperpla­
sia. Platelet thrombi occur late in this 
phase, well after vascular obstruction 
is visualized angiographically. The final 
necrotic phase is a consummation of 
the first two phases, with further archi­
tectural disruption and supervening in­
fection.2*-22
Our findings suggest that architec­
tural integrity of the lung persists until
FIG. 4—Tantalum angiogram of lung 7 
days after allotransplantation and post­
operative immunosuppression in pre­
treated donor. Vasculature of upper 
half of the lung (black arrow) is normal. 
Arteries of lower half (open white arrow) 
show loss of uniform tapering, and several 
filling defects representing thrombus 
formation are present intraluminally. Ab­
solute number of branches is diminished 
and filling occurs to fourth generation 
branches (“pruned tree” appearance).
terminal necrosis occurs irrespective of 
the presence or absence of infection. 
No histologic changes have been seen 
on light or electron microscopy in type 
I and type II pneumocytes, in endo­
thelium, or in basement membranes un­
til the final necrotic event produces 
rapid and total parenchymal dissolu­
tion. Acute and chronic rejection dif­
fer only in the quantity of T-lympho-
FIG. 5— Magnification of angiogram 
of Fig. 4 in area of rejection. Thrombi 
are present (white arrows) in both major 
and minor arteries. Loss of regular taper­
ing (open white arrow) occurs and pre- 
capillary vasculature is compromised cre­
ating pruned tree appearance.
FIG. 6— Tantalum angiogram of lung 9 
days after allotransplantation without im­
munosuppression. At final stage of rejec­
tion, many filling defects representing 
thrombus formation are present in all 
visualized branches. Filling to only sec­
ond generation branches produces com- 
ulete pruned tree appearance. Arteries 
have irregular and ragged intimal surfaces 
and abnormal tapering. Lung parenchyma 
shows consolidation (CN) with paren­
chymal infiltration encroaching upon 
smaller arteries and arterioles which, to­
gether with thrombus, prevents distal 
perfusion.
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cytes present in a unit of lung volume.
Tantalum, a radiopaque transitional 
metal that is physiologically inert, 
can be injected intravenously into labo­
ratory animals and selectively depos­
ited on injured vascular endothelium.23 
Particles of tantalum show virtually no 
tendency to attach to normal or grow­
ing vessels or to leak from capillaries 
or from small venules. Following in­
jury, however, tantalum adheres to the 
endothelial wall or to formed elements 
and appears to be transported by cir­
culating phagocytic cells. Tantalum 
particles are easily visible in capillary 
beds in vivo and in histologic sections 
prepared for light or electron micro­
scopy. Intravenously injected tantalum 
particles are useful in identifying a 
variety of vascular abnormalities in 
large vessels and in the peripheral mi­
crocirculation.
Conventional pulmonary angiography 
using radiopaque fluids has been 
performed at varying stages after lung 
transplantation in order to demon­
strate any abnormalities that may sug­
gest the pathogenesis of rejection. Two 
days after transplantation the angio­
gram demonstrated a normal pattern, 
that is, a venous appearance time of 
less than 2 seconds, an arterial phase of 
less than 3 seconds and a normal vas­
cular pattern. After 6 days the pul­
monary transit times increased during 
the arterial phase (3 to 5 seconds) and 
there was a delayed venous filling 
time. The vascular pattern became ab­
normal as evidenced by terminal arte­
riolar non-filling after more than 1 
minute. During chronic rejection there 
occurred a retrograde progressive 
obliteration of the pulmonary tree.20,24’26 
Conventional angiography is useful 
only in detecting the cause of impaired 
perfusion in a transplanted lung but in 
no way casts light on the more detailed 
and intricate pathogenesis of the de­
crease in perfusion.
Correlated histologic and angiogra­
phic data in our study suggest several 
novel concepts. Rejection may progress 
at different rates in various portions of 
the allograft and at any one time a 
range of events can be identified. 
Electron microscopy has been valuable 
in showing that previously suggested 
target organs (endothelium, basement 
membrane, pneumocytes) remain intact 
during rejection which is only identi­
fied by a progressive increase in the 
volume and number of infiltrative 
lymphocytes. As infiltrates increase, 
the interstitium becomes expanded and 
encroaches upon arteries producing 
progressive obliteration of the peri­
pheral microcirculation. T-lymphocytes 
produce thrombokinins and perhaps 
when they reach a certain titre (de­
pendent upon total numbers) acute 
thrombosis occurs. At this end stage
necrosis and disruption of parenchy­
mal architecture results from sudden 
thrombosis in all arteries.
We thank Mrs. Cathy Bennett for 
typing the manuscript.
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Recurrent Duodenal Ulcer
D a n iel  T asse, m d , f r c s [c ], L o u ise  C h o in ie r e , m d , 
St e p h e n  M organ , m d , f r c s [c ] and D en is  B ernard , m d , f r c s [c ]
In the past 6 years 26 patients 
underwent operation for recurrent 
duodenal ulcer after what was 
considered to be an “adequate" initial 
operation. In such patients it is 
necessary first to demonstrate the 
recurrent ulcer and then to determine 
its cause. Endoscopy was the best 
means of confirming the diagnosis. The 
cause of recurrence was determined 
by tests for gastric acid secretion; 
70% of patients had hyperacidity and 
80% had positive results of the 
Hollander test. Treatment is always 
surgical but varies depending on the 
type of initial surgery, the primary 
cause of recurrence and the condition 
of the patient. Ten patients underwent 
vagotomy, 12 had vagotomy with 
antrectomy and 4 had antrectomy alone. 
There were no operative deaths but 
nine (35%) patients experienced 11 
significant postoperative complications.
Vingt-six malades ont ete reoperes 
au cours des 6 dernieres annees pour 
recidive d’ulcere duodenal. Chez ces 
malades il faut d’abord faire la preuve 
de la recidive et en etablir la cause. 
L’endoscopie est le meilleur moyen 
diagnostic. Par la suite la recherche 
de la cause se fait a I'aide des tests 
de stimulation gastrique; 70% ont 
demontre une hyperacidite et 80% un 
Hollander positif. Le traitement a 
toujours ete chirurgical mais varia 
selon le type de chirurgie initiate, la 
cause premiere de recidive et I'etat 
du patient. Dix malades ont subi une 
vagotomie seule dont 6 par voie 
thoracique, 12 une vagotomie avec 
antrectomie et 4 une antrectomie. 
Aucune mortality operatoire n’est 
rapportee mais neuf (35%) malades 
ont eprouve 11 complications postope- 
ratoires significatives.
From the department of surgery, 
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Presented at the 1st annual meeting of the 
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Recurrent ulceration following “ade­
quate” surgical treatment of duodenal 
ulcer still represents a major challenge 
for the surgeon. Not only does he have 
to determine the cause of the recur­
rence, but he must also treat each pa­
tient by the means least likely to lead 
to further recurrence and associated 
with the least morbidity and mortality. 
We report our experience in the man­
agement of the condition accumulated 
over a period of 6 years.
Patients and Methods
Between Apr. 1, 1971 and Mar. 31, 
1977, we treated 26 consecutive pa­
tients with demonstrated recurrent ulcer 
following what is generally considered 
“adequate” surgical treatment of duo­
denal ulcer (Table I). In this retro­
spective study we excluded patients
Table I—Distribution of Recurrences
According to the Type of Primary Operation
Primary operation
No. of 
patients 
(and %)
Truncal vagotomy and
pyloroplasty 13 (50.0)
Truncal vagotomy and
gastroduodenostomy 1 (3.8)
Truncal vagotomy and
gastrojejunostomy 1 (3.8)
Selective vagotomy and
pyloroplasty 6 (23.1)
Truncal vagotomy and antrectomy
(Billroth 1) 1 (3.8)
Partial gastrectomy (Billroth II) 4 (15.4)
Total 26 (100.0)
Table II—Time Interval between Operations 
in Patients with Recurrent Ulcer
Interval, yr
No. of 
patients 
(and % )
<  1 4 (15.4)
1 5 (19.2)
2 4 (15.4)
3 3 (11.5)
4 1 (3.8)
5 2 (7.7)
>  5 7 (26.9)
Total 26 (100.0)
who underwent simple suture and epi- 
plooplasty for perforation or gastro­
enterostomy without vagotomy, patients 
with stomal ulcers that developed after 
a procedure not primarily directed to 
an ulcer, such as a pancreaticoduo­
denectomy, and patients with recurrent 
ulcer after surgery for a primary gas­
tric ulcer.
Our series comprised 22 men and 4 
women with an average age of 44 
years (range, 23 to 69 years). Almost 
two thirds belonged to type O blood 
group which is similar to the usual 
frequency of that blood group in pa­
tients with duodenal ulcer. The dura­
tion of the symptoms varied widely 
from 2 months to 14 years. Symptoms 
tended to reappear early following the 
primary operation; more than two 
thirds of the patients became symp­
tomatic within 2 years. Patients gen­
erally sought medical advice without 
delay when their symptoms recurred. 
Seventy percent underwent repeat op­
erations less than 1 year after recur­
rence of symptoms and altogether 
61.5% of the patients underwent a 
second operation within 3 years of the 
first one (Table II). In only 6 of the 
26 patients was the initial operation 
performed as an emergency procedure, 
in 2 for hemorrhage and in 4 for per­
foration. The site of the recurrence 
varied widely according to the type of 
initial surgery (Table III). Pain was
Table III—Distribution of Recurrences 
According to Anatomical Site
No. of
Site patients
Duodenal 8
Pyloric 4*
Prepyloric 7
Antral 2 *
Stomal
Billroth 1 1
Billroth II 4
Gastrojejunostomy 1
Total 27
*1 patient had 2 ulcers.
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the most frequent complaint (88%), 
followed by hemorrhage (42%), ob­
structive symptoms (15%) and per­
foration (3.8%). Recurrent ulceration 
had a deleterious effect on nutri­
tional status; 10 (38%) patients lost 
from 2.25 to more than 9.07 kg.
We attempted first to demonstrate 
the ulcer and then to determine its 
cause. Roentgenography after a barium 
meal revealed an ulcer in 76% of 
the cases in which it was done. En­
doscopy was diagnostic in 90% of 
cases. While endoscopy showed a re­
current ulcer in five patients whose 
roentgenogram was normal, it could 
not demonstrate an ulcer in one patient 
whose roentgenogram had previously 
been positive and also overlooked an 
ulcer on the lesser curve which had 
been seen on the roentgenogram and 
was confirmed at operation. The 
etiology of the recurrences was deter­
mined by gastric acid secretion tests: 
basal acid output (BAO) and maximal 
acid output (MAO) after pentagastrin 
stimulation, by the Hollander test and 
by the serum gastrin concentrations. 
For circumstantial reasons, all these 
studies were not done in every patient. 
The Hollander test showed that the 
vagotomy performed in 20 patients 
had been incomplete in 16. The 
serum gastrin concentration was nor­
Table IV — Distribution of Recurrences in 
Relation to Gastric Acid Output (nm ol/s)
Gastric acid output, 
innol/s (m eq /h )
No. of
recurrences
Basal acid output
<  0.8 (3.0) 3
>  0.8 (3.0) 11
Maximal acid output
<  5.6 (20.0) 5
>  5.6 (20.0) 8
mal in 12 of the 13 patients in whom 
it was determined. One patient, after 
a subtotal Billroth II gastrectomy, had 
a baseline gastrin value of 442 ng/L, 
leading us to suspect the presence of a 
gastrinoma. No gastrinoma was found 
and she was asymptomatic 18 months 
following vagotomy. Results of gastric 
secretion tests are shown in Table IV; 
70% of patients had hypersecretion.
Treatment and Complications
All patients with a recurrent ulcer 
following adequate surgical treatment 
underwent a second operation. The 
type of surgery performed took into 
consideration the following: (a) the 
nature of the primary operation, (b) 
the probable cause of recurrence, and 
(c) the patient’s general condition. Ta­
ble V lists the various secondary opera­
tions performed in relation to the 
primary procedures. Ten patients had 
vagotomy alone, 12 had vagotomy and 
antrectomy and 4 had antrectomy 
alone. All vagotomies were of the 
truncal variety; in 6 a thoracic ap­
proach was used. We had no 30-day 
operative mortality but morbidity was 
high. Nine (35%) patients had 11 se­
rious complications (Table VI); six pa­
tients had complications after antrec­
tomy and three after thoracotomy.
Discussion
Recurrent ulceration is the most 
frequent complication that requires a 
second operation following surgical 
treatment of duodenal ulcer. The wide 
variety of procedures still used to cure 
duodenal ulcer indicates that no single 
operation is without failure. In a ran­
domized study, Postlethwait1 deter­
mined the 5-year recurrence rate fol­
lowing vagotomy and drainage (6.2%), 
vagotomy and antrectomy (0.7%), 
vagotomy and hemigastrectomy (0.9%) 
and subtotal gastrectomy (3.7%) for 
treatment of duodenal ulcer. These re­
sults are comparable to those reported 
by Goligher and colleagues.2 The newer 
procedure of highly selective vagotomy 
also has a recurrence rate of 6% to 
7% as the duration of follow-up in­
creases.3'8
In our retrospective study, most of 
the findings were comparable to those 
recently reported.9'14 Recurrent ulcers 
occurred more commonly in men in 
a proportion of five to one. The latent 
period was short (less than 2 years in 
66%) and so was the symptomatic pe-
Table V I— Postoperative Complications in Relation to Type of Surgery*
Complication Type of surgery
Pulmonary atelectasis Antrectomy (B illro th  I I )
Repeat vagotomy, thoracic approach (2 patients)
Pulmonary atelectasis and pancreatitis Antrectomy (B illro th  1)
Gastric atony and retention Repeat vagotomy and antrectom y 
(B illro th  1) (2 patients)
Gastric hemorrhage and dysphagia Vagotomy, thoracic approach
Duodenal fistula Repeat vagotomy and antrectomy 
(B illro th  I I )
Subphrenic abscess Antrectomy (B illro th  I I )  
(catheter duodenostomy)
*There were 11 complications in 9 patients.
Table V— Surgical Treatm ent in Relation to the Prim ary Procedure
Second operation First operation, no. of patients
No. of patients Procedure TV +  P TV +  Jab TV +  GE S V +  P TV +  A (B l) PG (B ll)  Total
10 ReV— thoracic approach 2 1 2 — ___ 5
abdominal approach 1 —  — — 1 — 2
V— thoracic approach ___ ___ _ ___ ___ 1 1
abdominal approach — —  --- — — 2 2
12 ReV - f  A— Billroth 1 6 ___ ___ 1 __ ___ 7
Billroth  II 1 —  — 3 — — 4
V +  A—Billroth 1 __ __  ___ ___ ___ _ 0
Billroth  II — —  — — — 1 1
4 A— Billroth 1 2 __  ___ __ ___ _ 2
Billroth II 1 —  1 — — — 2
Total 13 1 1 6 1 4 26
ReV =  repeat vagotomy, V =  vagotomy, A =  antrectom y, TV = truncal vagotomy, P =  pyloroplasty, Jab = Jaboulay gastroduodenostomy, GE =  gas-
troenterostomy, SV =  selective vagotomy, Bl = B illro th  1, PG == partial gastrectomy, B ll =  B illro th  II .
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riod (less than 1 year in 70%). Further­
more, 60% of the patients were re­
operated on within 3 years of their 
initial operation. Our patient popula­
tion was relatively young (average age, 
44 years) and 66% belonged to blood 
group O. That the primary procedure 
was done as an emergency does not 
explain a recurrence, for 77% of our 
patients had an elective primary opera­
tion.
Endoscopy is the best way to dem­
onstrate a recurrence. It should be 
performed in any case in which recur­
rence is suspected but not demon­
strated by roentgenography. Interpreta­
tion of the roentgenogram after a 
barium meal is often misleading after 
any operation for duodenal ulcer ex­
cept parietal-cell vagotomy. Even when 
the roentgenogram is positive, endo­
scopy still provides useful information. 
For instance, it is the only means of 
demonstrating esophagitis or biliary 
gastritis, and the finding of a con­
comitant disease can change the sur­
gical approach.
Most (80%) of the recurrent ulcers 
occurred after vagotomy and a drain­
age procedure. This is in accordance 
with the findings of others.1,4 In 
our series the main factor in producing 
most of such recurrences was failure 
to achieve a complete vagotomy14 as 
shown by a positive Hollander test in 
80% of the patients in which it was 
done. Although a positive Hollander 
test indicating incomplete vagotomy 
does not mean that a duodenal ulcer 
is sure to recur, we find it valuable in 
determining the cause of a proven 
recurrence. Four of our patients with 
a negative Hollander test after vago­
tomy and drainage were explored 
through the abdomen for residual 
vagal fibres. In one patient an intact 
posterior vagal trunk was found. In all 
four patients, antrectomy was per­
formed. In the presence of a negative 
Hollander test and high basal acid se­
cretion, one should still suspect incom­
plete vagotomy.
Serum gastrin was determined in 
half of our patients. Fasting and 45- 
minute postprandial concentrations 
were not elevated enough to cause 
suspicion of Zollinger-Ellison syndrome 
or a G-cell hyperplasia in any patient. 
When a high gastrin concentration is 
found, investigation by secretin and 
calcium perfusion tests is called for. 
We have yet to discover our first gas­
trinoma.
The selection of the proper proce­
dure for the second operation is deter­
mined by the nature of the first, the 
suspected cause of recurrence and the 
general condition of the patient. Other 
factors can also modify surgical plan­
ning, namely, several previous ab­
dominal operations, obesity, advanced
age and concomitant abdominal dis­
ease. Every patient in whom an incom­
plete vagotomy is suspected should 
have at least repeat vagotomy as part 
of the treatment. For recurrence after 
vagotomy and drainage when there is 
a normal serum gastrin concentration, 
transthoracic vagotomy is our proce­
dure of choice when there is no ob­
struction, hemorrhage, or perforation.15 
It is most helpful in obese patients. 
Should there be a further recurrence, 
antrectomy could then be performed 
and would not be as difficult as if it 
were done as a tertiary abdominal 
procedure. The abdominal approach is 
mandatory for patients after vagotomy 
and drainage when there is obstruction, 
perforation or hemorrhage, marked hy­
persecretion, a suspicion of G-cell hy­
perplasia or concomitant abdominal 
disease. In any of these circumstances 
the procedure should be the most 
definitive available, namely, repeat 
vagotomy and antrectomy. This com­
bination still offers the lowest known 
rate of recurrence in most centres.
If the first operation was gastric re­
section without vagotomy, then vago­
tomy should be performed. If antral 
exclusion and Zollinger-Ellison syn­
drome are not suspected and there are 
no complications of the ulcer, the 
thoracic approach may be selected.
If recurrence follows vagotomy and 
antrectomy, one should highly suspect 
a gastrinoma or antral exclusion after 
a Billroth II reconstruction. Examina­
tion of a frozen section of a duodenal 
biopsy specimen during the primary 
operation assures prevention of the 
latter. Even in the absence of hyper- 
gastrinemia, surgery should be per­
formed using an abdominal approach 
to explore the pancreas, liver, stomach 
and duodenum. If such an exploration 
discovers no abnormality repeat vago­
tomy can then be performed.
We used antrectomy alone in the 
patients with a negative Hollander test 
and normal gastric acid secretion. In 
these cases, we still dissected the eso­
phageal hiatus to make sure that no 
vagal fibres remained. Even though 
antrectomy “protects” against incom­
plete vagotomy,13 exploration of the 
hiatus does not add to the morbidity, 
and making sure that the vagotomy is 
complete lessens the possibility of re­
currence after vagotomy and antrec­
tomy.
Most of our patients (21 of 26) were 
reoperated on in the past 3 years. Our 
follow-up is therefore short but in­
cludes 24 of the 26 patients. As yet 
there has been no known or suspected 
recurrence. The 30-day operative mor­
tality was zero.
Conclusion
If a given percentage of recurrence
following operation for duodenal ulcer 
is predictable, subsequent surgical 
treatment should aim at preventing any 
further recurrence while incurring the 
least morbidity and mortality. Thor­
ough investigation is necessary to make 
an accurate diagnosis of recurrence 
and to determine its cause as pre­
cisely as possible. Attention should be 
directed not only to the completeness 
of the vagotomy but also to its efficacy. 
Endocrine-secreting tumours should be 
sought. The single common denomina­
tor of all the recurrences is insufficient 
primary treatment—gastric resection 
without vagotomy, incomplete vago­
tomy, overlooked endocrine-secreting 
tumour, or too limited surgery (e.g., 
vagotomy and drainage) for virulent 
duodenal ulcer disease.
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Immunologic
The prevalence of carcinoma of the 
pancreas is increasing in North 
America. Primary prevention of this 
disorder is not yet possible and 
secondary prevention is difficult 
because most investigative procedures 
are either highly invasive or not 
universally available. The authors tested 
the efficacy of a simple immunologic 
assay, the leukocyte adherence 
inhibition (LAI) assay, in the detection 
of carcinoma of the pancreas. They 
investigated 55 patients who were 
divided into six groups— normal 
(control) patients (16) and those with 
carcinoma of the pancreas (9 patients), 
pancreatitis (15), other intra-abdominal 
carcinomas (9), obstructive jaundice (4) 
and pancreatic pseudocysts (2). The 
LAI assay proved highly effective in 
selecting patients who, at surgery, 
were shown to have carcinoma of 
the pancreas, but was not as effective 
in the other groups. This assay may 
therefore prove valuable in the early 
evaluation of patients with a suspected 
pancreatic malignant condition.
La frequence des carcinomes du 
pancreas est en augmentation en 
Amerique du Nord. La prevention 
primaire de cette affection n'est pas 
encore possible et la prevention 
secondaire est difficile car la piupart 
des techniques exploratrices sont ou 
tres envahissantes, ou pas generalement 
disponibles. Les auteurs ont teste 
I'efficacite d'un essai immunologique 
simple, le test d'inhibition de I'adherence 
des leucocytes (IAL), pour la detection 
du carcinome du pancreas. Ils ont 
examine 55 patients se repartissant en 
six groupes: les patients normaux 
(groupe temoin) (16) et ceux souffrant 
d'un carcinome du pancreas (9), de 
pancreatite (15), d'autres carcinomes 
intra-abdominaux (9), d’ictere par 
retention (4) et de pseudokystes
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Detection of Primary Carcinoma 
of the Pancreas
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pancreatiques (2). L'epreuve d'lAL s’est 
averee tres efficace pour selectionner 
les patients qui, a la chirurgie, ont 
presente un carcinome du pancreas, 
mais elle ne s’est pas montree aussi 
efficace pour les autres groupes. Cette 
epreuve peut done etre utile a 
revaluation precoce des patients chez 
qui Ton soupconne une atteinte maligne 
du pancreas.
The prevalence of carcinoma of the 
pancreas is reported to be increasing in North America.1,2 This entity is now 
reported to be the fourth most common cause of death due to cancer, being exceeded only by carcinoma of the lung, colon and rectum, and breast.3 
Most patients who suffer from carci­noma of the pancreas die within 6 
months of the diagnosis having been made. The mortality, therefore, very 
closely parallels the incidence.Improved methods for early diag­nosis of this fatal condition are clearly required. Many of the newer tests such as selective angiography, endoscopic retrograde pancreatography and com­puterized tomography are either in­
vasive, technically difficult or not uni­versally available. Such tests are not indicated in the evaluation of patients with minimal symptoms.In 1972 Halliday and Miller4 de­
scribed a simple technique for the in- vitro determination of cell-mediated 
immunity to tumours. They demon­
strated that the normal adherence of immune leukocytes on a glass surface could be inhibited by the presence of the specific antigen. This means of in­
vestigation was called the leukocyte adherence inhibition (LAI) assay. 
Numerous modifications have been de­scribed.5'8 In our laboratory, we have adopted the tube LAI assay as de­scribed by Grosser and Thomson.5 The present communication reports pre­liminary data on the diagnosis of car­cinoma of the pancreas using this assay.
Patients and Methods
Patients were referred for study if they were suspected of having carci­noma of the pancreas on the basis of weight loss, epigastric pain, jaundice, or an abnormality evident in contrast 
studies of the stomach and duodenum. Patients with other pancreatic disorders
were also assessed, as were a number of normal individuals and a few pa­tients with obstructive jaundice due to 
lithiasis.Patients were subsequently subdi­
vided into six main groups:
•  Patients with carcinoma of the 
pancreas confirmed at operation.
•  Patients with clearly demon­strated acute or chronic pancreatitis.
•  Patients with other malignant tu­
mours of the gastrointestinal tract.
•  Patients with obstructive jaundice due to stones, confirmed at operation.
•  Patients with pancreatic pseudo­
cysts confirmed at operation.
•  Normal healthy persons (con­
trols).
Antigen Preparation
Tumour tissue was usually obtained 
at autopsy and stored at -70 °C. A pool of tumour tissue, usually from two to four patients, was taken from the freezer and thawed. All excess fat and normal tissue were scraped away. The pooled tumour tissue was then minced with a scalpel and with scissors. 
The minced tissue was diluted with five volumes of ice-cold phosphate- 
buffered saline at pH 7.3 and homo­genized for 15 minutes at 40 000 rpm in a VirTis homogenizer (VirTis Co. Inc., Gardiner, NY). The homogenate 
was centrifuged at 20 000 g for 30 minutes. If a layer of fat was present 
on the surface it was removed and 2-mL aliquots of the clear supernatant 
were stored in small vials at -70°C.Normal control antigen, usually nor­mal liver tissue, was prepared in the same fashion and also stored in 2-mL vials. Before use in any assay, the protein concentration of an antigen ex­tract was determined by a Lowry as­
say.9
Leukocyte Preparation
From patients selected for study 20 mL of blood was collected into vacu- tainer tubes containing heparin. These tubes were then incubated vertically at 37°C for 1 hour. The resulting leukocyte-rich plasma fraction was aspirated and centrifuged at 200 g for 5 minutes. The supernatant plasma was discarded. Erythrocytes contamin­
ating the cell buttons were lysed by
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adding tris-buffered ammonium chlo­
ride and the tubes were left at room 
temperature for 15 minutes.10 The 
procedure was terminated by the addi­
tion of an equal volume of Medium 
199 (Grand Island Biological Co., 
Grand Island, NY). The tubes were 
again centrifuged at 200 g for 5 min­
utes and the supernatant was removed 
and discarded. The cells were then 
washed three times with approximately 
10 mL of Medium 199. Before the last 
wash a known volume of medium was 
added and a small aliquot of this cell 
suspension was withdrawn for cell 
counting. Cell counts were performed 
with a Coulter counter (Coulter Elec­
tronics, Hialeah, FL). Following the 
final wash the cells were resuspended 
in Medium 199 at a concentration of 
1 X 107 cells/mL.
Antigen Specificity and Titration
The specificity of all antigens pre­
pared was determined by performing 
a tube LAI assay with peripheral blood 
leukocytes from patients with known 
tumours. The appropriate protein con­
centration of the antigen was deter­
mined by constructing a titration curve 
of protein concentrations ranging from 
50 fig to 400 jxg for both test and 
normal antigens. Antigens causing a 
high degree of nonspecific release were 
discarded. In general, the appropriate 
protein concentration to yield optimal 
results was approximately 200 fxgf 
tube.
LAI Assay
The LAI assay was performed in 
glass tubes 16 X 150 mm. All assays 
were performed in triplicate. The ap­
propriate antigens to be tested in the 
assay were thawed and diluted to ap­
propriate protein concentration, usual­
ly 2 mg/mL, using Medium 199. A 
0.1-mL volume of leukocyte suspen­
sion (1 x  107 cells/mL) was carefully 
pipetted into the bottom of the glass 
tube. Then 0.1 mL of buffer, specific 
antigen, or control antigen was added 
to each set of triplicate tubes. Subse­
quently 0.3 mL of Medium 199 was 
added to bring the mixture to a final 
volume of 0.5 mL. Each tube was 
carefully mixed using a Pasteur pipette 
and the tubes were incubated horizon­
tally. This incubation process was 
aided by using a styrofoam tray which 
is readily available in most hospital 
wards that use vacutainer tubes.
The tubes were incubated at 37 °C 
in a humidified atmosphere of 5% 
carbon dioxide in air for 2 hours. Fol­
lowing this period of incubation the 
tubes were placed vertically and the 
number of nonadherent cells was 
counted using a Coulter counter. The 
data obtained were then converted to
a nonadherent index (NAI) using the 
formula shown in Table I.
Results
The results of our assay are set 
forth in Table I. The specificity of the 
pancreatic tumour antigen is demon­
strated by the fact that the NAI is sig­
nificantly (P <  0.01) higher in patients 
with carcinoma of the pancreas than 
in those with other intra-abdominal 
malignant tumours. Also, the breast 
tumour antigen, which had previously 
been shown to be present in patients 
with breast carcinoma, was absent in 
patients with carcinoma of the pan­
creas and other intra-abdominal malig­
nant lesions.
A positive NAI does not appear to 
be due to inflammation of the pan­
creas since in most patients with pan­
creatitis the index was not substantially 
elevated. Similarly, patients with ob­
structive jaundice not due to a malig­
nant condition did not have a notably 
elevated NAI. These preliminary data, 
although small in number, suggest that 
the LAI assay may be a simple, non- 
invasive means of selecting patients 
with a possible malignant tumour of 
the pancreas who require further in­
vestigative procedures.
When an NAI index of 50 or greater 
was arbitrarily selected as indicating 
malignancy, it was shown to be 
so in eight of nine patients with 
surgically proven pancreatic cancer. 
The false-negative rate would there­
fore seem to be acceptably low. The 
false-positive rate, however, has been 
disturbingly high. Five of 15 patients 
with pancreatitits, 3 of 9 patients with 
other gastrointestinal carcinomas and 
4 of 16 normal (control) patients had a 
positive index. Clearly, more patients 
must be studied to determine the effi­
cacy of this assay.
Discussion
The preoperative diagnosis of car­
cinoma of the pancreas continues to 
be difficult to establish. Laboratory in­
vestigations that are said to be helpful 
in making this diagnosis include pan­
creatic function tests,11,12 radionuclide 
scanning of the pancreas,13 ultrasono­
graphy,14,15 arteriography16,17 and endo­
scopic retrograde pancreatography.18'20 
With the exception of ultrasonography, 
which is not universally available, each 
of these investigative procedures is 
relatively invasive. A recent report 
has suggested that the triple study 
by ultrasonography, pancreatic func­
tion tests and endoscopic retrograde 
pancreatography has an accuracy rate 
of almost 90% in either diagnosing or 
excluding pancreatic malignant le­
sions.21
Few immunologic tests have been 
described for the detection of carci­
noma of the pancreas. The measure­
ment of carcinoembryonic antigen 
(CEA) was once believed to be of value 
in the diagnosis of this disorder.22 Un­
fortunately, various nonmalignant pan­
creatic disorders and other upper ab­
dominal diseases produce measurable 
CEA concentrations resulting in a very 
high rate of false-positive results.23 
More recently the amount of CEA 
present in the pancreatic juice obtained 
at endoscopic retrograde pancreato­
graphy has been investigated. While the 
results are encouraging there is no 
evidence that this is of greater assist­
ance in diagnosis than simple retro­
grade pancreatography.12'24
In 1974 Banwo, Versey and Hobbs25 
prepared an antibody to fetal antigen 
from the pancreas comparable to the 
CEA prepared by Gold and Freed­
man.26 They called it a new oncofetal 
antigen for human pancreas and found 
it in the serum of 36 of 37 
patients with carcinoma of the 
pancreas. However, a later report 
revealed that the pancreatic oncofetal 
antigen was also to be found in patients
Table I— Nonadherent Index (N A I)*  Activity to Pancreatic and 
Breast Antigens of Patients with Pancreatic Disorders
Pancreatic antigen, Breast antigen,
200 ij.g/tube 200 u.g/tube
Condition
No. of 
patients NAI ±  SEM
No. of 
patients NAI ±  SEM
Carcinoma of pancreas 9 179 ±  34 7 23 ±  8.3
Pancreatitis 15 29 ±  26 6 - 4 ±  9.9
Other carcinomas 9 29 ±  16 11 0 ±  14
Obstructive jaundice 4 -1 8 .7 ND
Pancreatic pseudocyst 2 -4 6 .5 ND
Control 16 24 ±  12 15 -1 .6 ±  9
SEM =  standard error of mean, ND =  not done.
*  No. of nonadhering cells No. of nonadhering cells 
in presence of specific —  in presence of nonspecific 
antigen antigen
No. of nonadhering cells in presence of nonspecific antigen
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with other types of abdominal carci­
noma, pancreatitis and miscellaneous 
disorders.27
The present communication has de­
scribed another immunologic assay for 
the detection of carcinoma of the pan­
creas While the number of false-posi­
tive results in patients with other malig­
nant tumours and with benign pan­
creatic disease has been disturbingly 
high, the rate of false-negative results 
in patients subsequently proved to have 
pancreatic carcinoma has been grati- 
fyingly low. This suggests that the LAI 
assay may be of value in the early in­
vestigation of patients with suspected 
malignant tumours. Such, patients 
whose LAI assay is positive should ob­
viously be subjected to the more in­
vasive tests that have been described. 
Patients whose LAI assay is negative 
may safely be kept under observation 
without any further investigative proce­
dures being carried out.
I acknowledge the technical assistance 
of Mrs. Margaret Turner and Mr. Chris 
Howitt.
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NOTICE
Canadian Association of 
General Surgeons 
Resident Research Contest
The Canadian Association of Gen­
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of $500 to the resident in general 
surgery submitting the best ab­
stract on a surgical topic. Included 
in the award will be an all- 
expenses-paid trip to Montreal to 
present the work at the annual 
meeting of the Canadian Associa­
tion of General Surgeons, Feb. 6 
to 8, 1979.
Eligibility
Any resident in general surgery 
conducting research during his 
residency training at a Canadian 
university is eligible to participate.
Abstract
The abstract must be submitted 
on the special form used by the 
Royal College of Physicians and 
Surgeons of Canada. The original 
plus five photocopies should be 
sent to: The research committee, 
Canadian Association of General 
Surgeons, c/o Dr. J.H. Duff, De­
partment of surgery, University 
Hospital, 339 Windermere Rd., 
London, Ont. N6G 2K3. Abstract 
forms can also be obtained at the 
above address. The deadline for 
submission of abstracts is Sept. 1, 
1978.
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Reoperation Following Failure of Aortoiliofemoral
Arterial Reconstruction
J o hn  A. K n u d so n , m d * and A llan  R. D o w n s , m d , F R C s[c]f
Over a 19-year period, 729 primary 
arterial reconstructions for aneurysmal 
and occlusive disease of the aortoiliac 
arterial system were performed at 
the Health Sciences Centre, Winnipeg. 
During the same interval 49 of these 
reconstructions required reoperation 
and 6 additional cases were referred 
for secondary repair from other 
institutions. The authors reviewed these 
55 cases to determine the reasons for 
reoperation and the cumulative results 
of secondary repair.
Secondary arterial repair was per­
formed in 11.5% of cases of occlusive 
disease and in 1.2% of cases of 
aneurysmal disease. The overall fre­
quency of reoperation was 6.7%. The 
mean interval between primary and 
secondary operation was 31.5 months. 
Perioperative failure, false aneurysm, 
graft infection, progression of disease 
and late technical problems were the 
major reasons for reoperation. Of the 
secondary repairs the results in 83.6% 
were satisfactory at 30 days. At 5 
years, 57% of secondary repairs at 
risk remained satisfactory. The operative 
mortality for secondary arterial repair 
was 5.4%. The authors believe that 
continued aggressive management of 
failed primary aortoiliac reconstructions 
is justified.
Au cours d'une periode de 19 ans,
729 reconstructions arterielles primaires 
pour anevrisme ou obliteration du
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systeme arteriel aortoiliaque ont ete 
effectuees au Health Sciences Centre 
de Winnipeg. Durant ce meme intervalle, 
49 de ces reconstructions ont exige 
une reintervention et 6 autres cas ont 
ete achemines pour reparation secon- 
daire d'autres institutions. Les auteurs 
ont etudie ces 55 cas dans le but 
de determiner les raisons ayant entraine 
une reintervention et les resultats 
cumulatifs des reparations secondaires.
Une reparation arterielle secondaire 
a ete effectuee dans 11.5% des cas 
d'obliteration et dans 1.2% des cas 
d'anevrisme. La frequence des reinter­
ventions pour I'ensemble a ete de 
6.7%. L’intervalle moyen entre la 
premiere et la deuxieme operation a ete 
de 31.5 mois. Les principales causes 
d’une deuxieme intervention ont ete 
I’echec peroperatoire, un faux ane­
vrisme, I'infection du greffon, I’evolution 
de la maladie et certains problemes 
techniques tardifs. Du nombre de 
reparations secondaires, des resultats 
satisfaisants a 30 jours ont ete obtenus 
dans 83.6% des cas. Cinquante-sept 
pourcent des reparations arterielles 
secondaires a risque eleve sont 
demeurees satisfaisantes apres 5 ans.
La mortalite operatoire a ete de 5.4%. 
Les auteurs croient que le maintien 
d’un traitement agressif dans les echecs 
des reconstructions aortoiliaques 
primaires est justifie.
The patency rate of aortoiliac and 
aortofemoral reconstructive procedures 
varies between 62% and 90% over 10 
years.1'7 Early and late complications 
leading to reoperation are uncommon 
in this form of surgery, but when they 
do occur corrective procedures can be 
challenging.
Between Jan. 1, 1958 and Oct. 31, 
1976, 729 primary arterial reconstruc­
tions for aneurysmal or occlusive dis­
ease of the aortoiliac arterial system 
were performed at the Health Sciences 
Centre, Winnipeg. During the same 
period 49 patients required reoperation. 
Six additional patients were referred 
for secondary repair from other insti­
tutions. Seventy-nine operations were 
performed in these 55 patients (Table 
I). We have reviewed these secondary
arterial reconstructions to examine the 
causes of failure leading to reoperation 
and to determine the cumulative re­
sults of secondary repair.
We define secondary repair as re­
operation because of failure of a 
primary arterial reconstruction; peri­
operative occlusion was included. 
Early reoperation for hemorrhage, 
other than that resulting from infec­
tion, is excluded from the definition.
Seventeen patients required more 
than one reoperation. However, all re­
operations related to the same primary 
reconstruction were considered as one 
statistical event.
There were 46 men and 9 women. 
The mean age was 59.9 years (range, 
36 to 79 years). Duration of follow-up 
ranged from 3 months to 9 years 
(mean, 3 years). Three patients with 
successful secondary repairs were lost 
to follow-up at 37, 37 and 33.5 months.
Occurrence of Failure of
Primary Operation
Vascular complications requiring re­
operation occurred following 45 
(11.5%) of 391 operations for occlu­
sive disease and after only 4 (1.2%) of 
338 operations for aneurysmal disease. 
The overall incidence of reoperation 
was 6.7%. The number of reopera­
tions was related to the type of primary 
procedure (Table II). Secondary pro­
cedures were required in 3.5% of all 
aortic bifurcation grafts and in 9.2% 
of cases in which aortic bifurcation 
grafts were introduced for the man­
agement of occlusive disease. Of pa­
tients who underwent unilateral pros­
thetic procedures, 18.3% required 
reoperation. One would expect the risk 
of failure of bifurcation grafts to be 
twice that of unilateral grafts. How-
Tab le  ^ S e c o n d a r y  A rteria l R ep a irs
No. of patients No. of reoperations
38 1
13 2
3 3
1 6
55 79
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T a b le  I I — F re q u e n c y  o f S ec o n d a ry  R e p a ir  R e la te d  to  P r im a ry  O p e ra tio n
N o . p r im a ry  
o p e ra tio n s
N o . fa i le d  
and re o p e ra te d %  r e o p e ra t io n s
A o r to ilio fe m o ra l p ro s th es is 479 17 3 .5
O cc lu s iv e  d is e a se 141 13 9 .2
A n e u rys m 338 4 1 .2
A o r to il ia c  e n d a rte re c to m y 43 6 1 3 .9
U n ila te ra l  p ro s th e s is 82 15 18 .3
U n ila te ra l  e n d a rte re c to m y 74 5 6 .8
U n ila te ra l  v e in  g ra ft 10 1 10
C ro s s -fe m o ra l g r a f t  (v e in  o r p ro s th e s is ) 24 0 0
A x ilto fe m o ra l g r a f t 17 5 29 .4
T o ta l 729 49 6 .7
T a b le  I I I — In d ic a tio n s  fo r  P r im a ry  an d  S eco n d ary  R e p a ir
P r im a ry  re p a ir , no. 
o f  p a t ie n ts  (a n d  % )
S eco n d ary  r e p a ir ,  no .
In d ic a tio n o f  p a tie n ts  (a n d  % )
C la u d ic a tio n 30 (5 4 .5 ) 14 (2 5 .4 )
L im b  s a lva g e 19 (3 4 .6 ) 25 (4 5 .4 )
A n e u ry s m 6 (1 0 .9 ) —
F a ls e  a n e u rys m — 9 (1 6 .4 )
G ra ft  in fe c tio n — 7 (1 2 .7 )
T o ta l 55 55
ever, in patients with occlusive disease 
only 30.8% of the primary bifurcation 
graft procedures were performed for 
limb salvage compared with 46.7% of 
the primary unilateral procedures, sug­
gesting that arteriosclerosis was more 
severe in the latter group. Reoperation 
was necessary in 13.9% of bilateral 
aortoiliac endarterectomies and in only 
6.8% of unilateral iliac endarterec­
tomies.
Symptoms attending failure of a 
primary vascular reconstruction were 
usually more severe than those in­
dicating the need for initial repair. Of 
the 55 patients who later required re­
operation, the indication for primary 
repair was claudication in 54.5% and 
limb salvage in 34.6% (Table III). 
Following failure of primary repair, 
these figures were 25.4% and 45.4% 
respectively. Graft infection and false 
aneurysm were the indications for 
secondary repair in the remaining pa­
tients.
Causes of Failure
Eight (14.5%) patients with peri­
operative occlusion required reopera­
tion on the day of surgery. The higher 
proportion of immediate failures in the 
endarterectomy group probably reflects 
the higher degree of technical skill re­
quired for endarterectomy as compared 
with bypass procedures.
Progression of arteriosclerosis was 
responsible for 21 (38.2%) reopera­
tions. Inadequate outflow from the 
deep femoral artery with concomitant 
chronic occlusion of the superficial 
femoral artery resulted in failure of
13 of 16 prosthetic procedures in this 
group. Only one patient had severe 
arteriosclerosis of the deep femoral 
artery and 12 had stenosis or occlusion 
at the origin of the deep femoral artery. 
These figures emphasize the importance 
of adequate management of the deep 
femoral artery at the primary recon­
struction. In the remaining eight cases 
in this category failure occurred more 
than 3 years after reconstruction be­
cause of recurrent arteriosclerosis at 
the site of endarterectomy or the distal 
anastomosis. The 10 late technical fail­
ures (18.2% of the total) were in pa­
tients in whom none of the other 
identifiable causes of failure were ap­
parent. Incomplete endarterectomy or 
inadequate initial anastomoses ac­
counted for the late failures in this 
group.
There were seven graft infections 
(12.7%) (one of which was fatal) and 
two amputations. Nine patients re­
quired a secondary repair for a false 
aneurysm which was located in the 
groin in eight. Of the nine patients 
with a false aneurysm (16.4% of 
the total), five had associated aneu­
rysmal disease. The higher frequency 
of false aneurysms in patients with 
aneurysmal disease suggests that the 
condition predisposes to false-aneurysm 
formation, but this awaits confirmation.
If immediate failures are excluded, 
the mean interval between primary and 
secondary operation was 31.5 months. 
Progression of disease necessitated a 
second operation an average of 31.6 
months after the first. Graft infections 
presented an average of 9.1 months
postoperatively. False aneurysm was a 
late complication developing an aver­
age of 56.2 months following surgery.
Operative Procedures
A variety of procedures were used 
for secondary operations.
False aneurysms in the groin are 
usually best managed by excision of 
the anastomotic site and insertion of a 
longer prosthesis (Fig. 1). In the pres­
ence of occlusion of the superficial 
femoral artery an end-to-end anastomo­
sis to the divided end of the deep 
femoral artery is preferred. If the 
proximal aortic anastomosis is aneurys­
mal, a graft replacement is indicated 
(Fig. 2). Eight of nine patients were 
managed successfully by these meth­
ods.
Recurrent occlusion of an endar- 
terectomized segment is best treated by 
a bypass graft. For unilateral iliac oc­
clusion, a cross-femoral bypass graft 
may suffice.
Occlusion of one limb of a pros­
thesis is usually due to outflow ob­
struction. Where there has been recent 
occlusion of the prosthesis it may be 
possible to remove the thrombus by
FIG. 1—Anastomotic false aneurysm, 
right groin, and occlusion, left prosthetic 
limb, due to anastomotic false aneurysm. 
Both treated by graft extension.
FIG. 2—Aortoiliac prosthetic graft, 
with false aneurysms at all three anasto­
moses.
VOLUME 21, NO. 4, JULY 1978 /  THE CANADIAN JOURNAL OF SURGERY 317
way of the groin without exposing the 
graft in the abdomen.8 A cross-femoral 
graft from the patent limb of the pros­
thesis may be the simplest reconstruc­
tive procedure (Fig. 3). It is most im­
portant to establish an adequate out­
flow to avoid reocclusion. If clot is 
present at the bifurcation of the graft, 
proximal control will be necessary, and 
thrombectomy of the occluded limb of 
the prosthesis may then be carried out 
(Fig. 4).
Graft infection usually necessitates 
removal of the graft and an amputation 
or an extra-anatomical reconstruction 
such as an obturator bypass (Fig. 5) or 
an axillofemoral bypass. Anastomotic 
stenosis requires patch-graft angio­
plasty or an extension of the prosthesis 
more distally to the site of an adequate 
outflow (Fig. 6). It cannot be overem­
phasized that the operation must be 
tailored to the individual patient.
Results
The evaluation of secondary repair
FIG. 3— Prosthetic limb occlusion
treated by cross-femoral graft from patent 
limb to deep femoral artery.
FIG. 4— Prosthetic limb occlusion with 
clot, extending into patent limb, requiring 
proximal control.
demands careful analysis of the results 
because the indications for such pro­
cedures are variable. We define success 
as improvement in disabling claudica­
tion, limb salvage when the limb has 
been at risk, management of infected 
prostheses without loss of life or limb 
and repair of false aneurysms without 
incurring new vascular symptoms. Ex­
cept in graft infections, patency of the 
repair parallels a successful result.
FIG. 5—Obturator vein bypass graft 
in groin for infection of prosthesis.
FIG. 6— Anastomotic iliac stenosis, re­
quiring graft extension to common 
femoral arteries.
The average duration of follow-up 
in our cases of secondary repair was 3 
years. We were interested in the ul­
timate result in patients, hence we con­
sidered more than one reoperation in 
an individual patient as a single statis­
tical event. To analyse success we used 
the life-table method.9
Nine failures occurred within 30 
days of operation. Our success rate at 
30 days was 83.6%; at 2 years it had 
fallen to 62.2% and at 5 years to 57% 
(Fig. 7). There were three operative 
deaths, giving a surgical mortality of 
5.4%. Two of the deaths were in pa­
tients with aortoenteric fistula and one 
followed unsuccessful repair of a 
ruptured iliac false aneurysm.
Discussion
All failed reconstructions do not 
necessarily lead to reoperation. Risk of 
reoperation has to be weighed against 
the expectation of technical success, the 
severity of symptoms and the possible 
mortality without operative interven­
tion. Patients undergoing reoperation 
often have life or limb at risk. A pa­
tient may require several reoperations 
before a successful result is achieved.
Improvement in prosthetic materials, 
the use of synthetic sutures for anasto­
moses and definition of the stress forces 
on vascular anastomoses have reduced 
the frequency of false aneurysm to be­
tween 1.9% and 8%.1<M4 The frequency 
of false aneurysm among patients in 
our series was about 1.2%. With the 
evolution of perioperative management 
and vascular techniques, and possibly 
with the prophylactic use of antibiotics, 
the infection rate of prostheses varies 
between 1.5% and 6%.15,16 Graft in­
fection accounts for the highest mor­
bidity and mortality, but aggressive 
surgical management can save most of 
these patients and their limbs as demon­
strated by our experience. Progression 
of arteriosclerotic disease was the prin­
cipal reason for failure of the primary 
operation.
There have been several reports on 
aortoiliac secondary repairs.8,17'19 How­
ever, the long-term results of aortoiliac 
reoperations have not been well docu-
FIG. 7— Analysis of success of second­
ary repair of aortoiliac disease by life- 
table method.
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merited. Continued aggressive manage­
ment of failed prim ary aortoiliac re­
constructions is indicated.
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Role of Doppler Ultrasonography in Determining the 
Hemodynamic Significance of Aortoiliac Disease
K.W . J o h n s t o n , m d , f r c s [c ], facs
Doppler ultrasound recordings from 
the common femoral artery were 
quantified by calculation of the 
pulsatility index (a number related 
to the maximum oscillatory energy of 
the wave). To demonstrate that the 
index permits detection of hemo- 
dynamically significant aortoiliac 
stenosis, studies were carried out that 
led to the following conclusions:
(a) in patients with aortoiliac occlusive 
disease and normal distal vessels, 
the index correlates with the ankle 
pressure ratio (the ratio of systolic 
blood pressure at the ankle to brachial
From the department of surgery,Toronto General Hospital, and the Institute of Biomedical Engineering, University of Toronto, Toronto, Ont.
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systolic blood pressure) (r =  0.70);
(b) the index allows distinction of 
subjects with significant aortoiliac 
disease, demonstrated arteriographically, 
from normal subjects; and (c) in 
patients with pure aortoiliac occlusive 
disease (no evidence of distal disease 
on arteriography) there is a strong 
correlation between the index and the 
percentage improvement (i.e., increase) 
in the ankle pressure ratio following 
operation (r =  0.80). When the femoral 
pulsatility index was greater than 5, 
the ankle pressure ratio did not 
improve following operation, but when 
it was 4 or less, an objective 
improvement in ankle pressure ratio 
was demonstrated.
Les examens aux ultrasons de Doppler 
de I'artere femorale commune ont ete 
quantifies par le calcul de I'index de 
pulsatilite (une valeur reliee au maximum 
d'energie oscillatoire de I'onde). Pour 
demontrer que le calcul de I'index 
de pulsatilite femorale permettait la 
detection d'une stenose aortoiliaque 
hemedynamiquement significative, des
etudes ont ete menees qui ont donne 
les conclusions suivantes: (a) chez les 
patients souffrant d'une maladie 
aortoiliaque occlusive et ayant des 
vaisseaux distaux normaux, I'index a 
montre une correlation avec le rapport 
de pression de la cheville (le rapport 
de la pression systolique a la cheville 
et la tension arterielle brachiale 
systolique) (r =  0.70); (b) cet index 
permet de faire la distinction entre les 
sujets ayant une maladie aortoiliaque 
significative demontree a I'arteriogra- 
phie, et les sujets normaux; et (c) 
chez les patients souffrant d'une maladie 
aortoiliaque occlusive pure (sans signe 
d'atteinte distale a I'arteriographie),
II existe une forte correlation entre 
I'index et le pourcentage d'amelioration 
(d'augmentation) du rapport de pression 
de la cheville apres I'operation 
(r =  0.80). En presence d'un index 
de pulsatilite superieur a 5, le rapport 
de pression de la cheville ne s'est pas 
ameliore apres I’operation, mais quand 
I'index etait de 4 ou moins, une 
amelioration objective du rapport de 
pression de la cheville a ete demontree.
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A successful vascular operation de­
pends primarily on good clinical judge­
ment combined with technical excel­
lence. In aortoiliac surgery, in spite of 
careful preoperative clinical and arteri- 
ographic assessment and a technically 
successful procedure, some patients 
are unimproved following operation. 
The failure rate of aortoiliac recon­
struction can be reduced by attention 
to certain technical considerations and 
perhaps by more precise objective as­
sessment of the hemodynamic signi­
ficance of aortoiliac stenosis.
The purpose of this study is to 
answer the question, Can noninvasive 
Doppler ultrasound recordings from 
the femoral artery determine if an 
aortoiliac stenosis is hemodynamically 
significant?
A New Doppler System
Before we could obtain quantitative 
information about the aortoiliac seg­
ment from femoral artery Doppler 
recordings, we had to overcome the 
inherent limitations of Doppler “flow­
meters”1'3 and solve the following prob­
lems: (a) to obtain meaningful direc­
tional Doppler signals: (b) to process 
the signals and produce a blood flow 
velocity wave free of artefacts; and (c) 
to quantify the Doppler wave. Our 
methods for accomplishing these ob­
jectives have been reported,4’5 but will 
be briefly reviewed here in order to 
clarify the inherent limitations of cur­
rently available commercial Doppler 
“flowmeters”.
Obtaining Meaningful Directional
Doppler Signals
The normal blood flow velocity 
wave is triphasic with a forward flow, 
a reverse flow and usually a second 
forward flow component. Unless the 
Doppler system is able to separate 
clearly the directions of blood flow, 
the resultant waveform may be in error. 
Many commercial Doppler instruments 
have serious limitations in their direc­
tion-resolving ability. To overcome this 
problem, we have designed and con­
structed a heterodyne Doppler velocity 
meter which has almost perfect direc­
tion-resolving capabilities (Kassam M, 
Johnston KW, Cobbold RSC: Unpub­
lished data, 1978).
Processing the Doppler Signals and
Producing a Blood Flow Velocity
Wave Free of Artefacts
Since our aim is to obtain quanti­
tative information from the Doppler 
waveform, it is essential to obtain one 
that is free of errors and artefacts. 
Current commercial instruments use a
zero crossing detector to process the 
Doppler signals, but unfortunately this 
method produces artefactual waveforms 
in many situations.1'3 We have overcome 
this problem by designing a relatively 
inexpensive real-time frequency analy­
ser which displays the Doppler wave­
form on an oscilloscope or on record­
ing paper.4
Quantifying the Doppler Waveform
At present there is only one way to 
quantify the Doppler waveform ac­
curately and that is by calculating the 
pulsatility index (a number that is 
proportional to the maximum oscilla­
tory energy of the wave).6'9 It would 
be ideal to calibrate the Doppler wave­
form and thus be able to measure ab­
solute velocity, but at present this is 
not possible with any degree of ac­
curacy.6 The theoretical basis for the 
calculation of the pulsatility index and 
its in-vitro and in-vivo validation are 
beyond the scope of this paper;5 suffice 
it to say that the pulsatility index can 
be calculated easily from the maximum 
instantaneous velocity wave by using 
a pencil and ruler.
Methods and Patients
In this study the hemodynamic sig­
nificance of aortoiliac disease was de­
termined from Doppler ultrasound 
velocity recordings taken from the 
femoral artery using our new Doppler 
system and a real-time frequency anal­
yser and display system. The pulsatility 
index was calculated and was used to 
quantify the wave. Normally, the 
pulsatility index is high. Distal to an 
arterial stenosis the waveform is dam­
pened (i.e., the peak is delayed and 
flattened and reverse flow is absent) 
and the pulsatility index is reduced.
FIG. 1—Relation between femoral pul­
satility index and ankle systolic pressure 
ratio (ratio of systolic blood pressure at 
ankle to brachial systolic blood pressure) 
in patients with aortoiliac occlusive dis­
ease and normal distal vessels.
Doppler ultrasound velocity record­
ings were made from the common 
femoral artery and the femoral pulsa­
tility index was calculated from these 
recordings. In order to demonstrate 
that the femoral pulsatility index was 
actually a hemodynamic measurement 
and to determine whether it could be 
used to estimate the severity of aor­
toiliac disease, femoral pulsatility in­
dex was compared with: (a) the meas­
urement of ankle pressure ratio (i.e., the 
ratio of systolic blood pressure at the 
ankle to brachial systolic pressure), 
(b) arteriograms graded according to 
the severity of the stenosis in the aor­
toiliac segment, and (c) the amount of 
improvement in the ankle pressure ratio 
following operation.
Results
Correlation between Femoral 
Pulsatility Index and Systolic Blood 
Pressure Ratio at the Ankle
Only patients with pure aortoiliac 
occlusive disease (i.e., no evidence of 
distal disease on arteriography) were 
studied; hence it is reasonable to as­
sume that systolic blood pressure meas­
ured at the ankle was directly related 
to femoral artery blood pressure. Ac­
cordingly it was to be predicted that 
the femoral pulsatility index would also 
be related to systolic blood pressure 
ratio at the ankle. As illustrated in Fig. 
1, for 38 points, ankle pressure ratio 
and femoral pulsatility index were 
related by a power equation of the 
form y =  axb with a correlation co­
efficient of 0.70.
Relation between Femoral Pulsatility 
Index and Arteriographic Grades in 
the Aortoiliac Segment
Although arteriography does not pro­
vide a hemodynamic measurement, the 
above relation is important to establish. 
When arteriography was used as a base­
line for comparison, in 155 limbs 
femoral pulsatility index appeared to 
be as discriminating (Fig. 2). It dis­
tinguished subjects with clinically and 
arteriographically significant lesions 
from the normal group.
Relation between Femoral Pulsatility 
Index and the Objective Improvement 
Following Operation
Arteriography has serious limitations 
when used for determining the signi­
ficance of lesions in the aortoiliac seg­
ment. Therefore in order to determine 
whether the measurement of femoral 
pulsatility index can detect and quan­
tify the hemodynamic significance of 
an aortoiliac lesion, a third relation-
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ship was assessed—that between the 
femoral pulsatility index and the re­
sults of operation as measured objec­
tively by the increase in the pressure 
ratio following operation. Forty-six 
limbs of patients with pure aortoiliac 
occlusive disease were studied. Pre- 
operatively, the femoral pulsatility in­
dex was measured and the ankle pres­
sure ratio calculated. The ankle pres-
FIG. 2— Femoral pulsatility index plot­
ted against corresponding arteriographic 
grade of aortoiliac segment. Grade 0 =  
normal subjects; grade 1 =  patients with 
intimal irregularity only; grade 2 =  pa­
tients with less than 50% stenosis; grade 
3 =  patients with greater than 50% 
stenosis; grade 4 =  patients with com­
plete arterial occlusion.
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FIG. 3— Relation between femoral pul­
satility index and percentage improve­
ment (increase) in ankle pressure ratio 
achieved by operation. Only patients with 
aortoiliac disease and normal distal ves­
sels were included.
sure ratio was remeasured postopera- 
tively and the percentage improvement 
in the pressure ratio was calculated 
(Fig. 3). As predicted, when the pre­
operative femoral pulsatility index was 
high, the ankle pressure ratio did not 
improve. On the other hand, when the 
femoral pulsatility index was low, the 
pressure ratio did improve. It is ap­
parent that the relation between 
femoral pulsatility index and percent­
age improvement in ankle pressure 
ratio, as expressed in Fig. 3, is an 
inverse function. Hence, if the inverse 
of the femoral pulsatility index is plot­
ted against the percentage improvement 
in the pressure ratio, a linear relation 
results as illustrated in Fig. 4. For 46 
limbs, we found a linear relation be­
tween inverse femoral pulsatility index 
and percentage improvement in the 
pressure ratio. The correlation coeffi­
cient was 0.80.
Summary and Conclusions
We have demonstrated that the 
pulsatility index calculated from Dop­
pler ultrasound recordings from the 
femoral artery is a quantitative meas­
ure of the hemodynamic significance 
of arterial occlusive disease in the aor-
Inverse femoral pulsatility 
index
FIG. 4— There is linear relation be­
tween inverse of femoral pulsatility index 
and percentage improvement in ankle 
pressure.
toiliac segment. When the femoral 
pulsatility index is less than 4, a hemo- 
dynamically significant lesion is present 
in the aortoiliac segment and opera­
tive repair produces an objective im­
provement. When the femoral pulsa­
tility index is greater than 5, no hemo- 
dynamically significant lesion is pres­
ent in the aortoiliac segment and 
operation does not produce an objective 
hemodynamic improvement.
The technical assistance of Mrs. B. 
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Oropharyngeal Dysphagia in Patients with 
Oculopharyngeal Muscular Dystrophy
C. Andre Duranceau, md, frcs[c], J ean Letendre, md, frcp[c], 
R ichard J. Clermont, md, frcp[c], H enri-Paul Levesque, md, frcp[c] 
and Andre Barbeau, md, frcp[c], facp
Sixteen patients with an established 
diagnosis of oculopharyngeal muscular 
dystrophy underwent clinical, radiologic 
and manometric assessment. Secondary 
pharyngo-oral and pharyngonasal re­
gurgitations are usually associated with 
this condition and chronic aspiration 
with consequent bronchorrhea is com­
mon. Such patients may present with 
marked oropharyngeal dysphagia.
Cineradiologic findings correlated 
well with the manometric results. The 
pharynx showed very weak contractions 
of longer duration than those observed 
in normal subjects. The proximal 
esophageal sphincter had a normal 
resting and closing pressure; however, 
relaxation and coordination of the 
sphincter were substantially different 
from those in a control group.
Eleven patients underwent crico­
pharyngeal myotomy. All had notable 
improvement of their symptoms. Surgery 
on the sphincter results in a substantial 
decrease in its resting pressure; 
pharyngeal contraction remains 
unaltered.
Seize patients porteurs d’une dystrophie 
oculopharyngee ont ete evalues. Ils 
ont eu un examen clinique, radiologique 
ainsi qu’une etude de la fonction 
oesophagienne. Ces patients presentent 
une symptomatologie typique qui est 
d'apparition tardive. Une dysphagie 
oropharyngee souvent severe est 
observee. Secondairement, des regur­
gitations pharyngo-orales et pharyn- 
gonasales surviennent. Des episodes 
repetes d’aspiration entrainent une 
bronchorrhee importante.
La radiologie et la manometrie
From the departments of surgery, 
medicine and radiology, Universite de 
Montreal, Hotel-Dieu de Montreal, 
Montreal, PQ
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s’accordent: le pharynx montre des 
contractions faibles et prolongees. Le 
sphincter pharyngo-oesophagien presente 
une pression de repos et une pression 
de contraction comparables au normal. 
Le relachement et la coordination du 
sphincter avec la contraction du 
pharynx varient cependant de facon 
significative d'avec les normaux.
Onze patients ont ete traites par 
une myotomie du sphincter pharyngo- 
oesophagien. Tous ont ete tres ameliores 
par cette intervention. Les effets 
observes de la chirurgie sur la fonction 
du sphincter sont une diminution 
marquee de la pression de repos dans 
celui-ci. La fonction du pharynx 
demeure identique.
Oculopharyngeal muscular dystrophy 
is a syndrome characterized by pro­
gressive palpebral ptosis and dysphagia. 
This condition was first described by 
Taylor1 in 1915; all his patients with 
this disease who had reached the age 
of 50 years died of starvation resulting 
from paralysis of the muscles of de­
glutition.
Subsequently a number of case re­
ports2’4 and a genetic study5 revealed 
that this syndrome afflicts mainly pa­
tients of French-Canadian ancestry al­
though it has been described in patients 
of Bohemian6 and Jewish origin2 as 
well as in people of Latin American7 
and Italian8 descent.
Most publications on the subject 
concentrate on the genetic and neurolo­
gic aspects of the disease.1'3*4,3 Late and 
progressive ptosis is a more striking 
clinical sign than the accompanying 
dysphagia. Dysphagia, however, is fre­
quently mentioned as a symptom that 
precedes the ptosis and causes the pa­
tient much discomfort.10’13
It is our intention in this paper to;
(a) document more precisely the oro­
pharyngeal, esophageal, laryngeal and 
tracheobronchial symptoms presented 
by a group of patients with this disease,
(b) assess the pharyngeal dysfunction 
through radiologic and manometric 
studies, and (c) evaluate the results of 
treatment.
Methods
Clinical Evaluation
In 16 patients (average age, 63 years) 
the diagnosis of oculopharyngeal mus­
cular dystrophy was established by a 
neurologist (A.B.). All were subsequent­
ly examined at the surgical outpatient 
clinic and underwent a full medical 
assessment by a gastroenterologist and 
a surgeon (J.L., R.C., A.D.).
Radiologic Investigation
Examination of the pharynx and 
recording of the act of swallowing were 
performed with the patient in a stand­
ing or sitting position. Initially, the 
cineradiographic technique was used 
in the frontal and lateral projections at 
a frame rate of 30 per second. The 
patient was instructed to hold a mouth­
ful of concentrated liquid barium (Mi- 
cropaque 95 %, Nicholas Laboratories 
Ltd., Slough, UK) (28 g in 30 mL 
water) until directed to swallow. The 
same procedure was repeated after the 
patient was given 5 mL of paste pre­
paration (Microtrast, Nicholas Labo­
ratories Ltd.).
The examination was completed by 
taking spot film exposures in the an­
teroposterior and lateral projections. If 
the patient had a history of trouble­
some aspiration, the examination was 
performed with cineradiography only 
using a water-soluble medium (Gastro- 
grafin, Squibb). All the radiologic ex­
aminations were reviewed and analysed 
by the same radiologist (H-P.L.).
Manometric Study
Manometric studies were performed 
in all 16 patients using a triple-lumen 
esophageal motility tube (USCI #1100, 
USCI International, Murray Hill, NJ). 
The body of the esophagus was per­
fused at a rate of 1.9 mL/min for each 
lumen and the proximal sphincter area 
at a rate of 7.6 mL/min for each lu­
men. Recording was done on a four- 
channel physiograph (model 7754A, 
Hewlett-Packard Co., Palo Alto, CA). 
All tracings were analysed according 
to fixed criteria and the statistical
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method used for interpretation was 
Student’s t-test for paired values.
Treatment
Four patients were given an anti­
cholinesterase medication and two 
were treated by dilatation using mer­
cury bougies.
Eleven patients underwent crico­
pharyngeal myotomy. The indications 
for surgery were severe dysphagia with 
regular pharyngo-oral and pharyngo- 
nasal regurgitations as well as frequent 
episodes of tracheal aspiration. Surgery 
was performed under general anesthe­
sia and using a left cervical approach. 
When the esophagus was isolated, a 
no. 42 mercury bougie was passed 
through the upper esophageal sphincter 
(UES) into the cervical esophagus. A 
5-cm myotomy including the UES and 
distal hypopharynx was carried out. 
The mucosa was dissected from the 
muscular layer over approximately 
40% of the circumference and the 
muscular layer was then fixed to the 
thyroid capsule.
Results
Clinical Findings
The clinical symptoms are set forth 
in detail in Tables I and II.
Generally, patients present complain­
ing of marked oropharyngeal dysphagia 
of long duration. Solids and eventually 
liquids cause dysphagia, which is exa­
cerbated by anxiety and by drinking 
cold liquids. Oropharyngeal and nasal 
regurgitations were experienced by near­
ly all patients. Consequently, alimenta­
tion time is longer and weight loss may 
follow. Odynophagia was noted and 
many patients reported a burning 
sensation in the pharynx on swallow­
ing.
Table I— Oropharyngeal Symptoms
Symptoms
Dysphagia Odynophagia Regurgitation
Patient
no.
Age,
yr Solids Liquids
Increased 
w ith cold
Increased 
with anxiety
Burning sensation in 
Severe pharynx on swallowing
Pharyngo-
nasal
Pharyngo-
oral
A lim entation  
tim e, m in*
Weight 
loss, kgf
i 76 + + + + + + 0 0 +  + + + — 0
2 61 + + + + + + 0 0 +  + + + 75 0
3 64 + + + + + + 0 0 +  + + + 30 18
4 68 + + + + + 0 0 0 4- 4- 35 9
5 61 + + 0 + + 0 0 +  + + + 45 0
6 74 + + + + + 0 + +  + 0 60 0
7 52 + + ~h + + 0 + + + + + 45 0
8 74 + + + + + + 0 + +  + + + 60 0
9 66 + + + + + + + 0 +  + + + 35 18
10 69 + 4- 0 + 0 0 4 - 4- + + 35 13.5
11 50 - f -  + + + 0 + 0 0 + + + + 30 6.75
12 57 + 0 0 0 0 0 + + 0 45 13.5
13 61 + 0 0 0 0 0 + 0 45 0
14 62 + 0 0 + 0 0 0 0 20 0
15 61 + 0 + + 0 0 0 0 45 0
16 56 + 0 0 0 0 0 + 0 45 0
*Average, 45 min. 
fA verage, 13.0 kg.
+  =  mild; + +  =  severe; 0 =  absent.
Most of the patients in this series 
had voice modification. Concomitantly 
with the dysphagia, episodes of airway 
aspiration supervene. This happens 
after every swallowing action in the 
more severe cases. During sleep, pool­
ing of saliva in the hypopharynx and 
larynx causes the patient to aspirate 
the secretion and a severe bronchor- 
rhea results. These symptoms were ob­
served in all 16 patients during their 
manometric evaluation.
Radiologic Findings
The radiologic findings are presented 
in Table III. The pharynx showed a 
weak or nonexistent contraction against 
the UES which relaxed incompletely or 
late in the majority of cases. The eso­
phageal lumen at the UES level re­
mained concentrically diminished in
Table I I I — Radiologic Findings in 16 Patients  
with Oculopharyngeal Muscular Dystrophy
Finding
No. of 
patients
Pharynx
Weak or absent contractions 14
Hypopharyngeal stasis 14
Nasal regurgitation 3
Upper esophageal sphincter (UES) 
Cricopharyngeus impression
Small 8
Marked 4
Absent 4
Lumen diameter
Diminished 10
Adequate 4
Complete obstruction 2
Relaxation
Incomplete or late 12
Absent 4
Laryngeal aspiration 9
Aspiration pneumonitis on lung
roentgenography 2
Table I I— Laryngeal, Tracheobronchial and Pulmonary Symptoms
Aspiration Bronchorrhea
Patient Voice While While W hile During m otility A fter Systemic
no. change eating sleeping Pneumonias sleeping study surgery* disease
i + +  + +  + 0 + + +  + + + +
2 + +  + + + 0 + + + + 4“ 0
3 + + + +  + + + + + + + + 0
4 + +  + +  + + + + +  + + + +
5 + + + + + 0 + + +  + 0
6 0 + + +  + + + + +  + + + *4 “
7 + 4 - 4- 0 + + + + + 0
8 + + + + + + + + + + + + +
9 + + + + + 0 + + +  + + + 0
10 + + + + + 0 + + +  + 4 - 4- 0
11 + + + + + 0 + + +  + + + 0
12 + + + 0 0 + — 0
13 + + + 0 + + + — 0
14 0 + + 0 0 + — 0
15 + + + 0 0 + — +
16 + + + 0 + + + — 0
Total 14 16 16 4 13 16 i i 5
*11 patients.
+  =  mild; + +  =  severe; 0 =  absent.
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response to swallowing in eight patients. 
Consequently, hypopharyngeal and 
laryngeal pooling induced aspiration in 
more than half the group. Repeated 
swallowing was necessary to empty the 
pharynx of its content.
Motility Studies
Table IV summarizes the significant 
findings of pharyngeal and proximal 
sphincter evaluation. The detailed study 
of esophageal function will be reported 
separately.
The pharynx was uniformly very 
weak so that its contraction time was 
significantly longer than in a control 
group (Fig. 1). The UES, while regis­
tering resting and contracting pressures 
comparable to those found in a normal 
group, showed a significant number of 
inadequate and incoordinated relaxa­
tions. The swallowing pattern was that 
of weak and repeated pharyngeal con­
tractions attempting to relax the upper 
sphincter (Fig. 2).
Evaluation of Treatment
The four patients for whom anti­
cholinesterase treatment was prescribed 
had had early dysphagia; they were 
clinically improved by the medication. 
Of the two patients treated by dilata­
tion, one was 50% better while the
other obtained no relief and subse­
quently underwent a cricopharyngeal 
myotomy.
Eleven patients underwent UES 
myotomy. Clinical and manometric ef­
fects of the operation are summarized 
in Table V. All experienced marked 
improvement of their symptoms. Eight 
patients reported that swallowing was 
“more than 100% better”. One patient 
declared it was 75% better and two 
patients admitted it was 50% better.
After surgery all patients ate faster 
and stopped regurgitating either nasal­
ly or orally during meals. Four out of 
five patients who had lost weight re­
gained it in the months following sur­
gery.
All patients who underwent the op­
eration experienced fewer episodes of 
aspiration and much less nocturnal ac­
cumulation of secretions; only one 
complained of having to get up at night 
as often as before to relieve his bron- 
chorrhea.
The two patients admitted with 
pneumonia showed a normal postoper­
ative evolution of the disease with sig­
nificant improvement of their condi­
tion.
Postoperative complications occurred 
in two cases. In one patient who had 
a cholecystectomy as well as UES myo­
Table IV—Significant Findings Resulting from Evaluation of the Pharynx and UES in Patients 
with Oculopharyngeal Muscular Dystrophy
Patients with
Finding
Control
subjects
oculopharyngeal muscular 
dystrophy P value
Pharynx
Peak contraction, mm Hg 40.6 ±  1.8 10.4 ±  2.2 < 0.001
Contraction duration, s 0.37 ±  0.03 0.73 ±  0.07 < 0.001
UES
Resting pressure, mm Hg 55.3 ±  4.1 54.7 ±  7.9 NS
Contraction pressure, mm Hg 81.2 ±  5.3 71.3 ±  7.3 NS
Relaxation, % 100 94.4 ±  2.7 < 0.02
Coordination, % 100 76.5 ±  9.5 < 0.01
NS =  Not significant.
Table V—Results of Surgery
Patient
no.
UES pressure 
before operation, 
mm Hg
UES pressure 
after operation, 
mm Hg
Clinical
response
Length of 
follow-up, mo
i 69 45 Excellent 24
2 100 33 Excellent 14
3 54 58 Excellent 12
4 35 16 Excellent 8
5 34 29 Good 6
6 61 28 Excellent 5
7 56 17 Excellent 5
8 125 14 Good 4
9 30 22 Excellent 3
10 53 19 Good 1
11 — — Excellent 18
61.7 ±  9.5* 28.1 ±  4.4*
*P <  0.002.
Excellent =  major improvement in all symptoms; good =  persistence of one or more incapa­
citating symptoms
tomy, postoperative respiratory insuf­
ficiency occurred, necessitating trache­
ostomy, long-term respiratory support 
and intravenous hyperalimentation. In 
the other patient a retropharyngeal 
hematoma developed and then resolved 
spontaneously. There were no deaths.
Discussion
Oculopharyngeal muscular dystrophy 
is considered a rare disease. In certain 
areas, however, it can be observed quite 
frequently. Since the genetic basis was 
established by Barbeau,5 a clear auto­
somal dominant transmission in a num­
ber of Quebec families has been de­
scribed. Most of the cases reported 
elsewhere are also of French-Canadian 
origin.
Because of the rarity of the disease, 
relatively little is known of the clinical 
aspects and management of these pa­
tients. Attention has focused mainly ort 
its genetic and neurologic aspects.
As early as 1915 Taylor1 had men­
tioned that with the passage of time 
a degree of dysphagia develops of such 
severity that these patients cannot eat 
and die of starvation. This was fre­
quently described by a number of our 
patients who remembered a parent 
dying of starvation, malnutrition or 
from clinically diagnosed “laryngeal or 
esophageal cancer”.
NORMAL OPM D
FIG. 1—Normal pharyngeal contraction 
generates peak pressure of 41 mm Hg. In 
patient with oculopharyngeal muscular 
dystrophy (OPMD), pharynx shows power­
less contractions. These voluntary con­
tractions must be repetitive since bolus 
cannot easily cross proximal sphincter area.
FIG. 2— Proximal manometric reading 
is in upper esophageal sphincter (UES) 
area. Adequate relaxation can be observed 
on swallowing but coughing from aspira­
tion eventually results. Two readings in 
proximal esophagus show absent peristal­
sis in waves that follow sphincter closure.
328 VOLUME 21, NO. 4, JULY 1978 / THE CANADIAN JOURNAL OF SURGERY
Most of the patients in our series 
had seen a number of doctors and ob­
tained little improvement from symp­
tomatic management. After clinical, 
radiologic and manometric evaluation, 
we conceived the pattern of oropharyn­
geal dysphagia to be as follows: pha­
ryngeal contractions are powerless 
against the normal resting pressure of 
the proximal esophageal sphincter and 
since an adequate pressure signal is 
essential for proper function of the 
UES, relaxation of the sphincter is late 
or incomplete. Oral and nasal regur­
gitation occur with repeated episodes 
of aspiration. These patients avoid eat­
ing with their families or in public.
Whether this malfunction of the 
UES is due to a disease or results from 
a weak signal secondary to a deficient 
pharyngeal contraction is still not clear. 
Present knowledge points to a primary 
pathologic condition of the muscle,3'4'7'12 
but the peripheral nervous system as 
well as neural transmission may be 
involved. Of interest is the clinical ob­
servation by one of us (A.B.) that in 
the early phase of the disease dysphagia 
responds to anticholinesterase medica­
tion. This is contrary to the conclusions 
of most reports published to date on 
the use of edrophonium chloride (Ten­
silon, Roche). More studies are needed 
to evaluate the response to this medica­
tion. Two patients who ceased to re­
spond to anticholinesterase treatment 
were submitted to esophageal dilatation 
by mercury bougies. This proved very 
helpful in one patient but brought 
about no change in the other.
Surgical treatment by cricopharyn­
geal myotomy, as reported by Mont­
gomery and Lynch,10 Peterman, Lilling- 
ton and Jamplis,11 Blakeley, Garety and 
Smith.14 Bender15 and Mills,16 brought 
about clinical improvement in most of 
the reported cases. It is surprising to
see such an improvement in patients 
with completely deficient pharyngeal 
contraction. The degree of improve­
ment was impressive in our patients on 
whom surgery was performed. The on­
ly physiologic explanation for this is a 
lowering of the pressure barrier at the 
UES level in the presence of normal 
activity and propulsive force of the 
tongue, permitting an easier transit of 
food from the pharynx to the esopha­
gus. The surgical treatment was re­
stricted to patients with severe symp­
toms. Lesser degrees of dysphagia ap­
pear to be manageable by medication 
or dilatation.
A word of caution is in order con­
cerning dilatation. At operation, in all 
patients with oropharyngeal muscular 
dystrophy, a tight and localized point 
of constriction was observed at the 
junction of the pharynx and the cer­
vical esophagus. Even under anesthe­
sia with the esophagus in hand, it may 
prove difficult to pass the bougie across 
the UES area. With such a resistance 
and the lateral dilatations of the pyri­
form sinuses, perforation could easily 
occur.
Even if surgery does not influence 
the underlying pathology of the dis­
ease, marked symptomatic improve­
ment may result from a simple myo­
tomy at the proximal sphincter level. 
Long-term results need to be assessed.
We thank Dr. Jacques Sylvestre and 
Dr. Gilles Beauchamp for constructive 
criticism and Miss Christine Holland for 
typing the manuscript.
References
1. Taylor EW: Progressive vagus-glos­
sopharyngeal paralysis with ptosis: a 
contribution to the group of family 
diseases. J Nerv Merit Dis 42: 129, 
1915
2. Victor M, H ayes R, Adams RD: 
Oculopharyngeal muscular dystrophy.
A familial disease of late life charac­
terized by dysphagia and progressive 
ptosis of the eyelids. N  Eng J Med 
267: 1267, 1962
3. Amyot R: Ptosis hereditaire familial 
et tardif des paupieres superieures. 
Union Med Can 77: 1287, 1948
4. Saucier J : The clinical significance 
of ptosis with special reference to 
ptosis of late onset. J Nerv Merit Dis 
119: 148, 1954
5. Barbeau A: La “myopathie oculaire” 
au Canada frangais: etude prelimi- 
naire, in Conipte Rendu du ler Con- 
gres International de N euro-G enetique 
et de Neuro-Ophtalmologie, Basel/ 
New York, Karger, 1968, pp 49-55
6. Myrianthopoulos NC, Brown 1A: 
A genetic study of progressive spinal 
muscular atrophy. Am J Hum Genet 
6: 387, 1954
7. Weitzner S: Changes in the pharyn­
geal and esophageal musculature in 
oculopharyngeal muscular dystrophy. 
Am J Dig Dis 14: 805, 1969
8. Lewis I: Late-onset muscle dystrophy: 
oculopharyngoesophageal variety. Can 
Med Assoc J 95: 146, 1966
9. Bray GM, Kaarsoo M, Ross RT: 
Ocular myopathy with dysphagia. 
Neurology (Minneap) 15: 678, 1965
10. Montgomery WW, Lynch JP: Ocu­
lopharyngeal muscular dystrophy 
treated by inferior constrictor myo­
tomy. Trans Am Acad Ophthalmol 
Otolaryngol 75: 986, 1971
11. Peterman AF, Lillington GA,
Jamplis RW: Progressive muscular
dystrophy with ptosis and dysphagia. 
Arch Neurol 10: 38, 1964
12. Roberts AH, Bamforth J: The
pharynx and esophagus in ocular 
muscular dystrophy. Neurology 18: 
645, 1968
13. Murphy SF, Drachman DB: The 
oculopharyngeal syndrome. JAMA 
203: 1003, 1968
14. Blakeley WR, G arety EJ, Smith 
DF: Section of the cricopharyngeus 
muscle for dysphagia. Arch Surg 96: 
745, 1968
15. Bender MD: Esophageal manometry 
in oculopharyngeal dystrophy. Am J 
Gastroenterol 65: 215, 1976
16. Mills CP: Dysphagia in pharyngeal 
paralysis treated by cricopharyngeal 
sphincterotomy. Lancet 1: 455, 1973
Critique of Item 20 (SESAP II)
Anemia is a common finding among postgastrectomy patients. The point at issue is whether the anemia is 
related to failure to absorb iron, to iron loss, or to the deficiency of extrinsic factors. Iron deficiency might re­
sult simply from inadequate intake or from inadequate absorption. Iron deficiency may also develop when rela­
tive or absolute achlorhydria is present, or when the ingested iron is diverted from the normal duodenal absorptive 
surface. Iron deficiency anemia would be expected in the presence of marginal ulceration and slow but chronic loss 
of blood. In either instance, the anemia would be microcytic and hypochromic. Anemia secondary to loss of the extrin­
sic factors B12 and folic acid is typically megaloblastic and therefore macrocytic and normochromic. Among the tests 
listed, the blood indices would be the most helpful. Commonly used methods for determining B12 absorption seem 
to be of little value after gastrectomy. If deficient B12 is suspected, studies of the level of serum B12 and red 
blood cell B12 are indicated.
20/1 . Deller DJ, Ibbotson RN, Crompton B: Metabolic effects of partial gastrectomy with special reference to 
calcium and folic acid: II. The contribution of folic aciddeficiency to the anaemia. Gut 5:225-229, 1964 
20/2 . Mahmud K. Ripley D, Doscherholmen A: Vitamin B)2 absorption tests: Their unreliability in postgastrectomy 
states. JAMA 216:1167-1171 (May) 1971
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To lower 
blood pressure 
during 
anesthesia
reduces excessive 
blood loss
Precautions
(sodium nitroprusside)
for controlled hypotension during anesthesia 
Rx Summary
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose 
in water without preservatives. Not for direct injection.
Indications
'Nipride' is indicated for producing controlled hypotension during 
anesthesia to reduce bleeding in surgical procedures where deemed 
appropriate. Benefit-risk ratio should be carefully considered on an 
individual basis.
Contraindications
Adequate facilities, equipment and personnel should be available 
for frequent and vigilant m onitoring of blood pressure. When the in fu­
sion is slowed or stopped, blood pressure usually begins to rise imme­
diately and returns to pretreatment levels w ith in one to ten minutes.
It should be used with caution and initially in low doses in elderly 
patients, since they may be more sensitive to  the hypotensive effects 
of the drug.
If, in the clin ica l situation, stress induced by pain or manipulation 
is reduced or eliminated during 'N ipride' infusion, the patient could 
experience a greater than expected reduction in blood pressure 
unless the rate of infusion is adjusted downward as required.
'Nipride' tends to deteriorate in the presence of light. Therefore, the 
infusion bottle should be wrapped with aluminum foil or other opaque 
material. Solutions of ‘N ipride’ should not be kept or used longer 
than four hours. 'Nipride' in aqueous solution yields the nitroprusside 
ion, which reacts with even minute quantities of a wide variety of 
organic and inorganic substances to form usually highly coloured 
reaction products (blue, green or dark red). If this occurs, the infusion 
should be replaced as quickly as possible.
In the treatment of compensatory hypertension, e.g. arteriovenous 
shunt or coarctation of the aorta. It is also contraindicated in physically 
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia 
or hypovolemia or in those with known inadequate cerebral circulation. 
In patients with liver disease, severe renal disease, Leber’s optic 
atrophy and disease states associated with vitamin B12 deficiency.
Warnings
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose 
in water without preservatives. Not for direct injection. Infusion rates 
greater than 8 /ig/kg/m inute are virtually never required. If at this 
rate an adequate reduction in blood pressure is not obtained within 
10 minutes, administration of ‘Nipride’ should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium 
nitroprusside administration. One factor is common to all known 
cases, namely that large amounts of nitroprusside were infused at 
high rates. Since detoxification relies upon enzymatic action, the 
rare possibility of deficient or atypical enzymes occurring in humans 
should always be considered. Patients most apt to run into difficul­
ties are those who are resistant to the hypotensive effect or those 
in whom maintenance at the selected blood pressure level is difficult 
or impossible.
Constant attention to the patient’s dose-response characteristics 
is mandatory, if infusion rates are in excess of 8 ^g/kg/m inute deter­
mine the nature of the response (effective constant response at 
higher dose; tachyphylactic; resistant -  none or less than expected). 
As soon as either tachyphylaxis or resistance is determined the infu­
sion of ‘Nipride’ should be discontinued immediately. In abnormal 
responders it has been noted that metabolic acidosis may occur 
at higher doses.
Caution should be exercised in using 'Nipride' in patients with hypo­
thyroidism or severe renal impairment.
Blood levels of thiocyanate should be determined if treatment is to 
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 mg/100 ml, it is 
probably safe to continue with the infusion. Peritoneal dialysis can 
be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect 
of sodium nitroprusside than are normotensive subjects. Patients 
receiving concomitant antihypertensive medications (especially 
hydralazine or hexamethonium) are more sensitive to the hypotensive 
effect of sodium nitroprusside and the dosage of 'N ipride' should 
be adjusted downward accordingly.
The following Warnings apply to the use of 'N ipride' fo r controlled 
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially 
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dim in­
ished. If possible, preexisting anemia and hypovolemia should be 
corrected prior to employing controlled hypotension.
3. Hypotensive anesthetic techniques may alter pulmonary ventilation 
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen 
partial pressure.
4. Resistance and tachyphylaxis occur more frequently in normoten­
sive patients infused with sodium nitroprusside. Induction of delib­
erate hypotension in healthy young individuals may prove to be 
more d ifficu lt than in other segments of the population.
5. Upon discontinuance of the sodium nitroprusside infusion for the 
purpose of controlled hypotension during anesthesia a rebound 
hypertension has been observed on rare occasions.
Usage in pregnancy
The safety of 'Nipride' in women who are or who may become preg­
nant has not been established; hence, it should be given only when 
the potential benefits have been weighed against possible hazard 
to mother and fetus.
Usage in children
The safety of 'Nipride' in children has not been established. Clinical 
experience is limited.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache, 
restlessness, agitation, muscle tw itch ing, retrosternal discom fort and 
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo­
minal pain, confusion and somnolence have been noted w ith too 
rapid reduction in blood pressure. These symptoms rapidly disap­
peared with slowing of the rate of infusion or temporary discontinua­
tion of infusion and did not reappear with continued slower rate 
of administration.
Irritation of the injection site may occur. Methemoglobinem ia and 
one case of hypothyroidism follow ing prolonged therapy have been 
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing 
deliberate hypotensive surgery must be restricted to carefully 
selected cases. There is a possibility of an abnormal response 
occurring in normotensive patients. In this event, the infusion of 
‘Nipride’ should be discontinued immediately. (See Warnings).
The contents of a 50 mg ‘N ipride’ vial should be dissolved in 3 ml 
of sterile dextrose in water w ithout preservatives. No other diluent 
should be used. Depending on the desired concentration, all of the 
prepared stock solution should be diluted in 500 or 1000 ml of 5 per­
cent sterile dextrose in water and promptly wrapped in aluminum 
foil or other opaque material. Both stock solution and infusion solu­
tion should be freshly prepared and any unused portion discarded. 
The freshly prepared solution fo r infusion has a very fa int brownish 
tint. If it is highly coloured, it should be discarded. (See Precautions). 
The solution should not be kept or used longer than four hours from 
initial reconstitution. The infusion fluid used for the administration 
of 'Nipride' should not be employed as a vehicle for simultaneous 
administration of any other drug.
'Nipride' dosage varies considerably from patient to patient, hence 
the need fo r individual titration. The infusion should be started at 
the lower dosage range, 0.5 ,ug/kg/m inute and increased by 
0.2 fjg /kg /m inu te  every 5 minutes until the desired reduction in 
blood pressure is obtained. The blood pressure usually starts to drop 
immediately or at least within a few minutes. Continuous m onitoring 
of the blood pressure is necessary. Blood pressure should not be 
allowed to drop at too rapid a rate and systolic pressure should not 
be lowered below 60 mm Hg.
Infusion rates greater than 8 jig /k g /m in u te  should rarely be used.
The maximum recommended dose is 800 mg/minute.
‘Nipride’ should be administered by an infusion pump, m icro-drip 
regulator or any similar device that will allow precise measurement 
of the flow rate. Avoid extravasation. The rate should be adjusted 
to maintain the desired hypotensive effect, as determ ined by frequent 
blood pressure determinations.
For the use of 'N ipride' in the treatm ent of hypertensive crises please 
refer to the Product Monograph.
Supply
'Nipride' is supplied in 5 ml amber-coloured vials containing the 
equivalent of 50 mg sodium nitroprusside fo r dilution with 5 percent 
sterile dextrose in water (available in packages of 10).
Product Monograph available on request.
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Hoffmann-La Roche Limited 
Vaudreuil, Quebec 
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Cholestatic Jaundice 
During Total Parenteral Nutrition
D.B. A lla rd y ce , m d , f r c s [c ], A.J. Salv ia n , m d  and N.F. Q u e n v il l e , m d , f r c p [c ]
Because of the frequent occurrence 
of cholestasis in patients receiving 
total parenteral nutrition (TPN), the 
authors reviewed 32 cases in which 
the patient had been so supported 
for over 30 days. The indications for 
this form of management were 
complications of gastrointestinal surgery 
or inflammatory bowel disease.
The initial protocol for administering 
TPN provided a total of 45 Cal/kg  
(188 kJ/kg). Sixty percent of the 
energy requirement was supplied as 
Intralipid 10% (Pharmacia), 3 g /kg  
daily, and 40% as hypertonic dextrose. 
Amino acids were supplied by Travasol 
(Baxter Laboratories), 100 g or 
2 g/kg of protein daily.
Twenty-four of the 32 patients treated 
according to this protocol showed 
elevated serum alkaline phosphatase 
values by 19 ± 2 .9  days. An increase 
in the concentration of serum bilirubin 
was evident at 30 ±  1.5 days; in 19 
of the 32 individuals the increase was 
progressive to above 2.5 mg/dL 
(43 jj.mol/L). Liver biopsy specimens from 
eight patients showed well-preserved 
hepatocytes, but bile-duct proliferation, 
periportal bile plugs and inflammatory 
infiltrates in portal areas.
The cholestasis was corrected and 
liver function returned to normal in 
all surviving patients when TPN was 
discontinued. Substantial reduction in 
the Intralipid component resulted in 
reversal of cholestasis in three patients.
The authors conclude that TPN 
supplies a high total and percentage 
of energy requirements in the form of 
lipid emulsion when combined with 
hypertonic dextrose and that a high 
protein intake (2 g /kg daily) will induce 
progressive cholestatic jaundice in a 
high percentage of patients if 
administered for more than 30 days.
From the departments of surgery and 
pathology, University o f British Columbia, 
Vancouver, BC
Presented at the 1st annual meeting of the 
Canadian Association o f General 
Surgeons, Vancouver, BC, Jan. 25, 1978
Reprint requests to: Dr. D.B. Allardyce, 
Department o f  surgery, University of 
British Columbia, 700 W 10th Ave., 
Vancouver, BC V5Z 1L5
A cause de I'apparition frequente d'une 
cholostase chez les patients recevant 
une alimentation parenterale complete 
(APC) les auteurs ont etudie 32 cas 
ou les patients ont ete maintenus de 
cette facon pendant plus de 30 jours.
Les indications de ce mode de traitement 
ont ete les complications de la chirurgie 
gastrointestinale ou une maladie 
inflammatoire de I’intestin.
Le protocole original d’APC assurait 
un total de 45 Cal/kg (188 kJ/kg). 
Soixante pourcent des besoins 
energetiques ont ete assures par de 
I'lntralipid 10% (Pharmacia), 3 g/kg  
par jour, et 40% sous forme de dextrose 
hypertonique. Les acides amines ont 
ete procures par le Travasol (des 
Laboratoires Baxter), 100 g ou 2 g/kg  
de proteine quotidiennement.
Vingt-quatre des 32 patients traites 
selon ce protocole ont presente une 
augmentation de la phosphatase alcaline 
serique a compter du jour 19 ±  2.9.
Une augmentation de la concentration 
serique de bilirubine a ete observee 
au jour 30 ±  1.5; chez 19 des 32 
sujets, (’augmentation a ete progressive 
jusqu'a plus de 2.5 mg/dL (43 umol/L). 
Chez huit patients, une biopsie du 
foie a revele une bonne conservation 
des hepatocytes, mais aussi une 
proliferation du canal biliaire, des 
bouchons biliaires peri-portes et des 
infiltrats inflammatoires de la region 
porte.
La cholostase s'est corrigee et la 
fonction hepatique est revenue a la 
normale chez tous les patients qui ont 
survecu, lorsque I'APC a ete interrompue. 
Une reduction substantielle de la 
partie Intralipid a amene une inversion 
de la cholostase chez trois patients.
Les auteurs concluent que I'APC 
procure un total eleve et un fort 
pourcentage des besoins energetiques 
sous la forme d’une emulsion de lipides 
quand elle est associee a une solution 
hypertonique de dextrose et qu'un 
apport proteinique eleve (2 g/kg par 
jour) provoque progressivement un 
ictere cholostatique chez un fort 
pourcentage des patients lorsqu'il est 
administre pendant plus de 30 jours.
Progressive cholestatic jaundice may 
develop in adult patients receiving to­
tal parenteral nutrition (TPN). Since 
1975 more than 150 patients under our 
care have been supported with TPN. 
In 37 of them this form of manage­
ment was continued for over 30 days 
but we omit from this review five cases 
in which the course of the illness was 
complicated by severe sepsis and re­
peated operations. In the remaining 32, 
enterocutaneous fistulas and inflam­
matory bowel disease were the com­
monest indications for instituting TPN  
(Table I). Cholestatic jaundice de­
veloped in 19 patients and the serum 
alkaline phosphatase concentration was 
elevated in 24.
We have examined the records of 
these patients with particular attention 
to the composition of the solutions 
administered, the monitoring of vari­
ous clinical and laboratory values and 
the effect of TPN on hepatic function.
Composition of Solutions
Parenteral nutrition was initiated 
using a mixture comprising 1500 mL 
of Intralipid 10% (Pharmacia, Dorval, 
PQ) (3 g/kg), 1100 mL of Travasol 
(Baxter Laboratories of Canada Ltd., 
Malton, Ont.) and 400 mL of 50% dex­
trose. The total nonprotein energy sup­
ply was 2300 Cal (9.63 x  103 kJ) 
(45 Cal/kg [188 kJ/kg]). Solutions 
were generally administered through 
centrally placed catheters, but through 
peripheral veins for short periods in 
some patients. Because of the develop­
ment of jaundice in a few patients,
Table 1— U n d e rly in g  C ond itions  of 32 
P a tien ts  Who Received TPN fo r  Longer than  
30 Days D u rin g  1976 and 1977
C ond ition
No. o f 
p a tien ts
In f la m m a to ry  bowel disease 10
Esophageal d isease 3
Duodenal f is tu la 5
In te s tin a l f is tu la 5
C olon ic  f is tu la 8
O ther 4
To ta l 35*
‘ M ore th a n  one c o n d itio n  was present in
some p a tie n ts .
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20% dextrose or a protein hydrolysate 
(Amigen 5% or Amigen 800 [Baxter 
Laboratories]) was substituted as the 
energy or protein source.
The major components and additives 
of the TPN solution are shown in Ta­
ble II. Folic acid (10 mg), vitamin 
B 12 (100 jug) and phytonadione (10 
mg) were given intramuscularly once 
a week. Zinc sulfate and other trace 
metals were given if the course of TPN 
extended beyond 3 weeks.
Monitoring
Patients receiving TPN had close 
monitoring of pulse rate, temperature 
and fluid balance. Values of serum 
electrolytes, blood urea nitrogen and 
creatinine, hemoglobin, and leuko­
cyte count and differential were deter­
mined twice weekly; values of serum 
alkaline phosphatase, glutamic oxalo­
Table II— Major Components and Additives 
of TPN Solution
Travasol (Baxter Laboratories),
mL 1050
Intralipid 10% (Pharmacia), mL 1500
Dextrose 50%, mL 450
Protein, g 105
Nitrogen, g 17.5
Nonprotein energy, Cal 2650
Additives
MVI (Arlington Laboratories),
mL 10
Calcium gluconate, meq/d 4.7-9.4
Magnesium sulfate, meq/d 4.0-8.0
Vitamin K, mg/wk 20
Vitamin B12, [xg/wk 100
Folic acid, mg/wk 10
acetic transaminase (SGOT), bilirubin 
(total and indirect), cholesterol, trigly­
cerides and proteins and the prothrom­
bin time were measured weekly. The 
bromsulfalein test was performed in 
three patients before the start of TPN.
Oral feeding was withheld in most 
patients. Access to water was permit­
ted for those able to take fluids. Two 
patients were able to take a fluid diet, 
and one patient was advanced to full 
diet while on TPN in order to observe 
the effect on cholestasis.
Liver Function during TPN
Table III sets forth, for the 32 pa­
tients studied, the composition of the 
TPN mixture infused, the duration of 
TPN when elevation of serum bilirubin 
first became apparent, and the peak
Table III —32 Patients on TPN Classified According to the Presence of: Progressive Cholestasis (19), Minimal Changes (5),
or No Change in Liver Function (8)
Patient
no. Sex
Age,
yr
Composition of TPN 
solution, mL
Serum bilirubin
Serum alkaline 
phosphatase
SGOT Duration 
peak of 
value, therapy, 
IU d
Base
value,
IU
Peak
value,
IU
Days of 
TPN
Peak
value,
mg/dL
Days of TPN
Diagnosis Travasol
Intralipid
10%
Dextrose
50%
Elevated 
at day
Peak at 
day
Elevated 
at day
i M 45 Crohn’s disease (ileum) 1050 1500 450 8.8 24 38 73 750 — — 35
2 F 34 Crohn’s disease (colon) 1600 2000 400 9.6 20 37 158 735 — 230 39
3 F 64 Ovarian carcinoma,
rectovaginal fistula 1050 1500 450 11.2 33 48 77 349 28 107 116
4 M 66 Esophageal necrosis 1050 1500 450 3.4 25 32 46 420 — 170 60
5 F 26 Crohn’s disease 1600 2000 400 4.7 30 60 — 700 24 — 52
6 M 37 Crohn's disease, gastric
outlet obstruction 1200 2000 600 4.5 27 40 68 655 15 152 52
7 F 58 Perforation of esophagus 1100 1500 400 4.0 38 — — 1150 10 58 62
8 F 69 Duodenal fistula, pan-
creatitis 1050 1500 450 4.6 30 37 — 520 20 50 41
9 M 61 Pancreatitis 1050 1620 450 24.5 — — — 400 — — 31
10 M 35 Crohn’s disease (ileum) 1150 1500 450 13.2 31 46 — 800 10 200 49
11 M 73 Postgastrectomy 1100 1500 450 4.9 30 51 91 1800 10 200 45
12 F 62 Small-bowel fistula 1100 1500 400 6.4 42 67 — 480 15 85 64
13 F 38 Perforated gastric ulcer 1050 1500 450 4.0 35 45 50 722 — — 42
14 F 66 Ulcerative colitis 1050 1500 450 3.6 36 52 65 1000 24 90 46
15 M 52 Diverticulitis 1500 200 500 6.2 32 60 120 750 20 210 109
16 M 64 Subphrenic abscess 1100* 1500 400 3.6 25 31 44 313 40 85 42
17 F 61 Crohn’s disease 1700 2000 300 9.8 30 54 — 758 20 202 64
18 M 28 Appendectomy, fistula 1100 1500 400 3.0 63 — — 767 — — 60
19 M 40 Duodenal fistula 1000 1000 — 2.5 26 28 30 — — — 33
20 F 78 Irradiation for carcinoma
of esophagus 1000 1500 400 1.3 28 — — — — 30 —
21 F 50 Colonic carcinoma 1050 1500 450 1.3 24 — — 580 24 29 80
22 F 52 Crohn’s disease 1100 1500 400 1.6 45 50 — 275 — 52 —
23 M 73 Abdominal wall sepsis,
fistula 1100 1500 400 1.3 27 — — — — 106 —
24 M 61 Hypernephroma, mesen-
teric thrombosis 1400 1500 600 1.4 30 34 39 203 — 38 56
25 M 17 Crohn’s disease 1500 ___ 1500 N — — — N — N 35
26 F 22 Crohn’s disease (recto-
vaginal fistula) 1500f 1500 400 N — — — 340 10 N 38
27 M 50 Small-bowel fistula 1500t 2000 600 N — — — N — N 54
28 F 18 Crohn’s disease, total
colectomy 1100 1500 400 N — — — — — N 38
29 M 70 Small-bowel fistula,
necrotizing fasciitis 1100 1500 400 N — — — 506 30 N 49
30 M 45 Duodenal fistula 1400 2000 600 N — — — N — N 77
31 M 64 Bladder carcinoma, bowel
obstruction 750 1500 750 N — — — — — — —
32 F 54 Pancreatitis 750 1500 — 1 . 0 — — — 449 — N 38
*Freamine (McGaw Laboratories, Santa Ana, CA).
tAmigen 800 (Baxter Laboratories).
N =  normal.
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FIG. 1— Case 1. Values of serum glutamic oxaloacetic transaminase (SGOT, IU), 
alkaline phosphatase (Aik. Phos., IU) and bilirubin (Bil., mg/dL) during this patient’s 
hospital course (days).
bilirubin and alkaline phosphatase con­
centrations reached.
The patients were divided into three 
groups—those demonstrating progres­
sive elevation of serum bilirubin and 
alkaline phosphatase (19 patients), 
those with bilirubin values between 1.0 
and 2.5 mg/dL (17.1 and 42.7 /zmol/L) 
associated with elevated serum alkaline 
phosphatase values (5), and those who 
maintained normal serum bilirubin 
concentrations (8). Two of the last- 
named group had elevated serum alka­
line phosphatase concentrations.
All patients who eventually exhibited 
progressive cholestasis had normal se­
rum bilirubin values when TPN was 
started. In three individuals tested, the 
bromsulfalein test also gave a normal 
result.
The earliest time at which the serum 
bilirubin concentration became elevated 
158 was on day 20 after starting TPN. By 
day 42, 18 of 32 patients were jaun­
diced. One individual received treat­
ment with TPN for 63 days before
FIG. 2— Case 2. Values of SGOT, serum alkaline phos­
phatase and bilirubin during hospitalization.
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FIG. 4— Case 4. Values of SGOT, serum alkaline phos­
phatase and bilirubin during hospitalization.
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FIG. 3— Case 3. Values of SGOT, serum alkaline phos­
phatase and bilirubin during hospitalization.
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FIG. 5— Case 5. Values of SGOT, serum alkaline phos­
phatase and bilirubin during hospitalization.
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elevation of the serum bilirubin value 
was noted.
Elevation of serum alkaline phospha­
tase was apparent before elevation in 
serum bilirubin; the average time at 
which it was first noted was on day 
19 ±  2.9 days. Peak values of 748 ±  
89 IU were reached. Moderate eleva­
tion of the SGOT concentration de­
veloped and stabilized at 100 to 200 
IU (normal, to 37 IU). The prothrom­
bin time and serum albumin value 
were normal or improved while the 
patient received TPN.
The course of bilirubin, alkaline 
phosphatase and SGOT values in six 
patients is illustrated by the cases re­
ported below (Figs. 1 to 7). Generally 
the first abnormality to appear is a 
progressive rise in the serum alkaline 
phosphatase value, followed by an in­
crease in SGOT and bilirubin con­
centrations. The bilirubinemia is large­
ly direct-reacting. Withdrawal of TPN 
resulted in prompt reversal of these 
trends in most patients, although “over­
shoot” and slow recovery were noted in 
four individuals (Figs. 2 to 5). The re­
sults of all liver function tests showed 
a return to normal in all surviving pa­
tients. Three deaths occurred in the 
group of jaundiced patients and two 
of these individuals were still jaun­
diced at the time of death. Deaths were 
due to cardiorespiratory complications 
or to an advanced malignant condi­
tion and did not appear to be related 
to cholestasis.
Case Reports
Case 1.—A diagnosis of Crohn’s dis­
ease with predominantly colonic involve­
ment had been made in a 34-year-old 
woman (patient 2, Table III) 2 years be­
fore admission and she was taking sul­
fasalazine (Salazopyrin, Pharmacia) and 
prednisone 20 mg/d. Exacerbation of her 
disease had developed and she was daily 
passing 10 to 20 liquid stools containing
blood. She was admitted for a period of 
intestinal rest. This patient had a slightly 
Cushingoid appearance and was mildly 
obese (weight, 58 kg). Her temperature 
was normal and her pulse rate was 90 
beats/min. She was allowed clear fluids 
by mouth up to 1000 mL/d. TPN was in­
stituted; the solution provided 1600 mL 
of Travasol and 2000 mL of Intralipid 
10% per day (3 g/kg of protein and 3.4 
g/kg of fat daily). Total intake was 2800 
Cal (11.72 X 103 kJ) daily or 50 Cal 
(209 kJ)/kg. The patient was managed 
on a medical service apart from the sur­
gical parenteral nutrition program and it 
is our belief that the protein and fat in­
take and total energy intake for a 58-kg 
patient, requiring maintenance only, was 
in excess of the requirements. The effects 
on her liver function are shown in Fig. 1. 
No manifestations of sepsis appeared dur­
ing her illness. Her tachycardia (between 
90 and 100 beats/min) persisted 
throughout her hospitalization. Leukocyte 
and differential counts were normal. Her 
gastrointestinal symptoms were much re­
lieved when she was discharged on the 
45th hospital day, although her SGOT 
and serum alkaline phosphatase and bili­
rubin values were still elevated. When 
she returned 5 months later for hemor­
rhoidectomy, all indices of liver function 
were within normal limits.
Case 2.—A 26-year-old woman (pa­
tient 5, Table III) had Crohn’s disease of 
the terminal ileum and cecum and com­
plained of persistent obstructive symp­
toms. She was admitted for intestinal rest. 
She was taking prednisone 50 mg/d and 
Salazopyrin 0.5 g six times daily. The 
same TPN protocol was observed as for 
the patient in case 1 for 52 days with 
similar effects upon liver function (Fig. 
2). Her pulse rate fluctuated between 90 
and 110 beats/min. Throughout her hos­
pitalization she remained afebrile, and the 
leukocyte and differential counts were 
normal. She was ambulatory and symp­
tomatically greatly improved. On admis­
sion she weighed 51 kg so that calculated 
amounts of Travasol and Intralipid 10% 
and her total energy supply were clearly 
excessive. After 75 days in hospital her 
symptoms were considerably relieved and
her weight had increased to 67 kg. Re­
sults of tests for liver function were still 
abnormal when she was discharged. She 
was kept under surveillance as an out­
patient and indices of liver function 
showed improvement. Approximately 150 
days later she was readmitted for intes­
tinal resection because of increasing ob­
struction. Liver function was normal at 
that time.
Case 3.—A 37-year-old man (patient 
6, Table III) was transferred to Vancou­
ver General Hospital because of recent 
perforation of a stomal ulcer at a gastro­
enterostomy site; the operation had been 
performed for obstruction of the duodenum 
caused by Crohn’s disease. Gastric outlet 
obstruction persisted with daily loss of 
large volumes of fluid. On admission he 
weighed 53 kg, his temperature was 38 "C 
and his pulse rate 100 beats/min; the 
leukocyte and differential counts were 
normal. Initially he was treated by naso­
gastric decompression and parenteral 
feeding. Calculated amounts of Travasol 
and Intralipid 10% administered were 
more modest than in cases 1 and 2 but 
were still excessive. On this regimen his 
weight increased to 60 kg and his strength 
and mobility greatly improved. However, 
the SGOT value showed a mild increase 
and the serum bilirubin concentration was 
elevated above 2 mg/dL (34.2 pmol/L) by 
hospital day 35 (Fig. 3). A repeat gastro­
jejunostomy was performed on day 36 to 
permit gastric drainage. Postoperatively 
he continued to show an upward trend of 
serum bilirubin, alkaline phosphatase and 
SGOT values. TPN was discontinued on 
hospital day 55, and after a short in­
terval and overshoot of serum alkaline 
phosphatase concentration, his liver func­
tion returned to normal. Intravenous 
cholangiography at this time showed nor­
mal-sized extrahepatic ducts.
Case 4.—This 62-year-old woman 
(patient 12, Table III) originally under­
went laparotomy for a pelvic mass. She 
was found to have ovarian metastases 
from a previous primary growth of the 
colon. As there was no evidence of spread 
elsewhere, the ovarian tumour was ex­
tirpated. A small-bowel fistula developed 
on the 10th postoperative day so TPN
FIG. 6— Case 6. Values of SGOT, serum alkaline phos­
phatase and bilirubin during hospitalization.
FIG. 7— Case 7. Values of SGOT, serum alkaline phos­
phatase and bilirubin during hospitalization.
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was instituted. Initially there was per­
sistent tachycardia and leukocytosis but 
these manifestations of sepsis regressed. 
After 40 days of TPN, however, th; 
fistula had not closed, so a small-bowel 
resection was performed. TPN was con­
tinued and an increase in concentrations 
of serum bilirubin and alkaline phospha­
tase was detected (Fig. 4). After 60 days 
of TPN the regimen was changed to 
Amigen with a partial reversal of cholesta­
sis. The patient was discharged after 95 
days in hospital. She returned 3 months 
later with evidence of further intra-ab­
dominal neoplasia; her condition deteri­
orated progressively and she died. At the 
time of death, liver function was normal.
Case 5.—A 35-year-old man (patient 
10, Table III) had recurrent Crohn’s dis­
ease of the ileum and left colon following 
previous resection of the terminal ileum 
and right colon. He had severe perianal 
complications with abscesses and fistulas. 
Following evacuation of a perianal abscess 
TPN was instituted to ensure intestinal 
rest and to improve his nutritional status 
prior to further surgery. Serum alkaline 
phosphatase concentration increased early 
and rapidly after the institution of TPN 
(Fig. 5). The serum bilirubin value was 
elevated after 38 days of TPN. Resection 
of the left colon and rectum was per­
formed on day 24 of TPN. At operation, 
calculi were found in the gallbladder, 
which was removed. An operative cholan- 
giogram showed a normal extrahepatic 
biliary tree without evidence of obstruc­
tion. Following surgery he exhibited no 
manifestations of bacterial infection. His 
pulse rate never rose above 100 beats/ 
min, he was afebrile and the band cells 
were never in excess of 10%. He received 
no medications commonly recognized as 
causing cholestasis. Because of progressive 
cholestasis, Travasol was deleted from his 
program on about day 40. He was sup­
ported on dextrose and lipid alone for 10 
days but cholestasis progressed neverthe­
less. During hospitalization he gained 5.4 
kg and was discharged on about hospital 
day 55, still icteric and with an elevated 
alkaline phosphatase concentration but 
feeling well and eating a full diet. On 
follow-up within 30 days of discharge, 
serum bilirubin, alkaline phosphatase and 
SGOT values had all returned to normal.
Case 6.—Cholestasis developed in a 
66-year-old woman (patient 14, Table III) 
who was receiving TPN and intestinal rest 
for severe ulcerative colitis. Because of 
progressive cholestasis (Fig. 6) her nutri­
tional support was changed from lipid, 
dextrose and Travasol to Amigen 800 on 
day 50 of her TPN program. Amigen 
800 supplies energy requirements as 
fructose and as a small quantity of ethanol. 
Cholestasis was reversed promptly on this 
regimen. Colectomy was performed on 
day 57. Liver function tests 117 days after 
TPN was instituted revealed normal serum 
bilirubin and SGOT values.
Case 7.—Six months before admission, 
this 73-year-old man (patient 11, Table 
III) had had a total gastrectomy for ade­
nocarcinoma of the stomach with a Roux- 
en-Y esophagojejunostomy. Partial ob­
struction appeared to have developed at 
the anastomotic site. Weight loss ensued 
and he was readmitted for intravenous
feeding and investigation. Early in the 
course of TPN, rapid elevation of alka­
line phosphatase and SGOT concentrations 
was noted (Fig. 7). The patient had no 
abdominal pain and was afebrile with a 
pulse rate of 80 beats/min. Leukocyte 
count was normal. He had received no 
icterogenic drugs. He was allowed clear 
fluids and took up to 1000 mL/d. Eleva­
tion of serum alkaline phosphatase values 
was suspected to be caused by recurrent 
tumour. Because of cholestasis, Travasol 
was deleted on day 23 of TPN. On lipid 
and 20% dextrose alone the patient re­
mained jaundiced with greatly elevated 
serum alkaline phosphatase values. All
Table IV—Evidence for Bacterial Sepsis in 19 
Cases of Progressive Cholestasis
No. of 
patients
Febrile (over 37°C orally) for more
than 5 of first 30 days on TPN 0
Pulse rate over 90 beats/min for 
m orethan5offirst30days 5
Total leukocyte count over 12.0 X 
109/L  in first 30days 5
Band forms over 20% in first 30 
days 2
Positive blood culture 2
Severe sepsis:
T emperature over 38°C 
Pulse rate over 120 
beats/min 0
Leukocytes over 20.0 X 
109/L , or
Band forms over 30%
Table V—Operation Prior to Onset of
Progressive Cholestasis
No. of 
patients
No operation prior to elevation of
serum bilirubin concentration 7
Operation (no halothane) prior to
elevation of serum bilirubin 
concentration 2
Operation with halothane
anesthesia 10
Table VI—Prior Use of Drugs in 
Progressive Cholestasis
Cases of
Drug
No. of 
patients
Phenothiazines 0
Androgenic steroids 0
Erythromycin 0
Chloral hydrate 2
Barbiturates 2
Flurazepam HCI 3
Sulfasalazine (Salazopyrin) 1
Steroids 2
Antibiotics
Chloramphenicol 2
Gentamycin 4
Ampicillin 2
Clindamycin 2
Cephalothin 3
Cloxaci Min 3
Tobramycin 1
Digoxin 2
parenteral feeding was discontinued on 
day 40 and he was supported on a mixture 
of 10% dextrose and water, Vivonex 
(Eaton Laboratories) and other fluids. A 
liver biopsy showed periportal inflamma­
tion and bile-duct proliferation. After dis­
continuance of TPN the results of all 
liver function tests returned to normal. 
At the same time the patient’s nutritional 
status was deteriorating. Terminally, pneu­
monia and ureteral obstruction developed. 
Autopsy showed recurrent tumour in the 
retroperitoneal tissues obstructing the 
ureter. No hepatic metastases were pre­
sent. The extrahepatic biliary tree was 
patent and of normal calibre. ~~
Other Causes of Cholestasis
A relationship of the course of 
cholestasis to coexisting sepsis, prior 
operation and anesthesia or to medica­
tion seemed unlikely (Tables IV to VI). 
Six patients did not have an anesthetic 
or operation. In three individuals their 
operation was performed 1 month be­
fore the onset of jaundice. None re­
ceived any medication commonly asso­
ciated with cholestasis. None of the 
32 patients suffered from severe bac­
terial sepsis, defined as pyrexia over 
38°C, pulse rate over 120 beats/min, 
leukocyte count over 20 X 109/L  or 
band forms in excess of 30% (Table 
IV).
The absence of a relation to bac­
terial sepsis is further illustrated by 
the case of a 66-year old man (patient 
4, Table III) who underwent resection 
of the thoracic esophagus as a result 
of strangulation of a paraesophageal 
hernia with mediastinitis. This was re­
constructed with left colon. Postopera- 
tively a leak developed from the prox­
imal coloesophageal anastomosis so 
TPN was begun. On the TPN regimen 
serum alkaline phosphatase and bili­
rubin concentrations became elevated 
(Fig. 8a). Travasol and dextrose were 
continued but the lipid was reduced to 
1000 mL weekly to avoid deficiency 
of essential fatty acids. On markedly 
reduced lipid intake serum bilirubin 
and alkaline phosphatase values re­
turned to normal. His temperature and 
pulse rate remained normal throughout, 
except on one occasion (Fig. 8b). Al­
though the percentage of band cells in 
the differential leukocyte count was in­
creased initially, it was below 10% 
throughout the period in which chole­
stasis was evident.
Patency of the biliary system was 
demonstrated by cholangiography, B- 
scanning, or at autopsy in seven of the 
jaundiced patients. Eight others were 
operated on before or during their 
course of TPN and the liver and biliary 
system were found to be normal (Table 
VII). No operative or radiologic evalu­
ation of the bile ducts was made in 
four patients, but their liver function 
returned to normal and remained so 
after TPN was discontinued.
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Liver Biopsy
Liver biopsy specimens were ob­
tained from eight patients and demon­
strated a consistent lesion typified by
IU mg/dL mg/dL
portal areas expanded by inflammatory 
cell infiltrates and bile-duct prolifera­
tion. Bile plugs were present in peri­
portal canaliculi. The liver cells were 
well preserved (Figs. 9 to 11).
Discussion
The development of abnormalities of 
liver function has not been detected 
by close observation of adults who have 
been maintained on long-term parent­
eral nutrition.1 Furthermore, it has 
usually been possible to ascribe hyper­
bilirubinemia in surgical patients receiv­
ing parenteral nutrition to sepsis, drugs, 
tissue trauma, resolving hematomas, 
anesthetic agents, hemolysis, hypoxia, 
shock, or extrahepatic ductal obstruc­
tion. Because these septic and metabolic 
insults have been identified in many of 
our patients, one might question 
whether the cholestatic jaundice we re­
port here was related to TPN.
The early phase of our patients’ ill­
ness often involved major trauma, op­
erative procedures and bacterial sepsis. 
The cholestasis seen later bore no rela­
tion to the earlier catabolic illness. In 
contrast, cholestasis appeared to de­
velop when patients were in a phase 
of rapid anabolism without manifesta­
tions of sepsis. Although some patients 
did demonstrate moderate tachycardia 
(pulse rate, 90 to 100 beats/min) and 
leukocytosis for extended periods, 
cholestasis supervened on an unchang­
ing pattern of pulse rate and leukocyte 
count.
Two patients with Crohn’s disease 
were receiving TPN to ensure a period 
of intestinal rest and to improve their 
nutritional status. No operation was 
performed and the only medications 
prescribed were prednisone and sulfa­
salazine (Salazopyrin, Pharmacia). Nei­
ther patient was febrile and the pulse 
rate was elevated only minimally 
throughout. Both individuals demon­
strated progressive elevation of serum 
alkaline phosphatase and SGOT con­
centrations and later a direct hyper­
bilirubinemia (Figs. 1 and 2).
Biochemical evidence of cholestasis 
appeared consistently within 2 to 3 
weeks of starting TPN, which strongly 
suggests an association.
Table VII—-Patency of Biliary System in 19
Cases of Progressive Cholestasis on TPN
No. of 
patients
Liver and gallbladder described as 
normal at operation 
Intravenous cholangiogram
8
normal 2
T tube in place, cholangiogram
normal. No obstruction found 
at autopsy 1
No obstruction found at autopsy 
B scan showed normal ducts and
1
gallbladder
Operative cholangiogram showed
1
patent ducts
Sinogram to common bile duct
1
normal 1
No information on biliary system 4
b e a t s / m i n  °C
1 Days
TPN Begun
Fig. 8b
FIG. 8— Absence of relation between cholestasis and bacterial sepsis, (a) Values 
of SGOT, serum alkaline phosphatase and bilirubin, (b) Pulse rate, temperature, leuko­
cyte count and band cells during hospital course of 66-year-old man who received TPN  
when leak developed at anastomosis after resection of thoracic esophagus.
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Although halothane was administered 
to 10 of the 19 patients in the pro­
gressively jaundiced group, 2 of the 
10 patients were given the general 
anesthetic more than 30 days before 
the onset of cholestasis. Moreover, the 
pathologic features were not similar to 
those seen in previously described cases 
of halothane hepatitis. Therefore to in-
FIG. 9— Gastric outlet obstruction (pa­
tient 13, Table III). Expanded portal triad 
shows mixed inflammatory infiltrate, in­
cluding numerous polymorphonuclear leu­
kocytes, moderate numbers of eosinophils 
and lymphocytes, and proliferation of bile 
ducts (hematoxylin and eosin, reduced by 
50% from X160).
FIG. 10—Same patient as in Fig. 9. 
Larger portal zone with interlobular ductal 
proliferation with associated mixed in­
flammation around margin of portal area. 
Limiting plate is intact (hematoxylin and 
eosin, reduced by 50% from x400).
fer that this agent contributed to the 
disturbed liver function would be to 
presume an extraordinary incidence of 
halothane hepatitis.1
Because there was no anemia, mor­
phologic abnormalities of erythrocytes, 
or indirect-reacting hyperbilirubinemia, 
hemolysis cannot have been a factor 
contributing to the occurrence of 
cholestasis.
If the cholestatic jaundice is due to 
the TPN regimen, it is difficult to iden­
tify the component of TPN that causes 
it. None of the routine additives (min­
erals, vitamins, trace elements) would, 
either by reason of their deficiency or 
excess, be responsible. However, there 
are identifiable differences between the 
composition of the solution we used 
and other TPN solutions that have not 
caused disturbance of liver function or 
histology when employed over extended 
periods. For long-term parenteral feed­
ing Jeejeebhoy and his colleagues2 used 
a solution supplying 25% of nonprotein 
energy requirements as Intralipid 10% 
and 65% as dextrose. Only three of 
their patients received Travasol as a 
source of amino acid, and no change 
was noted in measurements of liver 
function in these individuals. The 
amount of nitrogen supplied in their 
program was more modest than in ours 
(13 g/d or 1 g/kg). Our TPN program 
supplied 60% of energy requirements
FIG. 11—Pancreatitis, T tube in com­
mon bile duct (patient 9, Table III). Ex­
panded portal triad with ductal prolifera­
tion and heavy mixed inflammatory in­
filtrate consisting chiefly of polymorpho­
nuclear leukocytes and lymphocytes. In­
flammation extends into adjacent liver 
parenchyma but there is no piecemeal 
necrosis. Cholestasis is severe, bile thrombi 
being most prominent in periportal zone. 
Within lobule hepatocytes show degenera­
tion (hematoxylin and eosin, reduced by 
50% from x400).
as lipid, 40% as dextrose and 18 g of 
nitrogen daily.
It is possible that reducing the lipid 
contribution radically, supplying only 
1000 mL weekly to prevent essential 
fatty acid deficiency, resulted in re­
versal of cholestasis in the two cases 
where this was tried (Fig. 8).
The mechanism of this cholestasis 
remains to be elucidated, but it seems 
apparent that lipid/dextrose ratios ap­
proximating 3:2 combined with a high 
amino acid intake of 2 g/kg will cause 
cholestatic jaundice in 50% to 75% of 
patients who are given the solutions for 
30 days. Suggested mechanisms are de­
fective hydroxylation of bile acids and 
intrahepatic accumulation of lithocolic 
acid,3 or a direct toxic effect of a com­
ponent of the amino acid solution 
(methionine).4 Antioxidants added to 
amino acid solutions have been sug­
gested as causative agents of changes 
in liver function in patients receiving 
TPN.5
The absence of oral intake and the 
resulting absence of gastroduodenal 
stimulation of the water and electrolyte 
components of bile flow have been sug­
gested as contributory factors.6 How­
ever, two individuals in our series took 
a clear fluid diet throughout their 
course of TPN and this did not prevent 
the development of cholestasis (Figs. 1 
and 2). Full diet was introduced for 
one patient (patient 1, Table III) and 
failed to reverse the course of hyper­
bilirubinemia.
Abnormalities of liver function and 
histology that have developed in pa­
tients on other TPN regimens should 
not be confused with the condition en­
countered in the patients in this series. 
Infusion of a solution that will supply 
all nonprotein energy requirements as 
dextrose, as described by Grant,5 will 
lead to acute fatty infiltration of the 
liver which may be associated with 
elevated SGOT, serum alkaline phos­
phatase and serum bilirubin values. 
This lesion is preventable or can be 
reversed by addition of Intralipid 10% 
to supply 20% to 40% of energy re­
quirements.7 Cholestatic jaundice sub­
siding after discontinuation of TPN has 
been described in premature infants8 
and the histologic appearance of liver 
biopsy specimens from them is similar 
to what was observed among the adult 
cases in our program.
Summary
A TPN mixture supplying a lipid 
emulsion in a dose of 3 g/kg, supple­
mented by 900 Cal (3.8 x  103 kJ) as 50% 
dextrose and with a protein intake of 
2 g/kg led to development of progres­
sive cholestasis in 19 of 32 patients 
receiving long-term TPN. Elevated 
serum alkaline phosphatase concentra-
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tions appeared consistently around day 
20, and by day 42 jaundice was ap­
parent in 18 of the 32 patients. Serum 
proteins and prothrombin time were 
not appreciably affected, and serum 
bilirubin, serum alkaline phosphatase 
and SGOT values returned to normal 
when TPN was discontinued.
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Antibiotics in Surgery of the Colon
R.T. Lewis, mb, frcs[c], facs,* with C.M. A llan, md, frcs[c], facs,* 
R.G. Goodall, md, frcs[c], FACs,f W.C. Lloyd-Smith , md, frcs[c], facs,* 
B. Marien, md, frcs[c]* and F. Wiegand, md, frcs[c], facs*
In a randomized prospective study of 
patients undergoing elective colonic 
surgery the postoperative wound 
infection rate was 13% (early, 10%) 
in patients receiving systemic 
cephaloridine perioperatively and 12% 
(early, 7.3%) in those given oral 
neomycin and erythromycin base 
preoperatively. Wound infections were 
more frequent in patients with severe 
lymphopenia or hypoalbuminemia pre­
operatively, but the potential degree of 
wound contamination was the main 
determinant of postoperative infection.
Dans une etude prospective randomisee 
chez des patients subissant une 
operation non urgente du colon, le 
taux d’infection postoperatoire a ete 
de 13% (10% pour les infections
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precoces) chez les patients recevant 
un traitement peroperatoire a la 
cephaloridine systemique, et de 12% 
(7.3% pour les infections precoces) 
chez ceux qui ont recu de la neomycine 
et de I'erythromycine par voie orale 
dans la periode preoperatoire. Les 
infections de la plaie ont ete plus 
frequentes chez les patients ayant une 
lymphopenie ou une hypoalbuminemie 
severes avant I’operation, mais le 
potentiel de contamination de la plaie 
a ete le principal determinant des 
infections postoperatoires.
The determinants of bacterial surgical 
infection are well known:1 (a) con­
tamination by an inoculum of bacteria, 
(b) lodgement of bacteria in a favour­
able local environment, and (c) bac­
terial propagation unhindered by host 
resistance. Recent studies have at­
tempted to describe finite dimensions 
for these determinants, which may per­
mit their manipulation to minimize the 
risk of postoperative infection. Thus 
Robson, Krisek and Heggers2 have 
designated quantitatively the critical 
extent of bacterial contamination nor­
mally associated with bacterial wound 
infection. MacLean and his colleagues3,4 
have demonstrated that impaired nu­
trition may be an important determinant 
of diminished host resistance associated 
with surgical sepsis. Burke,5 Polk and 
Lopez-Mayor6 and Waterman and
Kastan7 have shown that the timing 
and dosage of antibiotics are critical 
to their successful use in preventing 
lodgement in potentially contaminated, 
contaminated and dirty wounds. Con­
troversy remains, however, as to the 
optimal route and antibacterial spec­
trum of antibiotics indicated in surgery 
of the colon. Polk8 administered peri­
operatively a systemic antibiotic that 
was effective mainly against aerobic 
bacteria. Nichols and associates9 pre­
ferred preoperative administration of 
an enteral antibiotic combination ef­
fective against both aerobic bacteria 
and the main colon anaerobes.
Starting in November 1975 a pro­
spective randomized study of patients 
undergoing elective colonic surgery 
was undertaken at the Queen Elizabeth 
Hospital of Montreal Centre to com­
pare these two modes of antibiotic 
prophylaxis and to examine the deter­
minants of wound sepsis in these pa­
tients.
Patients and Methods
Patients undergoing elective surgery 
of the colon were randomly assigned 
to two groups. All patients received a 
standardized mechanical bowel prepara­
tion as indicated in Table I. Group 1 
patients received cephaloridine, 2 g 
intravenously or intramuscularly, 2 
hours preoperatively and again 5 hours
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Table 1- Mechanical Bowel Preparation
Preoperative
day Procedure
3 1 tab bisacodyl (Dulcolax) at 
1800 h
2 Low-residue diet 
Magnesium citrate, 56.7 g, at 
1000,1400 and 1800 h 
Saline enemas to clear at 
1800 h
1 Clear fluids only, orally  
Magnesium citrate, 56.7 g, at 
1000 h
Saline enema at 1400 h
later. Group 2 patients received neo­
mycin and erythromycin base, 1 g of 
each orally, on the final preoperative 
day at 1300, 1400 and 1800 hours. At 
operation smears were obtained for 
culture from the open colon and from 
the subcutaneous tissues of the wound 
before closure; the degree of wound 
contamination was noted. Wounds 
were inspected for signs of infection 
on the fifth and seventh postoperative 
days and thereafter as required. 
Wounds showing tenderness, erythema, 
or induration were closely observed to 
resolution or discharge of pus. Wounds 
that discharged pus were regarded as 
infected (early wound infection) and 
the discharge was cultured. A follow­
up report was requested from each 
surgeon on wound infections not diag­
nosed until after the patient left hos­
pital but within the first month after 
operation (late wound infection). Pa­
tient records were reviewed to ascer­
tain lymphocyte counts and serum al­
bumin concentrations determined pre- 
operatively and prior to any transfusion 
of blood or blood products. Concentra­
tions were defined for severe hypopro- 
teinemia and lymphocytopenia accord­
ing to criteria suggested by Blackburn 
and associates10 and Lee and col­
leagues.11 Patients who underwent sur­
gery on a segment of colon previously 
defunctioned by proximal colostomy 
were excluded from the study. The age 
of the patients, the duration of pre­
operative hospitalization, the identity 
of the operating surgeon, diagnosis 
and the type of operation performed 
and its duration “from skin to skin” 
were noted. A risk index of postoper­
ative wound infection for each proce­
dure was calculated as recommended 
by Davidson, Clark and Smith.12 Statis­
tical analysis was performed where in­
dicated by the y1 test and by Student’s 
/-test.
Results
Seventy-nine patients were included 
in the study; 38 were allocated to group
1 and 41 to group 2. A comparison of 
the groups reveals that they were rea­
sonably well matched with respect to 
age and risk index (Table II). The 
groups were also matched with respect 
to the number of cases and frequency 
of wound infections for each operating 
surgeon. When wounds were classified 
according to the potential degree of 
contamination,13 5 of 13 contaminated 
or dirty wounds became infected, while 
in 5 of 66 clean-contaminated wounds 
infection developed (P <  0.002). A 
similar preponderance of infections in 
contaminated and dirty cases was seen 
within each group.
The overall rate of wound infection 
was 12.6% and of early wound infec­
tion, 8.8%. There were no significant 
differences in the frequency of wound 
infections between group 1 and group
2 (Table III). Anaerobic bacteria were 
cultured from 2 of 15 specimens taken 
from the colon in group 1 and from 4 
of 17 such specimens from group 2; 
anaerobes were isolated from one in­
fected wound in each group.
Table IV shows the relation between 
postoperative wound infections and
host resistance as indicated by absolute 
peripheral lymphocyte counts and se­
rum albumin concentrations measured 
before operation. The mean lympho­
cyte count before operation in the pa­
tients who had sepsis after operation, 
1.095 ±  0.498 x  107L, was signifi­
cantly lower than the 1.683 ±  0.706 X 
109/L  in those without postoperative 
sepsis (P <  0.03).
Discussion
This study confirms that, of the 
established determinants of wound in­
fection, the degree of wound con­
tamination is the pre-eminent factor. 
This appears to be true whether one 
assesses the potential degree of conta­
mination by classification of wounds,13,14 
as in the present study, or the actual 
degree of wound contamination as de­
termined by culture of the subcutaneous 
tissues after the fascia is closed.12,15 
Effective aseptic technique and anti­
sepsis to prevent contamination should 
therefore remain the primary approach 
to minimizing the frequency of wound 
infection.
Table I I— Comparison of Patient Groups
Factor Group 1 Group 2
Age, yr
<  60 13 11
60-80 20 25
>80 5 5
Risk index 27.9 28.7
Diagnosis and operative site,
no. of wound infections/no. of cases
Carcinoma 2/25 3/28
Inflammation 3/13 2/13
Operation in true pelvis 2/24 1/17
Operation outside true pelvis 3/14 4/24
Table I I I— Incidence of Wound Infections
No. of wound infections/total no. of cases
Group 1 Group 2 Total wound
Wound______________________________  (n =  38) (n =  41) infections (and % )
A. Clean-contaminated wounds 3/31 2/35 5 n  6)
B. Contaminated and dirty wounds 2 /7 3 /6 5 (38 6)
C. Total wound infections 5/38 5/41 10 (12 6)
D. Early wound infections 4/38 3/41 7 (8.8)
The difference between A and B is statistically significant (P  <  0.002).
Differences between groups 1 and 2 are not statistically significant.
Table IV— Host Resistance and Wound Infections
Laboratory measurement
No. of wound infections/ 
total no. of cases P value
Lymphocytes, X 10°/L
<  1.0 2/6
>  1.0 3/24 >  0.05
Serum albumin concentration, g /L
<  22.5 3/6
> 2 2 .5 0/23 <  0.005
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Antibiotic therapy is, however, an 
important adjunct in patients at risk 
of sepsis. Polk8 has demonstrated con­
sistently the diminished frequency of 
surgical infection brought about by 
administration of systemic cephaloridine 
perioperatively, but others16,17 have ex­
pressed dissatisfaction with this regi­
men, and have attributed its failures 
to its inability to deal with the bowel 
anaerobes. Since the completion of the 
present study Clarke and colleagues18 
have shown convincingly that oral ad­
ministration of neomycin and erythro­
mycin before operation reduces the fre­
quency of septic complications of colon 
operations.
Our investigation showed no differ­
ence in frequency of wound infection 
when systemic cephaloridine and orally 
administered neomycin-erythromycin 
were compared. The cephaloridine 
regimen employed was slightly differ­
ent from that used in Polk’s original 
study, in keeping with Waterman’s 
recommendations7 and Polk’s subse­
quent practice. We did not include a 
no-antibiotic group because we be­
lieved that the excellent studies of Polk 
and Lopez-Mayor6 and Washington and 
associates19 had already clearly demon­
strated the advantage of the use of 
antibiotic regimens in colon surgery. 
The wound infection rates in both our 
groups were somewhat • higher than 
those reported by Polk and Lopez- 
Mayor6 and Clarke and colleagues.18 
However, neither of these groups speci­
fically mentioned the inclusion of late 
wound infections diagnosed up to 1 
month postoperatively. Their total 
wound infection rates were approx­
imately the same as the early wound 
infection rates found in our study.
Our data do not explain why the 
differences in route of administration 
and spectrum of the antibiotics used 
in the two treatment groups were not 
associated with different infection 
rates. Moore, Cato and Holdeman20 
noted that the redox potential of the 
colon, which is the primary site of 
action of the neomycin-erythromycin 
combination, is -250 mV, in contrast 
to that of +120 mV of the normal 
wound, which is the primary site of 
action of cephaloridine. Stone, Kolb 
and Geheber21 indicated that in normal 
tissues elimination of the aerobic part­
ner of the usual aerobe-anaerobe sym­
biosis automatically increases redox po­
tential of the environment so that it 
becomes hostile to anaerobes. Thus, 
antibiotics acting on the wound and 
effective primarily against aerobes may 
afford adequate prophylactic therapy. 
In the colon the low redox potential 
allows anaerobes to thrive even when 
aerobic bacteria have been eliminated; 
hence for preoperative bowel prepara­
tion an antibiotic combination effective
against anaerobic as well as aerobic 
bacteria is required.
The association we discovered be­
tween lymphocytopenia, hypoproteine- 
mia and postoperative infection has 
not previously been reported. It is, 
however, in keeping with the established 
close correlation between peripheral 
lymphocyte counts and cell-mediated 
immunity (CMI)11 and the observed 
interaction of impaired CMI, impaired 
nutrition and postoperative sepsis.22,23 
Lee and coworkers11 noted a close rela­
tion between lymphocytopenia and 
anergy to 2,4-dinitrochlorobenzene skin 
testing in cancer patients; Pietsch and 
Meakins22 were able to identify surgical 
patients at increased risk of sepsis by 
preoperative anergy; and Law, Dudrick 
and Abdou23 as well as Spanier and 
associates4 have related diminished im- 
munocompetence in surgical patients 
to impaired surgical nutrition and hy- 
poproteinemia. Since the number of 
patients in the present report in whom 
lymphocytopenia and hypoproteinemia 
were studied is small, further investiga­
tion is required to corroborate these 
findings.
Conclusions
The determinants of wound sepsis 
have been examined in a prospective 
randomized study of patients undergo­
ing elective colonic surgery. Two modes 
of antibiotic prophylaxis, differing in 
route and antibacterial spectrum, were 
compared.
1. The potential degree of wound 
contamination remains the dominant 
determinant of postoperative wound 
sepsis.
2. Preoperative bowel preparation 
with oral neomycin and erythromycin 
base is as effective in prophylaxis as 
the systemic administration of cepha­
loridine perioperatively.
3. Preoperative lymphocyte counts 
and serum albumin concentrations may 
be useful guides to the role of host 
resistance in permitting postoperative 
sepsis.
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To control upper 
gastrointestinal bleeding 
due to stress ulcer, 
hemorrhagic gastritis, stress 
gastritis, bleeding gastric 
erosions, duodenal and 
gastric ulcers...
The 'Tagamet'effect
The precise mechanism by which 'Tagamet1 controls upper g.i. bleeding is not 
understood, although several theories exist, of which these seem the most likely.
Significantly Inhibits Gastric Acid Secretion,
raising the pH of the stomach to inactivate pepsinogen (thereby decreasing pepsin which is 
known to digest protein in an acidic environment) and possibly promoting clot formation.
May Decrease Gastric Mucosal Blood Flow
due to inhibition of acid secretion, allowing the body's hemostatic mechanism 
to control bleeding.
May Prevent Further Damage to the Mucosa
by acid through blockade of histamine H2 receptors, thereby encouraging 
healing of the mucosal injury.
65 patients in whom other non- 
surgical measures had failed, or 
for whom surgical intervention 
was considered impossible or 
unduly hazardous, were 
evaluated; the results are 
reported in the adjacent table.1
C o m p lete
S u cce ss
P a rtia l
S u c c e s s
C o m p lete  
& P a rtia l 
S u cce ss
F a ilu re
Heavy 65% 15% 80% 20%
Moderate 52% 22% 74% 26%
Subacute/recurrent 45% 25% 70% 30%
1. Data on file, SK&F Medical Department
The H2 Receptor Antagonist-A major clinical 
advance for uncontrolled g.i. bleeding
SMITH KLINE &FRENCH CANADA LTD.
Montreal, Quebec H4M 2L6
Tagamet®
(cim etidine SK&F)
Tablets
Injection
Prescribing Inform ation
(Product Monograph available to practitioners on request)
ACTION
Cimetidine competitively inhibits the action of histamine 
at the histamine Ho receptor, and thus represents a new 
class of pharmacological agents, the histamine 
^ -receptor  antagonists.
Cimetidine is not an anticholinergic agent. Studies have 
shown that cimetidine inhibits both daytime and nocturnal 
basal gastric acid secretion. Cimetidine also inhibits 
gastric acid secretion stimulated by food, histamine, 
pentagastrin, caffeine and insulin. Its ability to inhibit 
gastric acid secretion via this unique mechanism of action 
permits a new approach to the treatment of acid-related 
gastrointestinal disorders.
Cimetidine is absorbed rapidly after oral administration. 
The plasma half-life is approximately two hours. The 
principal route of excretion is the urine.
The degree and duration of inhibition of basal and 
stimulated gastric acid secretion are dose-related; the 
data suggest that 80% or higher inhibition throughout a 
24 hour period can be achieved by a dosage regimen of 
300 mg four times daily given with meals and at bedtime. 
Cimetidine 300 mg reduced total pepsin output as a result 
of the decrease in volume of gastric juice. The drug had no 
effect on the rate of gastric emptying or lower esophageal 
sphincter (LES) pressure.
INDICATIONS AND CLINICAL USE
Tagamet® (cimetidine) is primary therapy for conditions 
where the inhibition of gastric acid secretion is likely to be 
beneficial, such as:
□  Duodenal ulcer
□  Non-malignant gastric ulcer
□  Gastroesophageal reflux disease
□  Management of upper gastrointestinal hemorrhage
□  Pathological hypersecretion associated with Zollinger- 
Ellison Syndrome, systemic mastocytosis and multiple 
endocrine adenomas.
CONTRAINDICATIONS
There are no known contraindications to the use of 
'Tagamet' (cimetidine).
PRECAUTIONS
Use in Pregnancy: Nursing Mothers:
There has been no experience, to date, with use of 
'Tagamet' (cimetidine) in pregnant patients. Reproduction 
studies performed in rats, mice and rabbits have revealed 
no evidence of impaired fertility or harm to the fetus due to 
'Tagamet'. Studies have demonstrated that 'Tagamet' 
crosses the placental barrier. It is also secreted in the milk 
of animals. 'Tagamet' should be used in pregnant or 
lactating patients or women of child-bearing potential only 
when, in the judgement of the physician, the anticipated 
benefits outweigh the potential risks.
Use in Children
Clinical experience in children is limited. Therefore, 
'Tagamet' (cimetidine) therapy cannot be recommended 
for children unless, in the judgement of the physician, 
anticipated benefits outweigh the potential risks. In very 
limited experience, 20-40 mg kg per day has been 
administered in divided doses by mouth or intravenously. 
Use in Impaired Renal Function
Because 'Tagamet' (cimetidine) is excreted by the kidney, 
a reduced dosage should normally be administered to 
patients with impaired renal function. (See DOSAGE AND 
ADMINISTRATION)
Drug Interactions
Studies in animals revealed no pharmacological inter­
action between 'Tagamet' and commonly used drugs. No 
significant interactions have been observed in man.
ADVERSE REACTIONS
Mild and transient diarrhea, muscular pain, dizziness and 
rash have been reported in a small number of patients 
during treatment with 'Tagamet' (cimetidine). There have 
been reports that a few patients have developed mild 
nonprogressive gynecomastia during prolonged treatment. 
No evidence of induced endocrine dysfunction was found, 
and the condition remained unchanged with continuing 
'Tagamet' treatment. Some increases in plasma creatinine 
and serum transaminase have been reported.
OVERDOSAGE
In cases reported to date, involving oral ingestion of up to 
10 grams of 'Tagamet' (cimetidine), no untoward effects 
have been noted, and recovery has been uneventful. 
Treatment
The usual measures to remove unabsorbed material from 
the gastrointestinal tract, clinical monitoring and 
supportive therapy should be employed. Studies in animals 
indicate that assisted respiration may be of value and that 
any tachycardia may be controlled by administration of a 
B-blocker.
DOSAGE AND ADMINISTRATION
ADULTS:
(Experience with 'Tagamet' in children is limited and it has 
not been evaluated in clinical studies—see PRECAUTIONS) 
In clinical studies Tagamet' (cimetidine) has been used in 
divided doses of up to 2400 mg/day.
DUODENAL ULCER. NON-MALIGNANT 
GASTRIC ULCER, AND GASTRO­
ESOPHAGEAL REFLUX DISEASE
The recommended adult oral dosage for duodenal ulcer, 
non malignant gastric ulcer and gastroesophageal reflux 
disease is 300 mg four times a day, with meals and at 
bedtime.
While healing with 'Tagamet' often occurs during the first 
week or two, treatment should be continued for at least 
four weeks unless healing has been demonstrated by 
endoscopic examination.
Some patients may require concomitant antacids until 
symptoms disappear.
MANAGEMENT OF UPPER 
GASTROINTESTINAL HEMORRHAGE
In patients with upper gastrointestinal bleeding of 
sufficient magnitude as to require blood transfusions, 
'Tagamet' should be administered parenterally, 
preferably by intravenous injection or intermittent 
infusion or, if necessary, by constant intravenous infusion 
until 48 hours after active bleeding has stopped. At this 
time an oral dosage regimen may be instituted and should 
be continued for at least 7-10 days.
Recommended dosage for oral administration:
300 mg every 6 hours.
Recommended dosage for intramuscular injection 
administration:
300 mg every 6 hours. Inject the entire contents of a 2 ml 
ampul.
Recommended dosage for intravenous injection 
administration:
300 mg every 6 hours. Dilute 'Tagamet' in Sodium 
Chloride Injection (0.9%) (or other compatible i.v. 
solution) to a total volume of 20 ml and inject over 1-2 
minutes.
Recommended dosage for intermittent intravenous 
infusion administration:
300 mg every 6 hours. Dilute ’Tagamet' 300 mg in 100 ml 
of Dextrose Injection (5%) (or other compatible i.v. 
solution) and infuse over 15-20 minutes.
In some patients it may be necessary to increase dosage. 
When this is necessary, the increases should be made by 
more frequent administration of a 300 mg dose, but total 
daily dosage should not exceed 2400 mg.
Recommended dosage for constant intravenous 
infusion administration:
2 mg/kg. hour. Dilute 'Tagamet' for injection in a 
compatible i.v. solution, such as Sodium Chloride Injection 
(0.9%) or Dextrose Injection (5% or 10%). In some patients 
it may be necessary to increase dosage. Dosage should 
usually not exceed 4 mg/kg/hour.
DOSAGE ADJUSTMENT FOR PATIENTS WITH 
IMPAIRED RENAL FUNCTION
Patients with severely impaired renal function have been 
treated with 'Tagamet'. However, such usage has been 
very limited. On the basis of this experience the 
recommended dosage is 300 mg every 12 hours orally or 
by intravenous or intramuscular injection. Should the 
patient's condition require, the frequency of dosing may be 
increased to every 8 hours or even further with caution. In 
severe renal failure accumulation may occur and the 
lowest frequency of dosing compatible with an adequate 
patient response should be used. Hemodialysis removes 
circulating cimetidine, therefore, the timing of dosage 
should be adjusted to the dialysis schedule.
PATHOLOGICAL HYPERSECRETORY 
CONDITIONS
(e.g., Zollinger-Ellison Syndrome)
Recommended adult oral dosage:
300 mg four times a day with meals and at bedtime. In 
some patients it may be necessary to administer 300 mg 
doses more frequently to control symptoms. Dosage should 
be adjusted to individual patient needs, but usually should 
not exceed 2400 mg per day. If intravenous administration 
is required, the dosage schedule should be the same as 
that recommended for control of upper gastrointestinal 
bleeding.
SPECIAL CASES
In patients in whom control of gastric acid secretion is 
desirable, the recommended oral dosage of 'Tagamet' is 
300 mg four times a day, with meals and at bedtime. If 
intravenous administration is required, the dosage 
schedule should be the same as that recommended for 
control of upper gastrointestinal bleeding.
STABILITY O F INJECTABLE FORM
'Tagamet' injection, when added to or diluted with most 
intravenous solutions, such as Sodium Chloride injection 
(0.9%) or Dextrose injection (5% or 10%), is stable for 48 
hours at normal room temperature 'Tagamet' Injection 
should not be refrigerated.
AVAILABILITY
Tablets:
Pale green circular biconvex film coated tablets, each 
containing cimetidine 300 mg (monogrammed SKF T13). 
Bottles of 100 tablets.
Injection:
Each 2 ml dose contains cimetidine HC1 equivalent to 300 
mg of cimetidine, in Sterile Water for Injection. Preserved 
with phenol, 0.5% . Ampuls of 2 ml, packaged in 10's.
C l / T  F  SMITH KLINE & FRENCH CANADA LTD. 
O l l C f r  MONTREAL. QUEBEC H4M 2L6
TM;M18CA
PAAB
CCPP
BOOK REVIEWS
INFECTION IN  THE FEMALE. William 
J. Ledger. 240 pp. Illust. Lea &  Febiger, 
Philadelphia; The Macmillan Company 
of Canada Limited, Toronto, 1977. Price 
not stated. ISBN 0-8121-0560-5.
This monograph offers a well-organized 
approach to its subject. The first half deals 
mostly with bacteriology and is up-to-date. 
It includes a description of the latest 
information on etiologic agents such as 
mycoplasma and Bacteroides fragilis. The 
problems associated with specimen collec­
tions are detailed, and specific reference 
is made to anaerobic and aerobic infec­
tions. Ledger has also provided the reader 
with an excellent discussion on urinary 
specimens and their collection.
The second half of the book deals with 
clinical problems. Separate chapters are 
included on community and hospital- 
acquired gynecologic and obstetric infec­
tions. The investigation and treatment of 
postpartum infections is specifically dealt 
with. The author has not considered the 
use of IgM testing and gamma globulin 
therapy in rubella contacts. However, there 
is a good chart on what to do for the 
woman exposed to rubella during preg­
nancy and how to interpret rubella anti­
body titres. Included also is an excellent 
chart on vaccination during pregnancy 
and the effects of certain diseases such as 
measles, mumps, thyroid, polio, cholera, 
plague and rabies on mother and child.
While postoperative management of the 
gynecologic patient is carefully discussed, 
the description of some of the common 
office gynecologic problems is less than 
adequate. One of the most vexing prob­
lems for the office practitioner is treat­
ment of the patient with a persistent 
vaginal discharge; unfortunately a discus­
sion of this subject is not included. Can­
didal and trichomonal infections are only 
discussed in generalities. A more detailed 
account of how to handle acute herpes 
genitalis would have been welcome. This 
problem is mentioned in several areas of 
the book, but it is not all brought together 
in one place. What should the physician 
do when he or she sees the vesicles? How 
do you make the patient comfortable and 
what bath solutions can be recommended?
This book offers a good, although at 
times superficial, review of the subject; 
for this limited purpose, it can be rec­
ommended.
I r v i n g  S o l o w a y
Department of obstetrics and gynecology, 
Ottawa Civic Hospital,
Ottawa, Ont.
LYMPHEDEMA. Supplement to “L y m - 
phology”. Edited by Leo Clodius. 192  
pp. Illust. Georg Thieme Verlag, Stutt­
gart; Stratton Intercontinental Medical 
Book Corporation, New York, 1977. 
Price not stated. ISBN 3-13-544901-7.
Lymphedema is a concise readable text; 
its value far exceeds its modest format. 
For years clinicians of all specialties have
continued on page 366
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ORIGINAL CONTRIBUTIONS
Hypothermic Coronary Perfusion for Myocardial Protection
During Aortocoronary Bypass
Mant Haraphongse, md, frcp[c], R. Leighton F isk, md, frcs[c], R ichard E. Rossall, md, frcp[c], 
Carlos A.E. Basualdo, md, frcp[c], Robert S. Fraser, md, frcp[c], E lliott T. Gelfand, md, frcs[c]
and John C. Callaghan, md, frcs[c]
Numerous methods have been used in 
an attempt to prevent myocardial 
injury that results from the interruption 
of aortic flow during cardiac operations. 
The authors describe a relatively 
simple means of inducing cardioplegia 
during coronary bypass surgery by 
coronary perfusion with cold lactated 
Ringer's solution through the aortic 
root. When the results following the 
eqjployment of hypothermic coronary 
perfusion for intraoperative cardioplegia 
were compared with those obtained 
without its use, the procedure was 
found to confer a degree of intraopera­
tive myocardial protection and ap­
peared to lead to a decrease in intra­
operative myocardial infarction, 
subendocardial ischemia and intraopera­
tive mortality.
Plusieurs methodes ont ete utilisees 
dans I'intention de prevenir les lesions 
myocardiques qui resultent de ('interrup­
tion du debit aortique durant une 
operation du coeur. On decrit un moyen 
relativement simple de provoquer une 
cardioplegie par perfusion coronarienne 
d'une solution de Ringer refroidie 
dans le tronc aortique; celui-ci a ete 
utilise au University of Alberta Hospital
From the departments of medicine and surgery, University of Alberta Hospital, Edmonton, Alta.
Presented in part at the annual meeting of the Canadian Cardiovascular Society, Edmonton, Alta., Oct. 18-23, 1976
Reprint requests to: Dr. M. Haraphongse, Director, Hemodynamic laboratory, University Hospital, Edmonton, Alta. T6G 2B7
pour les interventions de pontage 
coronarien.
Comparativement aux resultats 
anterieurs, la perfusion coronarienne 
hypothermique employee pour provoquer 
une cardioplegie durant I'operation a 
confere un degre de protection myo- 
cardique et semble avoir entraine une 
diminution des infarctus myocardiques 
durant I'operation, de I'ischemie sous- 
endocardique et de la mortality 
peroperatoire.
Anoxic cardiac arrest is necessary for 
the adequate performance of cardiac surgery. It has been very useful in 
aortocoronary bypass surgery (ACBS) 
because it provides a dry, immobile operative field which is necessary for 
an accurate anastomosis. To avoid 
anoxic injury to an already ischemic myocardium is one of the most im­
portant goals in ACBS. Many methods have been used in an attempt to 
minimize the myocardial damage that results from the interruption of aortic flow during cardiac operations. A rela­
tively simple means of inducing car­dioplegia by coronary perfusion with cold lactated Ringer’s solution through the aortic root has been used at the University of Alberta Hospital, Ed­monton, for both valve replacement and coronary bypass surgery. The re­sults appear to be better following this procedure and the incidence of myo­cardial injury and intraoperative mor­tality have been reduced.
Patients and Method
Between May 1, 1975 and Apr. 30, 1976, 159 patients had ACBS with
aortic occlusion and myocardial hypo­thermia induced by perfusion with cold 
lactated Ringer’s solution. A reversed saphenous vein was used for the graft on each occasion. Cannulation for ex­tracorporeal circulation was carried out in a standard manner using transatrial vena caval catheters and arterial return from the extracorporeal circuit to the ascending aorta. A left atrial, left ven­
tricular or pulmonary arterial vent catheter was placed. In most instances both the distal and the proximal anas­tomoses were done during a single aortic occlusion. Hypothermic cardioplegia 
was induced by perfusion with 5 % 
glucose and lactated Ringer’s solution, to which was added potassium chloride (40 mmol/L) and sodium bicarbonate 
(44.6 mmol/L). This solution at 5°C 
was introduced into the aortic root after the start of cardiopulmonary by­
pass. Once the patient was on total by­pass, an aortic cross-clamp was placed and 500 to 700 mL of solution was introduced into the aorta proximal to 
the clamp through a small catheter 
placed through a purse-string suture in the aorta. Once the desired amount of solution had been introduced, the can­nula was withdrawn and the purse­string suture tightened. This site could later be used for an aortic vent or aortotomy for proximal coronary graft anastomosis. Cardiac arrest occurred after 200 mL of cold solution was in­jected. Additional hypothermic solution was placed initially in the pericardial well around the heart, but usually was aspirated before dissection of the ves­sels. If the period of aortic cross-clamp­ing needed to complete the procedure
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was long, additional cold solution was 
introduced through the aortic root and 
into the pericardial well. Upon release 
of the aortic cross-clamp and re-estab­
lishment of coronary arterial flow, re­
warming of the heart took place within 
minutes.
Results
There were six operative deaths. No 
patient died in the operating room. 
Three patients died of myocardial in­
farction postoperatively. Two patients 
were doing well after the operation but 
were found dead in the washroom, one 
on day 6 and the other on day 9 after 
operation, probably owing to cardiac 
arrhythmias. One death was attributed 
to septicemia.
Six percent of the patients experi­
enced subendocardial ischemia which
was diagnosed if symmetrical T-wave 
inversion was noted on the electrocar­
diogram within the first 24 hours fol­
lowing surgery. Eight percent of the 
patients had postoperative myocardial 
infarction which was diagnosed if new 
Q waves appeared. Supraventricular 
and ventricular arrythmias developed 
in 19% and 2% of patients, respective­
ly. Ten percent of the patients had 
heart failure postoperatively.
We compared the results of ACBS 
under hypothermic coronary perfusion 
for myocardial protection (group 1) 
with the results obtained from 185 pa­
tients who had similar preoperative 
characteristics (Table I) and who had 
undergone ACBS without hypothermia 
between. Jan. 1, 1974 and Apr. 30, 
1975 (group 2). The incidence of sub­
endocardial ischemia, postoperative 
myocardial infarction and intraopera­
tive mortality was significantly reduced 
in group 1 patients (Table II).
Postoperative serum concentrations 
of creatine phosphokinase, glutamic 
oxaloacetic transaminase and lactic 
dehydrogenase (CPK, SGOT and LDH) 
were analysed (Fig. 1) in all patients 
with a normal postoperative course. 
The values increased with the pro­
longation of anoxic arrest extended 
beyond 60 minutes in group 1 and 40 
minutes in group 2. Maximal values 
of enzymes in the patients with hypo­
thermia were significantly lower than 
in normothermic patients who had been 
exposed to the same durations of 
anoxia.
Discussion
A motionless heart and a dry opera-
10H l IU/1 )
NORMOTHERMIC HYPOTHERMIC
ANOXIC ARREST ( MIN )
FIG. I—Mean serum enzyme values 
following surgery in patients with normal 
postoperative course. Values of enzymes in 
patients with hypothermia were significant­
ly lower than in normothermic patients 
who had been exposed to same duration 
of anoxia (▲ =  P <  0.05, A =  P <  
0.025, ■ =  P <  0.01, O =  P <  0.005 
and □  =  P <  0.001). CPK =  creatine 
phosphokinase, SGOT =  serum glutamic 
oxaloacetic transaminase, LDH =  lactic 
dehydrogenase.
T a b le  1 - P re o p e ra t iv e  C h a ra c te r is t ic s  in  H yp o therm ic (G roup 1 ) and N orm otherm ic (G roup 2 )
P a t ie n ts
No.of p a tie n ts  (a n d % )
C h a ra c te r is t ic
Group 1 
(n  =  159)
Group 2 
(n  =  185)
M ean ag e , y r  
Men
A n g in a  a lo n e
A n g in a  +  p re v io u s  m yocard ia l in fa rc t io n
A n g in a  +  p re v io u s  m yocard ia l in fa rc t io n  +  h e a rt  fa ilu re
A n g in a  +  h e a r t  fa ilu re
H e a rt f a i lu r e  a lo ne
E le v a te d  le f t  v e n t r ic u la r  en d -d ia sto lic  p re ssu re  
N ew  Y o rk  H e a rt  A sso c ia tio n  fu n ctio n a l c la s s
I I
I I I
IV
54
140 (88) 
105 (65) 
49 (31 ) 
2 ( 1 )  
3 (3 )
78 (49)
19 (12) 
121 (76 ) 
19 (12 )
52
149 (80 ) 
160 (87 ) 
75 (41 ) 
2 ( 1 )
2 ( 1 )  
95 (51 )
17 (9 ) 
133 (72 ) 
35 (19 )
E x te n t  of a r t e r ia l  d isease
1 a rte ry
2 a rte r ie s
3 a r te r ie s
15 (9 ) 
66 (42 ) 
78 (49)
25 (13 ) 
81 (44 ) 
79 (4 3 )
T a b le  I I  - C a r d ia c  C o m p licatio ns in  H ypotherm ic (G ro up  1 ) and N orm otherm ic (G roup 2 ) P a tie n ts
No. of p a tie n ts  (and % )
C o m p lica tio n
Group 1 
(n  =  159)
Group 2 
(n  =  185) P  va lu e
D etected  by e le c tro card io g rap hy  
Su b en d o ca rd ia l ischem ia  
M yo ca rd ia l in fa rc t io n  
A r rh y th m ia s
S u p ra v e n tr ic u la r
V e n t r ic u la r
N o n fa ta l
Lo w  c a rd ia c  output
Lo w  c a rd ia c  output +  m yocard ia l in fa rc t io n  
H e a rt f a i lu r e
9 ( 6 )  
12 (8 )
31 (19 ) 
3 ( 2 )
16 (10 )
29 (16 ) 
35 (19 )
34 (18 ) 
8 ( 4 )
1 (0 .5 )
3 ( 2 )
9 ( 5 )
<  0.005
<  0.005
F a ta l
In tra o p e ra t iv e
P e r io p e ra t iv e
M yo ca rd ia l in fa rc t io n  
Sudden death 
Lo w  ca rd ia c  output 
+  m yo card ia l in fa rc tio n  
S ep ticem ia  
Em bo lism  
P u lm o n ary  
C e re b ra l
6 (3 .6 )
3 ( 2 )
2 ( 1 )
1 (0 .6 )
14 (8 )  
5 ( 3 )
5 ( 3 )
1 (0 .5 ) 
1 (0 .5 )
1 (0 .5 ) 
1 (0 .5 )
<  0.05
4
1
1
H
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tive field permit a rapid and precise 
anastomosis in ACBS. Cardiac arrest 
reduces metabolic requirements of the 
heart,1 thereby prolonging myocardial 
tolerance to ischemia. Improved meth­
ods for cardioplegia and myocardial 
protection during cardiac arrest have 
been developed recently. Early tech­
niques of cardioplegia using potassium 
citrate or acetylcholine were abandoned 
because they produced severe, some­
times irreversible, myocardial damage.2 
Iced saline (slush)3 for topical hypo­
thermia was introduced both to protect 
the myocardium and to provide a 
quiescent heart. The popularity of this 
technique declined because atrial fibril­
lation, epicardial reaction and phrenic 
nerve paralysis were associated with its 
use.4
Although coronary artery perfusion5 
gained wide acceptance for valvular 
surgery,6 it, too, appeared to be asso­
ciated with a number of complica­
tions.7'9 Bloodwell and associates10 
popularized the technique of normo- 
thermic anoxic arrest. Ischemic cardiac 
arrest under normothermic anoxic con­
ditions is a safe method for open-heart 
correction of congenital defects, valve 
replacement10 and ACBS.11 It has been 
shown that normothermic anoxic arrest 
is moderately well tolerated for 30 min­
utes.12'13 Beyond that time biochemical 
changes,14 subendocardial hemorrhage15 
and generalized myocardial damage are 
progressive and probably irreversible.13 
Topical cardiac hypothermia extended 
the safe period of ischemic arrest.16 
Various methods of producing myo­
cardial hypothermia topically are in 
use,17,18 but have been associated with 
a number of problems. Homogeneous 
reduction of myocardial temperature 
cannot be achieved rapidly by surface 
cooling of the heart particularly when 
severe left ventricular hypertrophy is 
present. Irrigation of the pericardial 
well requires the management of cold 
fluid supply and drainage. Blood is lost 
from the circulation to the wash solu­
tion in variable amounts. The use of 
selective cardiac hypothermia induced 
by perfusion of the coronary arteries 
with cold lactated Ringer’s solution 
through the aortic root19,20 avoids many 
disadvantages of topically induced hy­
pothermia. This method produces rapid 
cardioplegia and better myocardial 
preservation.13
Iyengar and associates15 related nor­
mothermic ischemic arrest directly to 
the production of subendocardial 
hemorrhagic necrosis. This damage has 
been attributed to stasis, sludging and 
thrombosis in the myocardial microcir­
culation.21 Deterioration of myocardial 
function and myocardial infarction fol­
lowing ACBS have been observed de­
spite the presence of a patent graft.22,23 
Hypothermic coronary perfusion for
intraoperative cardioplegia in ACBS has 
significantly reduced the incidence of 
subendocardial ischemia and myocar­
dial infarction in our series as assessed 
by electrocardiographic change.
Hypothermia has the advantage of 
conferring considerable protection on 
the myocardium by reducing the meta­
bolic rate24 and extending the safe pe­
riod of ischemic arrest.16 The functional 
recovery of the heart following the 
termination of arrest is related to the 
concentration of ATP and creatine 
phosphate in the myocardium at the 
end of the period of arrest.25 Hypo­
thermic coronary perfusion for intra­
operative cardioplegia provides rapid 
cardiac arrest and uniform cooling of 
the heart. Thus, the myocardium sus­
tains minimal hypoxia. Under these 
conditions the concentration of cellu­
lar high-energy phosphates is main­
tained and complete recovery is pos­
sible.25,26
The patients in the two groups had 
ACBS performed in two successive 
periods of time. Greater surgical ex­
perience, better selection of patients 
and more extensive revascularization 
may have been contributing factors in 
producing more favourable results in 
group 1. Nevertheless, the changes in 
serum enzyme values following opera­
tion indicated that more effective myo­
cardial protection during aortic cross­
clamping was provided in patients with 
hypothermic coronary perfusion than 
in patients operated on under nor­
mothermic conditions. Hypothermic 
coronary perfusion appeared to result 
in a decrease in the number of myo­
cardial complications and intraopera­
tive mortality.
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an urgent problem  
postoperative anaerobic
in gynecological 
infections
.. clindamycin is an important antibiotic in the 
therapy of such [gynecological] infections.” 
Swenson, R.M., et al. (1974). Obstet. & Gynecol., 44:699.
in abdominal 
infections
This study suggests “ ...clindamycin is an excellent 
and relatively safe antibiotic for treatment of 
[abdominal] infection caused by anaerobes when 
combined with surgery (when indicated) or other 
antibiotics active against aerobic gram-negative 
bacilli, if present."
Levison, M.E., et al. (Mar., 1974).
Antimicrob. Agents & Chemother., p. 276-280.
an accepted solution 
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Importance of a Fifth Parathyroid Gland in the Surgical 
Treatment of Hyperparathyroidism
J ohn A. Pa lm er , m d , frcs[c ], facs* and F rank R. Su tto n , m d |
Of 365 patients surgically treated for 
hyperparathyroidism at the University 
of Toronto hospitals, 3 had hyper­
calcemia due to an abnormal and ectopic 
fifth parathyroid gland.
Autopsy studies have shown that a 
fifth gland may be present in 3% to 
5% of patients with hyperparathyroidism.
The possibility of an abnormal fifth 
gland as the cause of primary hyper­
parathyroidism should be considered 
when four glands of normal size and 
histology have been found in the neck, 
and such a gland should be sought in 
all patients with the diffuse hyperplasia 
of secondary hyperparathyroidism. The 
fifth gland is usually in the lower 
neck or upper mediastinum, frequently 
within the thymus. If present, it can 
usually be recognized and excised.
Sur 365 patients ayant recu un traitement 
chirurgical pour hyperparathyroi'die 
aux hopitaux de I'Universite de Toronto,
3 avaient une hypercalcemie due a 
une cinquieme glande parathyroide 
anormale et ectopique.
Des etudes des resultats d'autopsie 
ont montre qu’une cinquieme glande 
peut etre presente chez 3% a 5% des 
patients souffrant d'hyperparathyroi'die.
La possibility d'une cinquieme glande 
anormale causant une hyperparathyroi'die 
primaire devrait etre envisagee quand 
quatre glandes de grosseur et 
d’histologie normales sont retrouvees 
dans le cou, et une telle glande devrait 
etre recherchee chez tous les patients 
presentant I’hyperplasie diffuse carac- 
teristique de I’hyperparathyro'idie 
secondaire. La cinquieme glande est 
habituellement retrouvee dans la partie 
inferieure du cou ou au dessus du 
mediastin, frequemment a I’interieur 
du thymus. Lorsqu’elle est presente, 
elle peut habituellement etre identifiee 
et excisee.
From the department of surgery, 
University of Toronto and the Toronto 
General Hospital, Toronto, Ont.
*Associate professor, department of 
surgery, University of Toronto
t Department of surgery, St. Michael's 
Hospital, Toronto
Reprint requests to: Dr. J.A. Palmer,
4 University Wing, Toronto General 
Hospital, Toronto, Ont. M5G 1L7
In 1925 Mandl1 successfully excised a 
parathyroid adenoma that had caused 
osteitis fibrosa cystica. For many years 
thereafter the identification and re­
moval of a single adenoma was con­
sidered to be the optimal treatment for 
hyperparathyroidism. However, as ex­
perience increased it was realized that 
abnormalities of more than one gland 
occurred in approximately 15% of pa­
tients,2 in the form of either diffuse 
hyperplasia or multiple adenomas, and 
it was considered advisable to identify 
four parathyroid glands and to remove 
those that were abnormal on visual 
examination or hypercellular on biop­
sy. In a further attempt to reduce the 
incidence of persistent or recurrent 
hypercalcemia, Paloyan and colleagues3 
recommended subtotal parathyroidec­
tomy for all patients with hyperpara­
thyroidism. We do not believe that this 
is necessary for patients with a single 
adenoma provided the remaining glands 
are normal in size and on biopsy, but 
we agree that subtotal parathyroidec­
tomy is advisable for patients with an 
abnormality of two or more glands.
This form of treatment has given 
excellent long-term results. However, 
approximately 5% of patients remain 
hypercalcemie postoperatively. The 
usual reason for persistent hypercal­
cemia is failure either to find an ade­
noma or to recognize and properly 
manage an abnormality of more than 
one gland.4 A hyperfunctioning fifth 
gland unrecognized at operation may, 
on occasion, be responsible for an un­
satisfactory result. In a University of 
Toronto hospital study of 365 patients, 
3 patients with primary hyperpara­
thyroidism, whose cases are reported 
herein, had a fifth gland that was of 
critical importance in surgical manage­
ment. A fourth patient with secondary 
hyperparathyroidism associated with 
chronic renal failure requiring dialysis, 
had persistent hypercalcemia following 
radical subtotal parathyroidectomy and 
is awaiting exploration for a fifth gland 
in the mediastinum.
Case Reports
Case 1.—A 50-year-old woman had 
recurrent renal calculi and hypercalcemia. 
The serum concentrations of calcium 
varied from 3.12 to 3.42 mmol/L (12.5 
to 13.7 mg/dL) and of phosphate from
0.613 to 0.839 mmol/L (1.9 to 2.6 mg/dL). 
A diagnosis of primary hyperparathyroid­
ism was made.
At operation, four parathyroid glands 
of normal size were indentified and 
examination of frozen sections of each 
revealed no abnormality. The left upper 
gland, the largest of the four, was re­
moved and on subsequent examination of 
paraffin sections was described as hyper­
plastic. Serum calcium concentrations 
remained unchanged after operation.
It was assumed that this patient had 
diffuse hyperplasia of all four glands, de­
spite their relatively normal size, and 
that subtotal parathyroidectomy should 
have been done at the original operation.
On re-exploration of the neck 10 months 
later, the right lobe of the thyroid gland 
and the right upper and lower parathyroid 
glands were removed; from the remain­
ing normal-sized left lower parathyroid 
gland a biopsy only was taken. Postopera­
tively the serum calcium concentration 
increased to 3.74 mmol/L (15 mg/dL).
Five months later the mediastinum was 
explored through a sternal-splitting inci­
sion. An adenoma measuring 3 x 3  cm 
was found in the left inferior pole of the 
thymus and removed. Serum calcium con­
centrations have since remained within 
normal range (2.24 to 2.32 mmol/L 
[9.0 to 9.3 mg/dL]). Thus in this patient 
three glands were removed from the neck, 
a fourth gland was biopsied and an ade­
noma of a fifth gland was removed from 
the mediastinum.
Case 2.—A 38-year-old woman had 
recurrent upper abdominal pain associated 
with diarrhea. On investigation she was 
found to have recurrent subacute pan­
creatic calcification, mild nephrocalcinosis 
and hypercalcemia (2.87 to 3.37 mmol/L 
[11.5 to 13.5 mg/dL]). There was no 
history of alcohol ingestion and her 
biliary system was normal.
Primary hyperparathyroidism with as­
sociated pancreatic and renal calcinosis 
was diagnosed. Venography and sampling 
of multiple veins in the neck and medi­
astinum for parathormone (PTH) revealed 
values in the high-normal range without 
a gradient in either the neck or medi­
astinal veins.5,6
On exploratory surgery of the neck 
four parathyroid glands were found in 
their usual positions; they appeared nor­
mal in size and colour. Subtotal para­
thyroidectomy was done, removing three 
glands; a biopsy was taken from the right 
lower gland and the remnant was marked 
with a silver clip. On examination of 
frozen sections the glands were considered 
normal. At this stage we decided that the
diagnosis of hyperparathyroidism was
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probably in error, so the operation was 
terminated. Postoperatively serum calcium 
concentrations remained elevated.
Further assessment included repeat 
venography and radioimmunoassay for 
PTH; as before there was no PTH gradient 
in any vein. The concentration of urinary 
cyclic AMP was elevated to 8.7 [janol/24 
h. There was no evidence of other causes 
of hypercalcemia and the cortisone sup­
pression test gave a negative result. We 
concluded that the diagnosis of primary 
hyperparathyroidism was correct and that 
the condition was caused by an adenoma 
of a fifth gland, probably in the medi­
astinum.
Five months later the previous neck 
incision was reopened. The recurrent 
laryngeal nerves were identified and the 
tissues inferior to the thyroid were dis­
sected to allow examination of the thymus 
and surrounding tissues. An abnormality 
was noted at the inferior aspect of the 
right lobe of the thymus; the gland could 
not safely be mobilized into the neck. A 
short sternotomy to the third interspace 
allowed excision of a parathyroid adeno­
ma, measuring 2 X 1.2 X 1 cm, situated 
within the thymus. Serum calcium values 
have remained normal since operation.
Case 3.—A 75-year-old woman with a 
20-year history of recurrent renal calculi 
was found to have serum concentrations 
of calcium ranging from 2.87 to 3.24 
mmol/L (11.5 to 13.0 mg/dL) and of 
phosphate ranging from 0.517 to 0.904 
mmol/L (1.6 to 2.8 mg/dL). Primary hy­
perparathyroidism was diagnosed. Veno­
graphy and radioimmunoassay for PTH 
were not considered necessary.
At operation four parathyroid glands of 
normal size were found in their usual 
positions. Biopsy specimens of all four 
glands were considered to be normal his­
tologically although there was a possibility 
that the right lower gland was mildly hy- 
percellular. We now believe that normal­
sized glands, even if hyperplastic, will not 
produce serum calcium concentrations of 
2.87 mmol/L (11.5 mg/dL) or higher. 
Therefore we decided to search for a 
fifth gland.
The fibrofatty tissues inferior to the 
thyroid lobes and the thymus were dis­
played and an adenoma measuring 1.5 x  
2 cm was identified in the midportion of 
the right lobe of the thymus. The adenoma 
and the right lobe of the thymus were 
removed through the cervical incision; 
quick section confirmed the diagnosis of 
a parathyroid adenoma. Because of the 
possibility of diffuse hyperplasia, we de­
cided to do a subtotal parathyroidectomy. 
Hence, both right glands, the left upper 
gland and the mediastinal adenoma were 
all removed; a biopsy of the left lower 
gland was done so that only a remnant of 
this gland remained.
Discussion
Autopsy studies, in which the neck 
is carefully examined for parathyroid 
glands and their presence and number 
are proved by microscopic examination, 
have shown that more than four para­
thyroid glands may be present.
In a detailed study of 428 cases, 
Gilmour7 found six parathyroid glands 
in 2 cases (a frequency of 0.5% ), five 
in 25 cases (6%), four in 374 cases 
(87%), three in 26 cases (6.1%) and 
only two glands in 1 case (0.2%).
Vail and Coller8 in a similar autopsy 
study found five glands in 10 of 202 
cases. None had more than five glands 
and all glands appeared normal on 
both gross and histologic examination.
Alveryd9 in 352 autopsies found five 
glands in 13 cases (3.7%), four glands 
in 319 cases (90.6%), three glands in 
18 cases (5.1%) and two glands in 2 
cases (0.6%).
It is difficult to evaluate the re­
ported occurrence of fewer than four 
glands because it is doubtful whether 
all glands were identified.
A fifth parathyroid gland is believed 
to be of surgical importance but its 
presence has been difficult to verify. 
By the time the presence of a fifth 
gland is suspected, the patient usually 
has had a number of operations be­
cause of persistent hypercalcemia and 
often the number of glands has not 
been verified by biopsy and micro­
scopic examination. In the past sur­
geons have been reluctant to do biop­
sies of parathyroid glands because of 
the possibility of interference with the 
blood supply. This need not be of con­
cern, although if a subtotal parathyroid­
ectomy is done, the surgeon must take 
care to preserve the vascular pedicle 
of the remnant.10
The clinical importance of the fifth 
gland in our patients is obvious be­
cause it was proved to be the cause of 
their hyperparathyroidism.
We conclude that the possibility of 
a fifth gland should be considered in 
all patients with primary and secondary 
hyperparathyroidism. If present, the 
fifth gland is usually located in the 
lower neck or upper mediastinum, in 
particular within the thymus gland. In 
Alveryd’s study,9 10 of the 13 fifth 
glands were in the lower neck and 3 
of these were within the thymus.
A search for a possible fifth gland is 
recommended in patients with diffuse 
hyperplasia, particularly if it is asso­
ciated with chronic renal disease. A 
fifth gland can be assumed to be 
present in approximately 3 % to 5 % 
of patients. If present in patients with 
secondary hyperparathyroidism this 
gland will also be hyperplastic, and if 
it is not excised surgical treatment will 
be unsuccessful. It is possible that this 
factor is of greater importance than the 
current controversy over the relative 
merits of subtotal parathyroidectomy 
and total parathyroidectomy with auto­
transplantation.
A possible fifth gland should also be 
sought in patients with primary hyper­
parathyroidism when four glands have
been identified but appear to be of 
normal size. There is a correlation be­
tween the size of an adenoma and the 
serum calcium value; in general, pa­
tients with serum calcium values above 
2.87 m m ol/L  (11.5 m g/dL) will have 
an adenoma measuring 1.5 cm in 
diameter, or larger. If such values are 
due to diffuse hyperplasia, the glands 
will appear enlarged. Thus, as in case 
3, the possibility of a fifth gland in the 
upper mediastinum or elsewhere should 
be considered if the four glands in the 
neck are normal or only slightly en­
larged.
The role of venography and selec­
tive radioimmunoassay for PT H  in the 
diagnosis of a fifth gland has not been 
clarified (Murray TM: Personal com­
munication, 1977). These methods are 
of questionable value in measuring 
concentrations of PTH in the large 
veins of the mediastinum. Of interest 
is the patient in our case 2 who had 
normal PTH values in the neck and 
mediastinum without gradients and 
who subsequently was found to have 
a fifth gland in the mediastinum. Fail­
ure to demonstrate a localizing gra­
dient in PTH  concentrations in the 
neck (provided the blood sampling 
from the neck veins has been meticu­
lous and complete) suggests that the 
hyperfunctioning gland is ectopic and 
is probably in the mediastinum.
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Aspiration and Gastroesophageal Reflux
R obert D. H enderson , m b , frcs[c]* and C olin  R. W o o lfe , md, FRCP[c]f
Gastroesophageal reflux is the com­
monest esophageal cause of chronic 
intermittent aspiration. The authors 
investigated 1000 consecutive patients 
with reflux with reference to their 
medical history, and by barium 
esophagography, esophageal manometry 
and pH studies. In patients with 
respiratory complications, chest ro­
entgenography and pulmonary function 
tests were also performed.
Of the total number, 279 patients 
aspirated either by coughing and choking 
during swallowing or as a result of 
night reflux; of these, 159 had 
associated respiratory symptoms, which 
included cough, voice change, recurrent 
respiratory infection, bronchiectasis 
and asthma.
Of the patients with aspiration, 120 
had surgical correction of reflux 
because conservative management 
failed. This form of reflux control 
improved the symptoms of cough and 
voice change and the condition of 
patients with recurrent infections or 
bronchiectasis, but alleviated the 
symptoms in only 8 of 28 asthmatic 
persons.
Le reflux gastro-oesophagien est la 
cause d'origine oesophagienne la plus 
frequente d’aspiration intermittente 
chronique. Les auteurs ont etudie 1000 
patients consecutifs souffrant de reflux, 
pour leur anamnese et par oesopha- 
gographie au barium, manometrie 
oesophagienne et etudes du pH. Chez 
les patients ayant des complications 
respiratoires, une radiographie 
pulmonaire et des tests de la fonction 
pulmonaire ont aussi ete effectues.
Du total, 279 patients aspiraient soit 
par acces de toux, soit en s’etouffant
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durant la deglutition, ou encore comme 
resultat du reflux durant le sommeil; 
de ceux-ci, 159 presentaient des symp- 
tomes respiratoires associes, incluant 
toux, changements de la voix, infections 
respiratoires recidivantes, bronchi- 
ectasie et asthme.
Des patients souffrant d’aspiration, 
120 ont subit une correction chirurgicale 
apres echec d'un traitement conserva- 
teur du reflux. Cette forme de 
controle du reflux a permis d'ameliorer 
la toux, les changements de voix et 
I’etat des patients souffrant d'infections 
recidivantes ou de bronchiectasie, 
mais n'a soulage les symptdmes que 
de 8 personnes asthmatiques sur 28.
Aspiration of food or gastric content 
into the respiratory tract can occur as 
an acute condition or as an intermittent, 
chronic phenomenon. Acute aspiration 
is usually secondary to diminished 
consciousness such as occurs with 
anesthesia, cerebral injury, or inebria­
tion.1'2 Chronic aspiration is most com­
monly caused by esophageal disease, 
and gastroesophageal reflux, the most 
common esophageal disorder, is most 
frequently responsible.
The reported frequency of hiatal 
hernia in patients with chronic aspira­
tion varies between 1.3%3 and 45%.4 
The frequency of aspiration in patients 
with reflux has not been adequately 
documented. Previous reports have 
indicated the potential severity of lung 
damage from aspiration and also the 
effectiveness of surgery in controlling 
reflux.5,6 The present study documents 
the frequency of reflux aspiration and 
the development of respiratory symp­
toms.
Patients and Methods
We investigated 1000 consecutive 
patients with gastroesophageal reflux 
who were admitted for a variety of 
reasons, including the investigation of 
chest pain and the assessment of the 
severity of reflux symptoms. In all pa­
tients a history of the esophageal and 
respiratory complaints was obtained 
and barium esophagography, esopha­
geal manometry and pH studies were 
carried out. In patients with symptoms 
of asthma or respiratory infection chest 
roentgenography and pulmonary func­
tion tests were also performed. The 
radiologic studies were done by several 
different radiologists and were not 
standardized in technique.
The history provided the most im­
portant diagnostic information. Besides 
documenting symptoms of reflux, we 
paid particular attention to symptoma­
tic aspiration. Aspiration can occur at 
night, when gastroesophageal reflux to 
the pharynx spills forward to the 
larynx and results in coughing and 
choking. Aspiration may also occur 
during the day when food sticks at the 
cricopharyngeus; forward spillage of 
food to the vocal cords results in chok­
ing.
The patient’s history was also used 
to determine the frequency of aspira­
tion and to indicate the type of aspirate 
(of oral or gastric content). The aspirate 
was considered to be of oral content 
when aspiration was associated with 
pharyngoesophageal dysphagia in which 
coughing and choking with swallowing 
allow aspiration of food and saliva. 
The aspirate was considered to be of 
gastric content when aspiration oc­
curred with night reflux; in these cir­
cumstances gastric content spills into 
the tracheobronchial tree and the 
aspirate may contain food, gastric se­
cretion and duodenal content. Fre­
quency of aspiration was categorized 
as mild (less than once per week), 
moderate (more than once per week, 
but less than once per day) and severe 
(at least once per day).
In the respiratory history attention 
was paid to cough and voice change 
and to symptoms of recurrent respira­
tory infection, chronic bronchitis, bron­
chiectasis and asthma.
Barium esophagography confirmed 
(he presence of a hiatal hernia or gas­
troesophageal reflux in all patients in­
cluded in the study. Reflux can be 
demonstrated radiologically, but in the 
conscious patient tracheal aspiration of 
reflux barium is rare and was not seen 
in this study. During deglutition barium 
may spill into the tracheobronchial tree 
owing to pharyngoesophageal obstruc­
tion. This is an intermittent phenome­
non and is difficult to demonstrate ra­
diologically,
Esophageal manometrie and pH 
studies were performed in the same 
unit on all patients to exclude other
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esophageal motor disorders and to 
identify reflux. Such studies may occa­
sionally be of value in the investigation 
of aspiration. They may demonstrate 
an abrupt decrease in pH in the body 
of the esophagus owing to reflux. At 
the time of reflux the patient may 
cough and choke and consequently 
aspirate, but, since this type of aspira­
tion is intermittent, the phenomenon 
cannot be reliably reproduced. When 
it does occur it is in the conscious pa­
tient and may be altered by the pres­
ence of tubes in the esophagus. This 
finding was recognized only late in the 
study and its frequency cannot be do­
cumented.
Results
The frequency of reflux and aspira­
tion as well as of pharyngoesophageal 
dysphagia and aspiration is shown in 
Table I.
Respiratory problems were associated 
with aspiration in 159 patients: 90 of 
the 279 patients with aspiration had 
chronic cough or voice change, or 
both, as the only symptoms; 27 patients 
had recurrent respiratory infection, 2 
had bronchiectasis and 40 patients 
were asthmatic.
No relation could be found between 
the frequency or quality of the aspirate 
and the development of respiratory 
symptoms. In patients who had pharyn­
goesophageal dysphagia and aspiration 
combined with night reflux and aspira­
tion, respiratory symptoms occurred 
more frequently.
Surgical Correction of Reflux
Of the 279 patients with aspiration 
120 were treated surgically for control 
of reflux. Surgery was indicated when 
medical management failed and severe 
esophageal symptoms persisted. Seven 
(5.8%) of the 120 patients had recur­
rent hiatus hernia demonstrated ra- 
diologically and 4 of these required 
further surgical correction. Following 
surgery all four patients had persistent 
pharyngoesophageal dysphagia and re­
quired a cricopharyngeal myotomy. 
Follow-up ranged from 3 to 5 years 
(average, 3.6 years).
Of the 90 patients with cough or
Table 1—Aspiration Associated with Gastro­
esophageal Reflux in 1000 Patients
No. of 
patients
Reflux to throat and aspiration  
Pharyngoesophageal dysphagia
115
and aspiration
Combined reflux and dysphagia
54
and aspiration 110
Total no. of patients w ith
aspiration 279
voice change, or both, 31 patients 
whose only symptom was cough at the 
time of aspiration were treated surgical­
ly. All became asymptomatic. Of 46 
patients with chronic cough or voice 
change who underwent surgery, 44 
were greatly improved. One patient had 
a persistent cough, but his spasms of 
coughing were fewer and less severe. 
One other patient, whose cough was 
not severe, was unimproved.
In the group of 27 patients with in­
termittent respiratory tract infection 13 
underwent surgery and none have had 
recurrent infections since the opera­
tion.
The two patients with bronchiectasis 
were markedly improved following sur­
gical control of aspiration. In both, less 
sputum was produced and the condi­
tion has been well controlled with con­
servative therapy.
In the group of 40 patients with asth­
ma 28 were treated surgically. Four 
showed marked improvement, 4 moder­
ate improvement, 9 slight improvement 
and 11 were not improved.
Discussion
Aspiration of esophageal or gastric 
content into the lungs has frequently 
been shown to be associated with second­
ary respiratory infection, but the fre­
quency and severity of respiratory 
symptoms have not been documented.5'6
In evaluating esophageal disease, the 
history alone provides an accurate diag­
nosis in 80% of patients.7 Roentgeno­
graphy, manometry, pH studies and 
acid perfusion measurements increase 
the diagnostic accuracy and allow clear 
distinction between the types of eso­
phageal disorder.8 For the diagnosis of 
aspiration a history of night reflux or 
of pharyngoesophageal dysphagia, re­
sulting in coughing and choking on 
food and saliva, must be obtained.
The quality, frequency and quantity 
of the aspirate, together with the re­
sponse of the lungs to the aspiration, 
are variables that are difficult to as­
sess. While the circumstances of aspira­
tion indicate the type of material 
aspirated, they do not provide an evalu­
ation of the gastric content, which may 
be acidic from gastric secretions or 
alkaline from duodenogastric bile re­
flux. Both bile and acid present in the 
stomach have been shown experiment­
ally to produce severe damage to the 
lung when aspirated.910 Pharyngoeso­
phageal dysphagia and aspiration of 
solid particles may produce bronchial 
obstruction.11,12 It is not possible to 
evaluate all of the factors from history 
alone and, in particular, the quantity 
of material aspirated at any one time 
cannot be determined.
In this study we have documented 
the presence of respiratory complica­
tions attributable to aspiration. To 
establish the relationship it is necessary 
first to control the aspiration and then 
to evaluate the resolution of the res­
piratory problems. In 120 patients with 
aspiration the reflux was corrected 
surgically and the condition of the pa­
tients evaluated at follow-up. Cough 
or voice change were effectively cor­
rected in 44 of 46 patients, indicating 
that this syndrome responds well to 
surgical correction. However, other 
causes of cough must first be excluded. 
The cough due to aspiration is second­
ary to laryngeal irritation and is often 
severe; it tends to be unproductive and 
minor inflammation of the vocal cords 
may be present.
Recurrent respiratory infections were 
also effectively controlled by surgical 
correction of reflux. Only two patients 
with bronchiectasis were included in the 
series and, although both were im­
proved, no conclusions can be drawn.
The association of asthma with 
aspiration is well recognized.13 In our 
experience surgical correction of aspira­
tion does not always confer benefit in 
this condition. Also, chest discomfort 
associated with reflux is often described 
as causing dyspnea, although some pa­
tients do recognize that this feeling of 
tightness differs from that induced by 
exercise. Chest discomfort causing 
dyspnea in the asthmatic person is very 
difficult to distinguish from that due 
to bronchospasm, so that the patient 
may mistake relief of the discomfort by 
correction of reflux for improvement 
of the asthma. Only 8 of 28 patients 
with asthma were notably improved by 
surgery and none were totally relieved 
of their symptoms. In some the symp­
tomatic relief may have been second­
ary to control of the chest tightness 
associated with heartburn and may not 
have been related to any change in 
respiratory function.
It seems that asthma is irritated by 
aspiration but is not caused by it. In 
some patients a major association can 
be demonstrated between episodes of 
aspiration and subsequent broncho­
spasm. The group of patients treated 
surgically were reviewed to see if this 
association could be substantiated. Of 
20 asthmatic patients who showed no 
improvement or only slight improve­
ment following reflux correction only 
1 described a clear association between 
reflux and asthmatic episodes. In con­
trast all eight patients who were great­
ly improved described such an associa­
tion. In asthmatic patients with reflux 
the decision to operate should be based 
on the need to control the symptoms 
attributable to reflux. The patient 
should be told that there may be a 
relation between the reflux and the 
asthma, but that improvement in the 
asthma after operation is unpredictable.
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Summary
Chronic intermittent aspiration is an 
important source of secondary respira­
tory disease. Aspiration was present in 
279 of 1000 consecutive patients with 
gastroesophageal reflux; in 159 of them 
respiratory disease developed. One hun­
dred and twenty patients with aspira­
tion were treated by surgical correction 
of reflux, which was effective in alle­
viating chronic cough and voice 
change, recurrent respiratory infections 
and bronchiectasis but less effective 
in treating asthma. In patients with 
asthma the history must indicate a rela­
tion between bronchospasm and epi­
sodes of aspiration for effective relief 
to be expected. Aspiration does not 
produce asthma, it merely aggravates 
the symptoms.
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The Anterior Interosseous Nerve Syndrome
E. W ien s , md, fr c s[c] and S.C.K. L au, m d*
A review of the literature pertaining 
to the anterior interosseous nerve 
(AIN) syndrome revealed that the 
diagnostic criteria for this syndrome 
need to be defined.
The authors describe the etiology of 
the AIN syndrome and use two cases 
of their own and 52 cases reported in 
the English literature to draw up a 
definition of the diagnostic criteria. 
The recommended criteria are: (a) 
demonstrable weakness of muscles 
innervated by the anterior interosseous 
nerve; (b) electromyographic findings of 
marked denervation potentials and 
decreased or absent voluntary motor 
unit potentials of these muscles;
(c) operative evidence of entrapment 
of, or injury to, the anterior interosseous 
nerve; and (d) improved power in the 
muscles and reversal of the electro­
myographic changes on follow-up after 
operation.
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Une revue de la litterature consacree 
au syndrome du nerf interosseux 
anterieur (NIA) a revele que les criteres 
de diagnostic de ce syndrome doivent 
etre definis.
Les auteurs decrivent I'etiologie du 
syndrome du NIA, et emploient 
deux de leurs propres cas et 52 
cas decrits dans la litterature de 
langue anglaise pour arriver a une 
definition des criteres de diagnostic.
Les criteres recommandes sont: (a) une 
faiblesse demontree des muscles 
innerves par le nerf interosseux 
anterieur; (b) des resultats electro- 
myographiques de potentiels de 
denervation marques et une diminution 
ou I’absence de potentiels d'unite 
motrice de ces muscles; (c) a ['opera­
tion, des signe de coincement ou de 
blessure du nerf interosseux anterieur; 
et (d) une amelioration de la puissance 
musculaire et une inversion des 
changements electromyographiques en 
post-observation.
The anterior interosseous nerve (AIN) 
syndrome is characterized by functional 
impairment of those muscles supplied 
by this nerve, namely the flexor pollicis 
longus, the radial aspect of the flexor 
digitorum profundus and the pronator
quadratus.1 Its terminal branches me­
diate sensation from the radiocarpal, 
intercarpal, carpometacarpal and distal 
radioulnar joints.2
Anatomy and Etiology
The anterior interosseous nerve 
arises from the posterior portion of the 
median nerve as its largest branch and 
runs as a separate bundle within that 
nerve for approximately 2.5 cm.3 The 
exit from the median nerve is 2 to 6 
cm below the medial epicondyle or 5 
to 8 cm distal to the lateral epicondyle 
of the humerus.
Injury to the anterior interosseous 
nerve is rare because of its well-pro­
tected course. However, it is vulnerable 
at several points.
Fibrous Arch of the Pronator
Teres Muscle
In 30 dissected limbs, Spinner and 
Schreiber4 found that the anterior in­
terosseous nerve passed through a con­
nective tissue arch (Fig. 1), usually 
composed of loose areolar tissue, aris­
ing from the deep head of the pronator 
teres muscle. In seven limbs this arch 
consisted of tough fibrous tissue. Com-
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pression of the nerve by a fibrous 
arch or band or, alternatively, by a 
tendinous insertion of the deep head 
of the pronator teres muscle may re­
sult in the AIN  syndrome.
Close Proximity to the Ulna
Spinner and Schreiber4 also pointed 
out that when a fibrous arch or band 
is present, the nerve is tightly held 
against the ulna (Fig. 2). They cited
FIG . 1— Fibrous arch of pronator teres 
muscle over anterior interosseous nerve.
FIG . 2— Close proximity of anterior 
interosseous nerve to ulna.
six cases in children of supracondylar 
fracture resulting in the AIN syndrom e. 
They suggested that the mechanism is 
traction applied by the proximal frag­
ment of the humerus to cause a te ther­
ing action of a fibrous arch or band at 
the level of the pronator teres muscle.
Compression o f the Anterior
Interosseous Artery
N ear its origin the anterior interos­
seous nerve is crossed by anterior in­
terosseous vessels (Fig. 3). It has been 
postulated that thrombosis of these 
vessels can result in the A IN  syn­
drom e.4,5
FIG . 3— Anterior interosseous artery 
causing compression of anterior interos­
seous nerve.
FIG . 4— Tendinous origin of flexor 
digitorum superficialis muscle affecting 
anterior interosseous nerve.
Tendinous Origin o f F lexor
Digitorum Superficialis
A pproxim ately 4 cm distal to  its 
origin the anterior interosseous nerve 
gives off a m otor branch to  the flexor 
pollicis longus m uscle (Fig. 4). A t this 
point it is crossed by the flexor digi­
torum  superficialis to the long finger. 
A tendinous origin of this m uscle has 
been implicated in producing the AIN  
syndrom e.6'8
Close Proxim ity to the R adius
W arren9 has drawn atten tion  to  the 
close proxim ity of the an terio r in teros­
seous nerve to the radius m ore distally 
in the forearm  (Fig. 5). H e cited two 
cases of forearm  fracture associated 
with the A IN  syndrom e. D irect traum a, 
traction, or form ation of a hem atom a 
at this site could account fo r the palsy.
FIG . 5— Close proximity of anterior 
interosseous nerve to radius and injury 
to  nerve caused by fracture of fo rearm .
FIG . 6— Penetrating injury of anterior 
interosseous nerve.
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P en etrating  Injury
Direct trauma to the anterior interos­
seous nerve at the time of a penetrating 
injury (Fig. 6)4 and during open reduc­
tion of a forearm fracture4 have both 
caused the AIN syndrome.
Iso lated  Neuritis
As well as resulting from trauma or 
pressure at various locations along the 
course of the nerve, the AIN syndrome 
has been attributed to an “isolated 
neuritis”,10'11 or associated with the 
“shoulder-girdle syndrome”.12 Parson­
age and Turner12 suggested that a case 
of paralysis of the flexor pollicis longus 
and flexor digitorum profundus muscles 
of the index finger with no other in­
volvement may have been due to polio­
myelitis. They stated: “This localized 
paralysis cannot anatomically be of 
peripheral nerve or nerve root distribu­
tion and is only explicable by an an­
terior horn cell lesion.” In the light 
of more recent reports,313 the above 
diagnosis should be discarded in fa­
vour of distinct anatomical lesions of 
the anterior interosseous nerve.
Clinical Diagnosis
The diagnosis of the AIN syndrome
Table I— Data of Cases of A nterior Interosseous Nerve Syndrome
Treatm ent
No. of
Authors cases Conservative Surgical Proposed etiology Final result
Parsonage and Turner, 194812 6 6 — 5 associated with shoulder-girdle syndrome 
1 anterior horn lesion
Not recorded
Kiloh and Nevin, 195210 2 2 — Isolated neuritis Delayed partial recovery
Thomas, 196211 2 2 — Compared to neuritis or neuralgic amyotrophy Full recovery
W arren, 1963» 2 2 — Associated with forearm fracture Full recovery
Fearn and Goodfellow, 196515 1 — 1 Fibrous band Full recovery
Stern, Rosner and Blinderman, 19676 1 — 1 Fibrous band Full recovery
Sharrard, 1968'® 1 — 1 Fibrous band Full recovery
V ichare, 1968- 4 4 2 intramuscular band 
1 fibrous band 
1 no cause found
Full recovery
Farber and Bryan, 196817 2 2 — No etiology proposed Partial recovery
M ills , M ukherjee and Bassett, 196913 1 — 1 Musculofibrous band Full recovery
Spinner and Schreiber, 19694 6 6 — Associated with supracondylar fractures 
Proposed traction of anterior interosseous
Full recovery
nerve
Spinner, 19702 10 — 3 1 tendinous band Full recovery
1 neuroma Tendon transfer
1 thrombosed vessels with scar tissue Full recovery
5 Etiology not clear 3 fu ll recovery 
1 partial recovery 
1 tendon transfer
2 — Associated with open reduction of forearm Both had tendon transfer
fracture
Schmidt and Eiken, 1971s 2 — 2 Fibrous bands 1 full recovery 
1 nearly fu ll recovery
O 'B rien and Upton, 1972'8 1 1 — Segmental demyelination Partial recovery
Gutmann, Hobbs and W iley, 19733 1 — 1 Fibrous band Good recovery
Smith and Herbst, 1974'9 1 1 — Unknown Full recovery
Lake,19742» 3 2 1 1 fascial bands
2 unknown
Satisfactory recovery
Gardner-Thorpe, 197421 2 2 — Unknown Full recovery
Krag, 197422 4 — 4 1 fibrous band 
3 neurogenic atrophy
Satisfactory recovery
Wiens 2 2 Fibrous bands 1 satisfactory recovery 
1 lost to follow-up
Total 54 33 21
is suspected if there is demonstrable 
weakness or paralysis of one or more 
of the flexor pollicis longus, radial por­
tion of the flexor digitorum profundus, 
or the pronator quadratus muscles.
The weakness of the long flexors of 
the thumb and the index finger can be 
elicited by the pinch-grip test. As 
pointed out by Spinner,1 the pinch- 
grip sign is characteristic of the AIN 
syndrome (Fig. 7). There is hyperex­
tension of the distal interphalangeal
FIG. 7—Characteristic pinch-grip with 
anterior interosseous nerve paralysis.
joint and increased flexion of the prox­
imal interphalangeal joint of the index 
finger. The metacarpal joint of the 
thumb is hyperflexed while the inter­
phalangeal joint is hyperextended.
The function of the pronator quad­
ratus muscle should be assessed with 
the elbow flexed at a right angle to 
minimize the action of the pronator 
teres muscle.4-7 This maneuver will per­
mit demonstration of weak resistance 
to forced supination of the hand with­
out interference from the pronator 
teres.
Pain is frequently mentioned as a 
presenting complaint. When present, 
pain is always poorly localized. It is 
most often referred to the forearm but 
may be felt in front of the elbow or 
rarely in the upper arm.
Electromyography
Electromyographic studies will con­
firm the diagnosis of the AIN syndrome 
by showing a marked denervation of 
the muscles supplied by the nerve. 
Voluntary motor unit potentials will 
be decreased or absent. The flexor 
digitorum profundus muscle will be 
variably involved depending on the ex­
tent of its innervation from the an­
terior interosseous nerve.
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Anatomical Variations
The clinical picture of the AIN syn­
drome can be quite variable because 
of differences in innervation of the 
muscles concerned. In fact, the flexor 
pollicis longus is the only muscle that 
is always innervated by the anterior 
interosseous nerve. Sunderland14 has 
reported a case in which the entire 
flexor digitorum profundus muscle 
was innervated by the ulnar nerve. In 
the “all median hand” the anterior in­
terosseous nerve supplies all of the 
flexor digitorum profundus. When a 
communication exists between ulnar 
and anterior interosseous nerves, the 
communication carries motor fibres to 
the first, second and third dorsal in- 
terossei and the adductor pollicis 
muscles.
We have recently treated two patients 
with the AIN syndrome and our ex­
perience is summarized below.
Case Reports
Case 1.—A 26-year-old man complained 
of aching pain, poorly localized in the 
right forearm and antecubital fossa. He 
was treated conservatively and the pain 
was relieved. The pain returned several 
months later and was accompanied by 
weakness of flexion at the interphalangeal 
joint of the right thumb. Examination re­
vealed the characteristic pinch-grip sign 
associated with the AIN syndrome. He 
also had demonstrable weakness of prona­
tion of the right hand. Sensory apprecia­
tion was intact over the entire right arm. 
On electromyography, denervation poten­
tials were demonstrated in the right flexor 
pollicis longus and pronator quadratus 
muscles which also indicated reduced 
voluntary motor activity.
The median nerve was explored in front 
of the elbow. The anterior interosseous 
nerve was identified posteriorly at its site 
of origin and was followed distally. It 
was found to be stretched over a tendinous 
insertion of the deep head of the pronator 
teres muscle The nerve was attenuated 
but there was no true neuroma. The 
tendinous insertion of the pronator teres 
muscle was transected allowing the nerve 
to fall into its normal position without 
tension.
Two weeks later muscle power in the 
flexor pollicis muscle was much improved 
and 8 weeks later recovery was complete.
Case 2.—A 54-year-old carpenter had 
experienced weakness of the left thumb 
and index finger for 2 months. He com­
plained of difficulty in holding nails while 
hammering and also in buttoning his shirts. 
There were also areas of numbness over 
the flexor aspect of the left forearm. Ex­
amination showed weakness of flexion of 
the distal phalanx of the left thumb and 
index finger. There was deep tenderness in 
the left forearm between the brachioradialis 
and the pronator teres muscles. Electro­
myography demonstrated denervation po­
tentials in the left pronator quadratus and
the flexor pollicis longus muscles; there 
was no voluntary activity in these muscles. 
Sensory potentials and motor conduction 
along the left median, ulnar and radial 
nerves were normal.
The left antecubital fossa and forearm 
were explored through an S-incision. The 
median and anterior interosseous nerves 
were identified proximal to the pronator 
teres muscle and were followed into the 
lower third of the forearm. Where the an­
terior interosseous nerve passed under the 
arch of the flexor superficialis it was 
compressed by a tight tendinous band. 
The nerve was attenuated and edematous 
but there was no neuroma. The tendinous 
band was excised and the compression of 
the anterior interosseous nerve was re­
lieved.
Unfortunately, repeated attempts to 
contact the patient for follow-up examina­
tion have failed.
Discussion
Fifty two cases of the AIN syndrome 
have been reported in the English 
literature. These cases and our two are 
summarized in Table I.2*4'”'13’15'22 The 
AIN syndrome and its diagnostic cri­
teria have hitherto been only vaguely 
described. We believe that this condi­
tion needs to be defined. The AIN syn­
drome is characterized by weakness of 
flexion at the distal interphalangeal 
joint of the index finger and at the 
interphalangeal joint of the thumb; in 
addition there is weakness in pronation 
of the hand. The syndrome is caused by 
entrapment of or injury to the an­
terior interosseous nerve, with subse­
quent denervation of the flexor pollicis 
longus, radial portion of the flexor 
digitorum profundus and the pronator 
quadratus muscles. Clinically, the mo­
tor weakness can be demonstrated by 
the characteristic pinch-grip sign, and 
by impaired resistance to forced supina­
tion of the hand with the elbow flexed 
at a right angle. The criteria for diag­
nosis include: (a) demonstrable weak­
ness of one or more of the three mus­
cles innervated by the anterior interos­
seous nerve; (b) electromyographic 
findings of marked denervation poten­
tials and decreased or absent voluntary 
motor unit potentials of the correspond­
ing muscles; (c) operative evidence of 
isolated entrapment of or injury to the 
anterior interosseous nerve; and (d) in­
creased power in the affected muscles 
and reversal of electromyographic 
changes when the nerve is released.
Of 52 cases meeting the criteria for 
the AIN syndrome compiled from the 
English literature, the majority were 
due to pressure applied by a fibrous or 
tendinous band, or were associated with 
trauma. It seems clear from the litera­
ture that palsy associated with closed 
fractures should be treated in the ex­
pectation of good results. In cases not 
associated with fracture, exploration
should be performed; the results are 
gratifying. Prolonged conservative man­
agement appears unwarranted.
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Congenital Syndactyly: A Reappraisal
M a r t in  A . E n t in , m d , c m , m  sc , f r c s [c ]*
Digital syndactyly is a common con­
genital anomaly and is associated with 
other anomalies affecting the digits, 
the hand, the arm or even the entire 
body.
In the past it has been considered 
a single entity. However, recent 
information provided by experimental 
embryology, studies of morphogenesis 
and other sources, suggests that there 
are at least two distinct entities: 
primary syndactyly due to interference 
with the sequence of events that 
normally culminate in the division of 
digits into discrete parts and secondary 
syndactyly due to readhesion of 
adjacent digits as a result of close 
contact between raw surfaces.
Primary syndactyly may arise de novo, 
or it may occur as a manifestation 
of a mutation phenomenon or as a 
genetically controlled syndrome. 
Secondary syndactyly is the result of 
mechanical adhesion of adjacent parts 
involved in a general reparative or 
healing process. The initial insult leading 
to amputation of a portion of the 
digits may or may not be genetically 
controlled; adhesion is fortuitous.
Management of syndactyly is deter­
mined by the complexity of the 
malformation. For simple cutaneous 
syndactyly the surgeon should make 
a zigzag incision and provide a rec­
tangular, proximally based flap for the 
floor of the web, usually before the 
child is 2 years of age. A full- or 
split-thickness skin graft should be 
applied to the defects. For complex 
deformities involving several digits 
and associated with postural or osseous 
malformation, several operative 
procedures may be required. The
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surgeon must be vigilant to note and 
correct the sequelae resulting from 
recurrent contractures and imbalances 
associated with growth.
La syndactylie est une malformation 
congenitale frequente qui est associee 
a d’autres anomalies des doigts, 
de la main, du bras ou meme du corps 
tout entier.
On I'a consideree dans le passe 
comme une entite simple. Toutefois,
■ ’information recente issue de I'em- 
bryologie experimental, des etudes 
de morphogenese et d'autres sources 
indiquent qu’il y a au moins deux 
entites distinctes: une syndactylie 
primaire due a une interference dans 
la sequence des evenements qui 
culmine normalement par la division 
des doigts en parties separees, et une 
syndactylie secondaire due a un 
recollement des doigts adjacents, 
resultant d'un contact etroit entre deux 
surfaces vives.
La syndactylie primaire peut survenir 
de novo, ou elle peut etre la mani­
festation d’un phenomene de mutation 
ou representer un syndrome controle 
genetiquement. La syndactylie 
secondaire resulte de I'adhesion me- 
canique de parties adjacentes impliquees 
dans un processus de reparation 
generale ou de cicatrisation. L’agres- 
sion initiate conduisant a I’amputation 
d'une partie des doigts peut etre 
ou ne pas etre sous dependance 
genetique; I’adhesion est fortuite.
Le traitement de la syndactylie est 
determine par la complexity de la 
malformation. Dans le cas d’une 
syndactylie cutanee simple, le chirurgien 
devrait faire un incision en zigzag et 
preparer un lambeau rectangulaire 
rattache a la partie proximale et 
destine a servir de membrane inter- 
digitale; I’operation devrait habituelle- 
ment etre pratiquee avant Page de 
2 ans. Une greffe cutanee pleine 
epaisseur ou demi-epaisseur devrait 
etre appliquee sur les defauts. Pour 
les difformites complexes impliquant 
plusieurs doigts et associees a des 
malformations de la posture ou des os, 
plusieurs interventions chirurgicales 
peuvent etre necessaires. Le chirurgien 
devrait etre pret a noter et corriger 
les sequelles resultant des contrac­
tures recurrentes et des desequilibres 
associes a la croissance.
Digital webbing is a common conge­
nital anomaly. It accounted for about 
20% of 350 cases of congenital digital 
malformation recently reviewed at the 
Royal Victoria Hospital and Shriners 
Hospital for Crippled Children in 
Montreal.1 Webbing of the digits may 
be an isolated entity or may be asso­
ciated with other anomalies of the 
hand, the arm, or the entire body. In 
the past, syndactyly was considered to 
be a single entity. Recent studies of 
morphogenesis2-6 suggest that there are 
at least two distinct forms of syndac­
tyly: primary syndactyly, which results 
from interference in the normal sequen­
tial development of the parts, and 
secondary syndactyly which is caused 
by readhesion of adversely affected or 
partially amputated adjacent parts. 
Both forms of syndactyly can either 
arise de novo or be secondary to 
genetic causes; the latter form may 
recur in succeeding generations.7 While 
the subject is still controversial, we can 
best begin to understand the patho­
genesis of these conditions by con­
sidering the evolvement of the upper 
limb.
Morphogenesis of Anomalies
The upper limb begins its evolve­
ment as a limb bud; within the bud a 
sequential reciprocal process takes 
place between the outer epiblast and 
the inner mesenchyme. Epiblast thick­
ens to form an ectodermal cap which 
induces the mesenchyme to differen­
tiate. The differentiation begins prox­
imally and continues in a distal direc­
tion. In this manner the various areas 
of the upper arm, forearm and the hand 
are established.8
This regionalization begins about 
the fifth week of gestation. Each area 
is destined to produce the appropriate 
component parts: the proximal portion 
will form the humerus and surround­
ing soft tissue; the ulnar portion will 
form the ulna and the ulnar digits; the 
radial area will form the radius, the 
thumb and the appropriate carpal 
bones; and the central region will form 
the index and middle fingers with their 
carpal bones.6,9 Malformations occur 
when any one of these regions is ad­
versely affected by a deforming force, 
but the force must act before differen­
tiation takes place. After the seventh
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week of gestation all elements of the 
hand have been laid down and normal­
ly only maturation and growth will 
subsequently take place.
The deforming forces affecting the 
developing limb may be environmental 
or genetic. The genetic manifestations 
may occur sporadically as a mutation 
when one or several genes may be af­
fected. In addition, these genetic 
alterations may be inherited in a 
dominant or recessive mode. The local 
defect may occur by itself or may be 
part of a systemic condition associated 
with other malformations. If such asso­
ciations occur repetitively a syndrome 
complex may be described.7,10
Fig. la
The malformation can occur as a 
result of the adverse effect of a tera­
togenic agent or of the environment on 
the developing embryo. Interesting in­
formation became available from care­
ful analysis of pregnant mothers who 
took thalidomide and subsequently gave 
birth to children with malformed limbs. 
It was established that the effect was 
produced between the 39th and 50th 
day after the last menstrual period.11 
Other agents may affect the developing 
limb in similar sequences, but the type 
of deformity and the timing of its 
production depend upon the suscepti- 
iblity of the differentiating cells and 
the specificity of the teratogenic agent.11
Fig. lc
Fig. lb
FIG. 1—Primary syndactyly, (a) Partial syndactyly between middle and ring fingers 
in child, (b) Bilateral cutaneous syndactyly which is usually familial, (c) Cutaneous syn­
dactyly between middle and ring fingers showing secondary contracture.
Primary Syndactyly
There is a progressive division of 
cartilaginous masses destined to form 
the bones of individual digits from the 
fifth to eighth week of embryonic de­
velopment. If this evolvement is inter­
fered with, either by a gene or by a 
teratogenic agent, and the process of 
division is delayed or arrested, syn­
dactyly occurs; it may be a simple 
cutaneous syndactyly or a combined 
bony and cutaneous form (Figs. 1 and 
2). This nondivision produces a “pri­
mary” syndactyly whose complexity 
depends on the timing and the severity 
of action of the teratogen or on the 
penetrance of the genetic factor.
Fig. 2a
Fig. 2b
FIG. 2— Complex syndactyly, (a) Com­
plex syndactyly with amputation of index 
finger and hypoplasia of thumb, (b) Com­
plex syndactyly affecting index and long 
fingers associated with absent ring and 
little fingers.
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Several anomalies may be produced 
simultaneously in different areas of 
the body by the same gene or terato­
genic factor. New syndromes are de­
scribed when several anomalies con­
sistently occur together in the same 
individual. Several syndromes occur in 
association with syndactyly: for exam­
ple, craniosynostoses may be associated 
with syndactyly of the fingers (Fig. 
3) 2,5,12-u These patients suffer from a 
premature closure of the cranial and 
facial sutures. As a result brain growth 
is restricted and brain damage may re­
sult. Characteristic facial deformities 
also occur. In Poland’s syndrome15"18 as 
well as syndactyly there is absence of 
a portion of the ipsilateral pectoralis 
muscle. Digital webbing is prominent 
in a number of other syndromes1,7'10'19 
such as oculodentodigital dysplasia and 
the orofaciodigital syndrome.
Secondary Syndactyly
Losch5'20 was the first to point out 
the difference between primary and 
secondary syndactyly; he based the dis­
tinction on his careful anatomical 
studies of a number of hands with 
webbed digits. Differentiation of the 
mesenchymal structures into individual 
phalanges takes place about the fifth 
to sixth week of gestation; consequent­
ly, the end of the fifth week is the 
critical time for formation of osseous 
syndactyly.5 In his anatomical dissec­
tions Losch was able to clarify the 
detailed structural alterations of the 
osseous, ligamentous, tendinous and 
cutaneous elements in cutaneous and 
osseous syndactyly.20
FIG. 3— Complex syndactyly with
craniosynostosis of Apert’s type showing 
fused nails of three fingers.
Even after the various parts of the 
limb have been formed, environmental 
or teratogenic factors may adversely 
affect their development and bring 
about secondary changes through vas­
cular complications or through some 
other mechanism.21 These changes may 
alter or destroy developing parts and 
produce necrosis. The ulcerated seg­
ments then become fused during the 
process of healing. Because these mal­
formations result from antecedent de­
fects, it may be appropriate to term 
them “secondary” syndactyly. The 
findings among several patients in our 
series who were seen at birth and 
followed through childhood substan­
tiate the concept of secondary syn­
dactyly (Figs. 4 and 5).
The specific cause of secondary 
syndactyly is still controversial. Several 
different mechanisms have been sug-
Fig. 4b
FIG. 4— Secondary syndactyly, (a) 
Right hand of 1-week-old male infant 
showing constriction of middle finger by 
adhesion of stump of thumb to adjacent 
ring and little fingers, (b) Immediate sur­
gical release was carried out to improve 
circulation to middle finger. Dimple be­
tween stumps of ring and little fingers is 
remnant of web space.
gested, each having its supporters. 
Ring constrictions have been considered 
important by several authors.2,5'22'23 
Annular constrictions are frequently 
found in individual fingers adjacent to 
obviously “amputated” digital rem­
nants. Constrictions are also found on 
digits associated with webbing of 
neighbouring digits. Under such cir­
cumstances, the webbed digits invari­
ably lack their distal portions. Conse­
quently, this is considered to be one of 
the mechanisms whereby coalescence 
of raw or ulcerating neighbouring 
structures can produce “secondary” 
syndactyly of previously separated di­
gits.1,20
It has been suggested that the forma­
tion of amniotic bands associated with 
some defect in the amnion is the speci­
fic morphogenetic factor that leads to 
intrauterine amputation. The amnion 
becomes separated from the chorion 
leaving a mesh of mesodermal threads 
or bands in which the fetal parts be­
come entangled. Such constricting 
bands around trapped fingers can pro­
duce edema, ischemia, atrophy or, if
Fig. Sb
FIG. 5—Secondary syndactyly, (a)
Right and left hands of 7-year-old child. 
Ring constriction on missing distal pha­
langes on right hand suggests intrauterine 
amputation (acrosyndactyly). (b) Roent­
genogram of right hand shown in (a).
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they persist, complete amputation.19'24
The association of the amniotic band 
syndrome in pregnant mothers exposed 
to lysergic acid (LSD) with the birth 
of infants having “distal” syndactyly 
has been reported.22'24 However, 
others19,21'25 support different theories 
of etiology. They state, on the evidence 
of vascular anomalies, that it is not the 
amniotic bands but rather the paucity 
of mesodermal proliferation or the 
necrosis of tissue that is responsible 
for this type of digital webbing. In any 
case, these entities do not appear to be 
genetically controlled,7,10 although the 
problem of morphogenesis still awaits 
elucidation.
Classification of Syndactyly
It is essential to have a classification 
even if it is not universally accepted; 
otherwise the reports become a mere 
listing of seemingly isolated items, and 
comparative studies of, for example, 
the incidence and the results of treat­
ment are not possible.26"29
We have chosen the basic classifica­
tion of congenital anomalies of the up­
per extremity that was originally 
recommended by the American Society 
for Surgery of the Hand and that was 
subsequently adopted by the Interna­
tional Federation of Hand Societies30’31 
and later modified by the International 
Society of Prosthetics and Orthotics.31 
It comprises seven main divisions.
Syndactyly belongs primarily to the 
second division of the classification, 
namely, the failure of differentiation 
of parts. The malformation of syndac­
tyly is confined to the digits of the 
hand, but frequently associated are 
conditions affecting other areas and 
remote organs. These too must be in­
cluded in the classification. As men­
tioned earlier, the anomalies that are 
due to failure of differentiation or 
separation are considered as “primary”, 
whereas those that appear to result 
from antecedent defects and are pro­
duced by “refusion” are termed “sec­
ondary” syndactyly. Based on these 
considerations, the syndactylies are 
classified as described in Table I. It is 
particularly difficult to provide an all- 
inclusive classification of congenital 
malformations associated with syn­
dactyly because almost any type of 
congenital deformity involving the 
digits may have some element of syn­
dactyly. While there may not be uni­
versal agreement on this classification, 
it should be adopted provisionally by 
centres involved in treatment of these 
conditions so that the evaluation of the 
collated results will be meaningful.
Management of Syndactyly
While it is not our purpose in this 
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presentation to consider the treatment 
of various forms of syndactyly, we 
would be remiss if some basic princi­
ples of management were not outlined. 
The ideal is to restore normal function 
and appearance to the malformed limb. 
There is no universal agreement re­
garding the timing of the individual 
surgical procedures. In complex de­
formities early intervention is manda­
tory, especially if in the developing 
infant there is interference with pre­
hensile function of the hand.26'27'32
For simple cutaneous syndactyly a 
zigzag incision and fashioning of a 
generous dorsal, proximally based, rec­
tangular flap for the floor of the web 
are usually carried out before the child 
reaches 2 years of age. Full-thickness 
skin grafts from the groin or moder­
ately thick split-thickness grafts taken 
from the lateral aspect of the buttocks 
provide coverage for the lateral skin 
defects.
Earlier separation of digits may be 
desirable for complex syndactylies as­
sociated with postural deformities and 
flexion contractures. If several digits 
are affected, the marginal fingers are 
separated first.
In secondary syndactyly, a constrict­
ing effect may threaten the survival of 
a digit soon after birth; under these cir­
cumstances surgical release becomes 
an immediate necessity (Fig. 4).
Table I— Classification of Syndactyly
Primary (nondivision)
Cutaneous or simple 
Soft tissue only 
Two digits only
Multiple digits without postural de­
formities
Complex 
Soft tissue 
Synonychia
Multiple digits with postural de­
formities
Skeletal
Fusion
Phalangeal
Metacarpal
Brachysyndactyly
Disarray
Others*
Syndromes
Poland’s, Apert’s, orofaciodigital, 
oculodentodigital and others
Secondary (refusion)
Cutaneous 
Terminal fusion
Associated with digital amputation
Skeletal 
Acrosyndactyly 
“ Mitten hand”
Others*
‘ Syndactyly may be associated with a variety 
of malformations such as reduction in 
number of digits (ectrosyndactyly) or in­
creased number of digits.
Recurrence of webbing and con­
tracture may take place, and newer 
imbalance may occur with unequal 
growth of affected parts. Constant 
vigilance is required to correct these 
deformities.
References
1. Entin MA: Syndactyly of upper limb. 
Morphogenesis, classification, and 
management. C'lin Plast Surg 3: 129, 
1976
2. Degenhardt KH: Zum entwicklungs- 
mechanischen Problem der Akroce- 
phalosyndaktylie. Z Menschl Vererb 
Konstitutionsl 29: 791, 1950
3. Entin MA: Reconstruction of con­
genital abnormalities of the upper ex­
tremities. J Bone Joint Surg [Am] 41: 
681, 1959
4. Ingalls TH, Curley FJ, P rindle 
RA: Medical progress: experimental 
production of congenital anomalies; 
timing and degree of anoxia as factors 
causing fetal deaths and congenital 
anomalies in mouse. N  Engl J Med 
247: 758, 1952
5. Losch GM: Syndaktylien. Anatomie, 
Entwicklung, Therapeutische Aspekte. 
Normale und pathologische Anatomie, 
Stuttgart, Georg Thieme Verlag, 1970
6. Zwilling E: Ectoderm—mesoderm
relationship in the development of 
the chick embryo limb bud. J Exp 
Zool 128: 423, 1955
7. Wynne-Davis R: Genetics and mal­
formations of the hand. Hand 3: 184, 
1971
8. Saunders JW JR: The proximo-distal 
sequence of origin of the parts of the 
chick wing and the role of the ecto­
derm. J Exp Zool 108: 363, 1948
9. Waddington CH: Developmental
Mechanisms. Second International 
Conference on Congenital Malforma­
tions, New York, International Medi­
cal Conference, 1964, p 213
10. T etamy S, McKusick VA: Sympo­
sium on hand malformations with 
particular emphasis on genetic fac­
tors, in Limb Malformations. Clinical 
Delineation of Birth Defects— First 
Conference, Bergsma D, McKusick 
VA (eds), Baltimore, Williams & Wil­
kins, 1969, p 125
11. Lenz W: Der Zeitplan der menschli- 
chen Organogenese als Massstab fiir 
die Beurteilung teratogener Wirkun- 
gen. Fortschr Med 24: 520, 1969
12. Apert E: De l’acrocephalosyndactylie. 
Bull Soc Med Hop [Paris) 23: 1310, 
1906
13. Barksy AJ: Congenital Anomalies of 
the Hand and Their Surgical Treat­
ment, Springfield, CC Thomas, 1958, 
pp 26-47
14. Birch-Jensen A: Congenital De­
formities of the Upper Extremities, 
Copenhagen, Munksgaard, 1949, pp 
127-133, 242, 243
15. Brown JB, McD owell F: Syndac­
tylism with absence of pectoralis ma­
jor. Surgery 7: 599, 1940
16. Clarkson P: Poland’s syndactyly.
Guy Hosp Rep 111: 335, 1962
17. Epstein LL, Bennett JE: Syndactyly 
with ipsilateral chest deformity. Plast 
Reconstr Surg 46: 236, 1970
18. Poland A: Deficiency of the pec­
toral muscles. Guy Hosp Rep 6: 191, 
1841
19. David TJ: Nature and etiology of 
the Poland anomaly. N  Engl J Med 
287: 487, 1972
THE CANADIAN JOURNAL OF SURGERY 363
20. L osch GM, Dunckkr HR: Anatomy and surgical treatment of syndactyl­ism. Plast Reconstr Surg 50: 167, 197221. Streeter GL: Focal Deficiency in Fetal Tissues and Their Relation to Intrauterine Amputation, publ no. 414, vol 22, Washington, Carnegie Inst, 1930, p 122. Tordin RC: Fetal MalformationsCaused by Amnion Rupture During Gestation, Springfield, CC Thomas, 196823. W alsh RJ: Acrosyndactyly. A study of twenty-seven patients. Clin Orthop 71: 99, 1970
24. Blanc WA, M attison DR, Kane R, et al: L.S.D., intrauterine amputations, and amniotic-band syndrome. Lancet 2: 158, 1971
25. W arkany J : Production of congenital malformations by dietary measures. Experiments in mammals. JAMA 168: 2020, 1958
26. E ntin MA: Congenital anomalies of the upper extremity. Surg Clin North Am  40: 497, 1960
27. F latt AE: Treatment of syndactyl­ism. Plast Reconstr Surg 29: 336,1962
28. O’Rahilly R: Morphological patterns
in limb deficiencies and duplications. Am  J Anat 89: 135, 195129. Patterson TJ: Classification of the congenitally deformed hand. Br J Plast Surg 17: 142, 196430. E ntin  MA, Barsky A, Swanson A: Classification of congenital malforma­tions of the hand and upper extremity. Hand 4: 215, 197231. Swanson AB: Les malformations con- genitales du membre superieur, A pro- pos de leur classification et de leur traitement. Ann Chir 29: 433, 197532. K ettelkamp DB, F latt AE: An evaluation of syndactylia repair. Surg Gynecol Obstet 113: 471, 1961
Renal Artery Embolism: Diagnosis and Treatment
M B. B u c k spa n , dds, m d , f r c s [c ] and M.R. G old berg , m d , m  sc , f r c s [c]
A 59-year-old woman presented with 
flank pain, atrial fibrillation and a 
nonfunctioning left kidney. A diagnosis 
of renal artery embolism was made 
and she was treated successfully by 
embolectomy. A review of the literature 
reaffirms the role of embolectomy, 
even in cases with delayed diagnosis.
Une femme de 59 ans s’est presentee 
souffrant de douleur au flanc, de 
fibrillation auriculaire et de blocage 
du rein gauche. Un diagnostic d'embolie 
de I'artere renale a ete pose et la 
patiente a ete traite avec succes par 
embolectomie. Une revue de la 
litterature confirme le role de I’embo- 
lectomie, meme dans les cas ou le 
diagnostic est retarde.
Renal artery embolism as a clinical 
entity is uncommon. However, Hoxie 
and Coggin1 reported finding renal in­
farction in 1.4% of 14 411 consecutive 
autopsies. Trabue2 first described this condition in 1856, but it was not until 1962 that a successful renal artery em­
bolectomy was described by Duncan and Dexter.3
In patients who present with the syndrome of flank pain, atrial fibrillation and a nonfunctioning kid­ney, the possibility of a renal artery
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embolus must be considered. If the 
diagnosis is confirmed, even after some delay, prompt treatment may 
preserve normal renal function.
Case Report
A 59-year-old woman was admitted for 
elective cholecystectomy. She had rheu­
matic heart disease with chronic atrial 
fibrillation but no other cardiac symp­
toms. Her blood pressure was 140/90 
mm Hg and her pulse rate 90 beats/min 
and irregular. There was a grade 2 mitral 
diastolic murmur and no clinical evidence 
of heart failure. The electrocardiogram 
showed atrial fibrillation and right ventri­cular hypertrophy.
Digitalization was commenced and 24 
hours later she suddenly experienced 
severe left flank pain associated with 
tenderness in the left loin, and nausea 
and vomiting. A provisional diagnosis of 
left ureteral colic was made, but urinalysis 
at that time disclosed no abnormal find­
ings. Intravenous pyelography did not 
visualize the left collecting system. Cys­
toscopy revealed no efflux of urine from 
the left ureteric orifice, and on retrograde pyelography the left collecting system 
appeared unobstructed (Fig. 1). An isotope flow study and renal scan showed no 
perfusion of the left kidney (Figs. 2 and 
3). An emergency aortogram showed a 
single left renal artery, which was ob­
structed just distal to its origin (Fig. 4). 
Selective arteriography demonstrated the 
occlusive embolus and propagated thrombi 
in several of the secondary intrarenal vessels (Fig. 5).
Operation was performed approximately 12 hours after the onset of symptoms. 
The abdomen was opened through a long 
midline incision and the left colon mobi­
lized, exposing the aorta and the origin of 
the left renal artery. The kidney was soft 
and cyanotic and no pulsation was noted 
in the left renal artery distal to its origin. 
The embolus was removed through a trans­
verse arteriotomy and a Fogarty catheter 
was passed proximally and distally. The 
vessel bled immediately and retrograde 
bleeding was also noted. The arterial in­
cision was closed with 6-0 Polydek vascu­
lar sutures. Good pulsations were evident 
and there was some bleeding from cap­
sular vessels at the lower pole of the kidney.
FIG. 1— Preoperative retrograde pye- logram showing unobstructed left collect­ing system.
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FIG. 2—Preoperative renal isotope flow study showing no perfusion of left kidney.
The patient received heparin intra­
venously 12 hours after the operation and 
warfarin after 24 hours. Her postoperative 
course was uneventful and her renal func­
tion and blood pressure were unchanged 
from their preoperative values. A renal 
scan obtained on the fourth postoperative 
day showed improved renal perfusion 
(Fig. 6) and an intravenous pyelogram on 
the 10th postoperative day showed a func­
tioning left kidney (Fig. 7).
She was discharged from hospital on 
the 12th postoperative day and treatment 
with digoxin and oral anticoagulants was 
continued. Three months later her blood 
pressure and renal function were normal. 
FIG. 3—Preoperative renal isotope scan Mitral commissurotomy is to be con- 
showing nonfunctioning left kidney. sidered.
FIG. 4—Preoperative aortogram showing single left renal artery obstructed distal 
to its origin.
Discussion
The principal condition, antecedent 
to acute renal artery embolism is mitral 
valvular disease with fibrillation, sec­
ondary to rheumatic or atherosclerotic 
heart disease. Other less common 
causes are congenital valvular disease, 
mural thrombi developing after myo­
cardial infarction, subacute bacterial 
endocarditis and emboli from prosthetic 
heart valves and primary cardiac tu­
mours. Paradoxical emboli originating 
in the deep venous system can pass 
across intracardiac septal defects into 
the systemic circulation.4
In recent years, atheroembolic renal 
disease has been reported with increas­
ing frequency, either as a primary con­
dition presenting as rapidly progressive 
irreversible renal failure, or as an acute 
complication of aortic surgery or aorto­
graphy.5 There have been reports of 
bilateral renal artery embolism,6 and 
emboli to a solitary kidney.7 In both 
these circumstances the patients were 
anuric and this would constitute a 
surgical emergency.
Renal artery embolism usually affects 
the elderly. The youngest reported pa­
tient was aged 25 years. The reported 
duration of ischemia has ranged from 
5 hours8 to 35 days9 before surgical 
intervention. In all reported cases there 
was sudden onset of flank pain, failure 
of the kidney to be visualized on intra­
venous pyelography and no evidence of 
ureteral obstruction.
The length of time before irrevers­
ible, total loss of function occurs in the 
human ischemic kidney is not known, 
but has been estimated at 20 minutes
FIG. 5—Preoperative selective left 
renal arteriogram showing embolus just 
distal to artery’s origin, with propagated 
thrombi in several secondary branches 
and poor parenchymal perfusion.
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to 2 hours. Recent investigations have 
shown collateral intrarenal arterial 
anastomoses and an extrarenal supply 
from capsular vessels.10 Therefore, 
acute renal artery obstruction, while 
rendering the kidney ischemic, may not 
actually produce necrosis. Urine forma­
tion may be suppressed temporarily but 
may improve after revascularization. 
While prompt recognition and treat­
ment are important, a delay should not
contraindicate embolectomy in patients 
medically fit for surgery. Nor should 
the gross appearance of the kidney at 
operation lead to nephrectomy or aban­
donment of planned embolectomy.
In patients whose condition contra­
indicates emergency surgery, systemic 
anticoagulation or selective administra­
tion of thrombolytic agents through the 
angiography catheter may be given a 
trial.11
FIG. 6— Postoperative isotope renal scan showing improved left renal function, 
especially at upper pole.
FIG- 7—Postoperative nephrotomogram showing functioning left kidney.
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treated patients with lymphedema, but 
they have had insufficient concrete in­
formation on which to base their planning 
for long-term management. Investigators 
interested in experimental and clinical re­
search of the lymphatic system have been 
confronted with a diverse literature. Papers 
often were written in a foreign language 
and appeared in foreign journals. The 
editor of this text has solved many of 
these problems by bringing together an 
international panel of authorities to deal 
with the subject; they have done their 
work in a refreshingly critical scientific 
manner.
In two excellent chapters, Clodius cor­
relates detailed experimental investigations 
with carefully documented clinical cases 
providing the requisite long-term follow­
up. The review of secondary lymphedema 
of the arm will be of particular interest to 
the general surgeon and to the radiother­
apist. Olszewski offers a rational scheme 
explaining the pathophysiology of lym­
phedema, which is supported by detailed 
experimental studies. Casley-Smith, Foldi 
and other contributors offer a stimulating 
and scholarly review of new concepts in 
lymphatic anatomy and physiology. The 
book is profusely illustrated with accurate 
photographs plus the necessary tables and 
is extensively referenced.
The only criticism of the text is directed 
at its publisher. There are numerous spell­
ing errors and an inconsistency in refer-
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Cake Kidney with Abdominal Aneurysm
M artin G. M cL oughlin , m d , frcs[c], T im othy  J. G ardner, md 
and G. M elville  W illia m , md
The authors describe a case of cake 
kidney occurring in association with 
a ruptured abdominal aneurysm with 
special reference to preoperative 
evaluation by angiography. They discuss 
the need to prepare these patients for 
possible in-vivo or ex-vivo renal 
manipulation during the removal of the 
aneurysm and the placement of the 
Dacron graft.
Les auteurs decrivent un patient ayant 
un rein en galette et une rupture 
d’anevrisme abdominal. Une attention 
particuliere est accordee a revaluation 
preoperatoire par angiographie. Ms 
discutent egalement du besoin de 
preparer ces patients en vue d’une 
manipulation renale eventuelle in vivo 
ou ex vivo, durant la resection de 
I'anevrisme et la pose d’un greffon 
de Dacron.
Complete fusion of the nephroblastic 
masses early in fetal development 
results in the formation of a solitary 
renal mass commonly termed a cake 
kidney. This rare renal anomaly 
has been described in association with 
renal vascular malformations1 but not 
with an abdominal aortic aneurysm. 
We describe one such case, associated 
with a ruptured abdominal aneurysm, 
with special reference to the use of 
angiography in defining the renal blood 
supply. By this means the surgeon can 
prepare the patient for possible in-vivo 
or ex-vivo renal manipulation to ensure 
adequate exposure for removal of the 
leaking aneurysm.
Case Report
A 64-year-old man experienced sudden onset of abdominal pain on the left side radiating to his left hip. He was admitted to his local hospital where a diagnosis of a leaking abdominal aneurysm led to an emergency laparotomy. Exploration re­vealed a large retroperitoneal hematoma and a cake kidney overlying an aortic
From the division of transplantation, department of surgery, The Johns Hopkins Hospital, Baltimore, MD
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aneurysm. The incision was closed, the patient’s condition was stabilized and he was transferred to the Johns Hopkins Hospital, Baltimore, for further assessment.His blood pressure on admission was 210/120 mm Hg, his pulse rate was 100 beats/min and his temperature was nor­mal. Blood urea nitrogen concentration was 13.6 mmol/L (38 mg/dL) and serum creatinine concentration 221 i/.mol/L (2.5 mg/dL). After the blood pressure was controlled, a retrograde femoral arterio­gram was obtained which confirmed the presence of an abdominal aortic aneurysm with an overlying cake kidney. The vas­cular supply to this kidney appeared as a single anteriorly placed vessel originating proximal to the aneurysm. Severe back pain indicated further leakage from the aneurysm. An exploratory operation dis­closed a large retroperitoneal hematoma that had extended up into the lesser sac. Compression of the aorta below the origin of the single renal artery provided enough vascular control to allow the cake kidney to be separated from the aneurysm, aneurysmectomy performed and a bi­furcation Dacron graft inserted. Postoper- atively the patient required supportive therapy for respiratory, hepatic and renal insufficiency but was discharged after 4 weeks with a serum creatinine value of 309 jxmol/L (3.5 mg/dL) and a blood urea nitrogen value of 23.2 mmol/L (65 mg/dL) (he had some renal ischemia but was recovering). He is now enjoying an active life and requires no medication.
Discussion
The early fusion of the metanephric 
elements in utero prevents the ascent 
and rotation of the renal mass to its 
normal position.2,3 In its lower ab­
dominal ectopic position the single 
fused cake kidney is usually described 
as a flat retroperitoneal mass with a 
lobulated anterior surface and an an­
teriorly placed pelvis.4 The blood sup­
ply is variable but usually arises from 
the adjacent vessels. These abnormally 
situated kidneys are prone to ureteral 
obstruction, blunt trauma and infective 
episodes.
The association of cake kidney with 
ruptured aortic aneurysm has not been 
previously reported. Angiography in our 
patient defined the anomalous blood 
supply to the kidney and enabled us 
to plan the definitive surgical proce­
dure. If the blood supply had arisen
from the section of the aorta involved 
in the aneurysm, we were prepared to 
remove the kidney, perfuse it in an 
ex-vivo setting, then perform the aneu­
rysmectomy and place the Dacron graft 
and finally replace the cake kidney in 
the abdomen and anastomose its vas­
cular supply to the vena cava and Da­
cron graft. This patient was fortunate 
to have the renal blood supply arising 
above the aneurysm, thus permitting 
proximal control of the aorta below its 
origin after mobilization of the cake 
kidney anteriorly.
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ence styles. In the second edition one would like to see an expanded format dealing with each aspect of the lymphatic system from embryology through pathol­ogy to diagnostic modalities and treatment. Both primary and secondary lymphedema 
should be covered.In summary, this text will be of value to surgeons of all specialties and to re­searchers dealing with the various vascular systems. We are all indebted to Leo Clodius for its obvious academic excel­lence and careful editing. He has, in the final analysis, produced the modern equiv­alent to Gasparo Aselli’s classical treatise on the structure and function of the lym­phatic system, but with emphasis on clin­ically important conditions and surgical treatments.
Rollin K. D aniel
Chief of plastic surgery,Royal Victoria Hospital,Montreal, PQ
PHYSIOLOGY OF THE HEART AND CIRCULATION. Robert C. Little. 334 pp. Illust. Year Book Medical Publish­ers, Inc., Chicago, 1977. Price not stated, paperbound. ISBN 0-8151-5475-5.
This text contains material presented to medical and beginning graduate students. The author, who is chairman of the de- 
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Interstitial Pregnancy Following Ipsilateral 
Salpingo-oophorectomy
Louis B u r g e n e r , m d  and R onald  C. St r ic k l er , m d , f r c s [c]
A case of interstitial pregnancy, which 
occurred 12 years after ipsilateral 
salpingo-oophorectomy, was managed 
by cornual wedge resection.
Internal (transuterine) migration 
of the fertilized ovum is the most 
probable explanation for this ectopic 
gestation. During the past 10 years 
three other cases of interstitial 
gestation have been managed at 
St. Michael's Hospital, Toronto, an 
incidence of 3% of all ectopic 
pregnancies seen at the hospital during 
that period.
line grossesse interstitielle, survenant 
12 ans apres une salpingo-oophorectomie 
ipsilaterale, a ete traitee par resection 
en pointe de la corne uterine. Une 
migration interne (transuterine) de 
I'ovule fertilise est I'explication la 
plus plausible de cette gestation 
ectopique. Durant les 10 dernieres 
annees, trois autres cas de gestation 
interstitielle ont ete soignes au 
St. Michael's Hospital, Toronto, pour 
une incidence de 3% de toutes les 
grossesses ectopiques vues a I’hopital 
durant la meme periode.
Interstitial (uterine cornual) pregnancy 
is an uncom m on type of ectopic gesta­
tion and its occurrence following total 
ipsilateral salpingectomy, with or with­
out associated oophorectomy, is rare. 
Kalchman and M eltzer1 found 73 re­
ports of interstitial pregnancy in the 
literature up to 1966 and added two 
cases which occurred after ipsilateral 
salpingectomy. Our search of the world 
literature located three reports2-4 not in­
cluded in the Kalchm an and Meltzer 
total and a further 12 cases5"12 re­
ported after 1966. We describe what 
is presumably the 91st such case 
and review our experience with inter­
stitial ectopic pregnancy during the 
past 10 years.
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Case Report
A 31-year-old white woman complained 
of crampy abdominal pain located in the 
midline and left lower quadrant that was 
associated with nausea and the passage of 
several loose stools during the previous 
2 days. These symptoms, although an­
noying, had not prevented her from per­
forming housework and supervising young 
children at a day-care centre. Her last 
menstrual period had begun 6 weeks pre­
viously; she was not using contraception 
and a urine test for pregnancy done by 
her family doctor 3 days earlier had given 
a negative result.
At the age of 19 years the patient had 
had a serous cystadenoma of the right 
ovary which had necessitated salpingo- 
oophorectomy. The operative report de­
scribed cross-clamping of the right cornual 
area which was then oversewn. In 1974 
she was delivered vaginally at term of a 
normal female infant. In October 1976, 
following a Shirodkar procedure for cer­
vical incompetence at 24 weeks’ gestation, 
premature labour began and she was 
delivered of a stillborn infant.
On admission the patient weighed more 
than 145 kg and was not greatly dis­
tressed. Mild lower abdominal tenderness, 
especially to the left of the midline, was 
present but there was no guarding or re­
bound tenderness. There was no vaginal 
bleeding. Bimanual examination was un­
satisfactory because of the extreme obesity 
but movement of the cervix to the right 
produced pain.
During 24 hours of observation and bed 
rest the patient’s symptoms remained un­
changed. Because of persisting cervical 
excitational pain, laparoscopy was under­
taken. Clotted blood was seen on the 
fundus of the uterus. At laparotomy, per­
formed through a Pfannenstiel incision, 
approximately 300 mL of old clotted 
blood was seen in the peritoneal cavity. 
The left ovary contained a corpus luteum 
and the normal left fallopian tube was 
freely mobile. The uterus, which was 
slightly enlarged and soft, had a bluish 
swelling 3 cm in diameter at the right 
cornu, to which organized blood clot and 
omentum were adherent. No active bleed­
ing was evident. Trophoblast had invaded 
and penetrated the cornual area and had 
become implanted on the peritoneum over- 
lying the bladder. No tubal remnant could 
be identified and the right ovary was absent.
A deep wedge resection of the cornual 
lesion was performed and the uterine de­
fect was closed in layers. The right round
ligament was used to cover the cornual 
scar. The implant of trophoblast on the 
bladder peritoneum was incompletely re­
moved by blunt dissection and hemostasis 
effected by electrocauterization. The ab­
dominal wall was closed in layers and 
drains were placed in the subfascial and 
subcutaneous spaces.
Despite the patient’s obesity, there were 
no respiratory or wound complications. 
She was discharged home on the seventh 
postoperative day. Menstruation resumed 
5 weeks after the operation. When the 
patient was seen 2 months postoperatively 
she was completely well, was following a 
program for weight reduction and had 
agreed to use contraception for at least 
1 year.
Discussion
The rare cases of interstitial preg­
nancy following total ipsilateral ad- 
nexectomy emphasize that salpingec­
tomy, with or without cornual resec­
tion, does not invariably protect 
against a subsequent ectopic gestation 
at the ipsilateral cornual area. There 
are several theories to explain this oc­
currence. Im plantation of the fertilized 
ovum on the serosal surface of the 
uterus and subsequent invasion of the 
myometrium has been suggested.13 Or 
the cornual rem nant of the tube may 
recanalize to open onto the serosal 
surface and thus permit entry of the 
fertilized ovum at the site of previous 
surgery. However, the observation that 
the fallopian tube is attracted to the 
developing follicle and that the fimbria 
are almost a necessity for egg entrap­
ment makes the random transfer of an 
ovum from  the ovary to a nonmobile 
uterine aperture seem improbable.14 
When the ipsilateral ovary is also ab­
sent, as in the case we report, transperi- 
toneal migration of the ovum, a sec­
ond improbable occurrence, must also 
be postulated. We believe that internal 
migration across the uterine cavity of 
an ovum that was captured by, fer­
tilized in and transported through the 
contralateral normal fallopian tube is 
a distinct possibility. The internal route 
of migration favoured in the recent 
literature reflects a better appreciation 
of the requirements for ovum capture 
than was available a decade ago.6,15’16 
In support of the internal migration
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theory is the explanation of McElin 
and Iffy17 that reflux menstrual flow, 
which occurs early when the concep­
tion cycle has a shortened luteal phase, 
carries the embryo to the uterine cor­
nual area.
Interstitial pregnancies, and indeed 
ectopic gestations whatever their loca­
tion, usually rupture through the im­
plantation site and the conceptus dies. 
It has been postulated that abdominal 
pregnancy occurs in most cases as a 
result of the gradual delivery of the 
intact “embryo-trophoblastic unit” 
through the uterine wall.18 In our case 
the trophoblast had penetrated the 
uterine cornu and become implanted 
on the peritoneum overlying the blad­
der. Although intraperitoneal bleeding 
had occurred, the cornu had not rup­
tured and the omentum was sealing off 
the area of trophoblastic invasion. 
These findings are consistent with the 
above genesis of abdominal pregnancy, 
but whether this interstitial pregnancy 
would have suffered the same fate can 
only be conjectured.
In most reports the ipsilateral in­
terstitial pregnancy has developed 
shortly after the total salpingectomy. 
Since the healing operative site may 
predispose to ectopic implantation, 
contraception for at least a year fol­
lowing cornual resection has been ad­
vised.19 The interval of 12 years be­
tween the initial operation and the 
interstitial gestation in this case is 
longer than in all earlier reports but 
one20 and the interposition of two in­
trauterine pregnancies is unusual.
Between January 1966 and March 
1977 three other patients with an in­
terstitial ectopic pregnancy were 
managed at St. Michael’s Hospital, 
Toronto, out of a total of 135 women 
in whom a diagnosis of ectopic preg­
nancy was proven by the pathological 
findings. The incidence of interstitial 
pregnancy has therefore been 3 %; in 
the literature the figure varies from 
1% to 6% of all extrauterine gesta­
tions.7 The thickness of the uterine wall 
surrounding the interstitial portion of 
the tube in comparison with the peri­
toneum covering the remainder of its 
length permits longer growth of a preg­
nancy in the cornual area. Consequent­
ly, interstitial,21 angular,5 and cornual22 
ectopic pregnancies usually cause 
symptoms late in the first or in the 
second trimester. This greater gesta­
tional size combined with the vascu­
larity of the uterine cornu can lead to 
severe hemorrhage. Most patients with 
an interstitial pregnancy are first seen 
when in hemorrhagic shock and repre­
sent an acute surgical emergency. The 
benign presentation in this case was 
unusual. A pregnancy at the cornual 
area, although it may in theory be 
suspected from the asymmetrical ute­
rine growth, is usually not recognized 
prior to rupture.
The surgical management of ectopic 
gestation in all locations is individual­
ized according to anatomic factors 
(extent of the rupture, associated pelvic 
disease), the patient’s desire for more 
children, and her clinical state at the 
time of operation. When salpingectomy 
is indicated, we believe that a cornual 
resection (which should not be so deep 
as to enter the uterine cavity) will 
prevent a “stump recurrence” and will 
lessen, although not eliminate, the pos­
sibility of a future interstitial preg­
nancy.
According to reports in the litera­
ture of women with an interstitial 
gestation as many have had a hysterec­
tomy as have had a wedge resection 
of the cornual area.1,6,7'21 The more 
conservative form of operative manage­
ment can be accomplished without 
hazard to most patients. Prompt rec­
ognition of intraperitoneal bleeding, 
accessibility of surgical units, early 
operation, availability of blood and 
fluid replacement, improved techniques 
of anesthesia and accurate physiologic 
monitoring of acutely ill patients have 
reduced the surgical risk to women with 
ectopic gestation. In performing an 
extensive cornual resection we recog­
nize that a myometrial scar is left 
similar to that produced at a classical 
cesarean section or a uterine reunifica­
tion procedure, and infrequently the 
scar may rupture during a subsequent 
pregnancy.23 Simpson, Alford and 
Miller16 found in the literature at least 
nine recorded instances of rupture of 
the gravid uterus at the site of a de­
fective cornual scar. We have discov­
ered one further case19 reported since 
1961. Therefore, we believe that there 
is insufficient evidence to justify the 
conclusion that conservative surgery 
may jeopardize future reproduction. 
Furthermore, there is no evidence to 
support or refute the suggested desir­
ability of performing elective cesarean 
section in women who have had a 
previous cornual resection for an in­
terstitial pregnancy.7’16
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Total Replacement of the Hip Joint Affected
by Paget’s Disease
G.B. H a’E r i, m d * and J. Schatzker, m d , b sc, frcs[c]
A
In seven patients with Paget’s disease 
involving the bones about the hip 
joint, associated degenerative changes 
of the joint caused such severe pain 
and disability that total hip replacement 
was necessary. The results were 
uniformly satisfactory and no serious 
complications were encountered.
Chez sept patients souffrant de maladie 
de Paget avec atteinte des os de la 
hanche, les modifications degeneratives 
de cette articulation qui s’ensuivirent 
ont ete la cause de tellement de 
douleur et d'incapacite qu'un remplace- 
ment complet de la hanche a ete 
necessaire. Les resultats ont ete 
uniformement satisfaisants et aucune 
complication serieuse n’est survenue.
Total hip replacement has provided re­
lief of pain and improvement in func­
tion for patients suffering from various 
pathologic conditions of the hip joint. 
One of these conditions is Paget’s dis­
ease, where involvement of one or both 
hip joints may cause disability suffi­
cient to justify total hip replacement. 
Yet the orthopedic surgeon is often 
reluctant to perform replacement in 
such patients because of the possibility 
of excessive bleeding and later loosening 
of the prosthesis, and because of tech­
nical problems related to bowing of 
the femur. This paper describes our 
experience with total hip replacement 
in seven patients with Paget’s disease 
involving the hip, in none of whom 
these complications developed.
Patient Data
Seven patients underwent total hip 
replacement for Paget’s disease (by 
Muller’s technique1) at the Wellesley 
Hospital, Toronto between 1970 and
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1975. All had severe pain and stiffness 
of the hip. Six patients could walk on­
ly with the help of a cane and one was 
unable to walk at all. All were women. 
Their average age was 75.5 years. At 
the time of writing all patients were 
alive. The shortest follow-up was 2 
years and the longest 7 years (average, 
44 months).
Only one patient was receiving cal­
citonin preoperatively (60 MRC units 
three times a week, subcutaneously). 
She had the most severely deteriorated 
hip joint, associated with advanced 
Paget’s disease involving the pelvis and 
femora. A similar dosage of calcitonin 
was prescribed for another patient fol­
lowing surgery. Two of our patients 
had Paget’s disease of the pelvis 
and femur (Fig. 1), and the other 
five of the pelvis only (Fig. 2). The 
serum alkaline phosphatase value 
was elevated in all of our patients 
(average, 343 IU; normal range 25 to 90 
IU). All our patients except one had an 
elevated erythrocyte sedimentation rate 
(average, 34.4 mm/h; normal value: 
men, <  10 and women, <  20 mm/h). 
There was no serious technical diffi­
culty owing to hardness of bone. Blood
loss ranged from 500 mL to 1500 mL 
(average, 915 mL), without the use of 
hypotensive anesthesia. (The blood loss 
in total hip replacement in 10 random­
ly selected uncomplicated osteoarthri- 
tic patients ranged from 400 mL to 
1500 mL [average, 850 mL].) The ra­
diologic appearance of degenerative 
arthritis of the hip associated with 
Paget’s disease has been described 
previously.2,3
The results of total hip replacement 
were assessed clinically and radiolo- 
gically with respect to fixed flexion 
deformity (FFD), flexion, abduction, 
adduction, and external and internal 
rotation, using the Harris hip rating.1
Results and Discussion
The overall subjective and objective 
results were satisfactory. Pain was re­
lieved in all seven patients, except in 
one woman with a Pagetoid pelvis, who 
complained of only minor hip pain 6 
years after the hip replacement.
This patient had no clinical or labo­
ratory evidence of infection. Radio- 
graphic examination revealed progres­
sion of the Paget’s disease so that it 
involved the whole pelvis. There was
FIG- 1— Paget’s disease of pelvis and femur with associated degenerative arthritis 
of hip joint.
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no indication of loosening of the pros­thetic components. We believe there­
fore that the pain was due to active Pagetoid involvement of the pelvis.
Postoperatively, five patients were able to walk independently and two 
required a cane. Hip flexion contrac­tures were corrected, and all had a 
greater range of joint movement (Table 
I). The results were uniformly satis­
factory; according to the Harris hip rating,4 the average increase was from 
39 preoperatively to 91 postoperatively.
Although this is a small series, our 
experience parallels that of others5 and 
indicates that total hip replacement is 
an effective method of treatment for 
patients with pain and deformity asso­
ciated with Paget’s disease and hip in­
volvement. We believe that operative 
bleeding is not excessive when com­
pared with that of total hip arthroplasty 
for other arthritic conditions.
The increased osteoclastic resorption 
of existing bone which occurs in Paget’s 
disease could theoretically produce an 
increased incidence of prosthetic 
loosening. However, our early results 
in the small number of cases reported 
here do not support this supposition.
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THORACIC SURGERY — EXAMINATIONS
The first examinations leading to the Certificate of Special Competence in the specialty of Thoracic Surgery will be held in 
September, 1979. Prospective candidates should note the following:
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3. Further information may be obtained from:
Division of Training and Evaluation,
Royal College of Physicians and Surgeons of Canada,
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Le premier examen en vue du certificat de competence particuliere en chirurgie thoracique aura lieu a I’automne de 1979. Tous les 
candidats qui sont intbresses a se presenter a cet examen devront prendre connaissance de ce qui suit:
1. Les candidats qui ddsirent se presenter aux examens en chirurgie thoracique doivent etre detenteurs du certificat de specialiste en 
chirurgie gbnbrale du College royal.
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avec preuve a I'appui, a I'adresse ci-dessous, le plus tot possible et au plus tard le 1er decembre 1978. Les candidats ne peuvent etre 
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FIG. 2—Paget’s disease of pelvis with associated degenerative arthritis of hip joint.
Table I— Comparison of Range of Movement (in Degrees) (Pre- and Postoperatively) in Seven 
Patients Who Had Total Hip Replacement
Fixed
Patient
no.
flexion
deformity Flexion Abduction Adduction
External
rotation
Internal
rotation
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
i 15 0 60 90 5 25 5 15 5 20 5 15
2 15 0 95 90 20 45 25 30 10 40 0 15
3 5 0 75 90 10 30 5 20 10 25 5 25
4 0 0 70 90 20 45 20 30 20 40 0 30
5 20 5 70 80 10 20 20 20 5 15 0 10
6 5 0 115 95 5 20 5 20 15 25 0 10
7 10 0 70 90 10 30 15 25 10 20 5 15
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partment of physiology and professor of 
medicine at the Medical College of 
Georgia School of Medicine in Augusta, 
has designed the book with these readers 
in mind, although it would also constitute 
an excellent concise review of the field 
for those further advanced in their careers.
There are three sections, on physiologic 
principles, the heart and the circulation. 
The first section considers fluid movement 
in the body, composition of blood, cardiac 
anatomy and biophysics of the cardiac cell. 
The second concerns the electrical and 
mechanical aspects of myocardial contrac­
tion, electrocardiography, cardiac output 
and its control, and cardiac metabolism. 
In the final section the author describes 
the anatomy, hemodynamics and regula­
tion of the circulation; particular emphasis 
is placed on the control of blood pressure 
and regional circulation.
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The book does not pretend to be en­
cyclopedic, and for the sake of brevity 
conflicting interpretations have been 
avoided in favour of generally accepted 
opinion. The book is of special value 
because it is the work of a single author 
who has a broad perspective and experi­
ence. The text includes much worthwhile 
information and it is illustrated with 
clear line drawings, graphs and charts.
The author has succeeded in providing 
a concise readable text that summarizes 
basic cardiovascular physiology.
A nthony R.C. D obell 
Director,
Cardiovascular surgery,
Royal Victoria Hospital,
Montreal, PQ
TECHNIQUES OF PATIENT CARE. A 
MANUAL OF BEDSIDE PROCE­
DURES. 2nd ed. Clarence E. Zimmer­
man, 272 pp. Illust. Little, Brown and 
Company, Inc., Boston, 1976. Price 
not stated, paperbound. ISBN 0-316- 
98868-5.
This small book attempts to discuss the 
bedside procedures that most of us learned 
by unsupervised trial and error or by word 
of mouth from our peers. Four of the 
chapters concern the use of needles in 
vascular techniques, aspiration techniques, 
lumbar puncture and biopsy. Three chap­
ters about tubes include respiratory tech­
niques, nasogastric intubation and urethral 
catheterization. The remaining chapters 
deal with skin preparation and infiltration, 
endoscopy, nasal packing, dialysis tech­
niques, dressing care and techniques of 
resuscitation.
In general, each section is treated by 
listing the material and equipment neces­
sary followed by a detailed description of 
“how I do it”. Reference is made to in­
dications, complications and subsequent 
management. Adequate line drawings and 
diagrams supplement the text in most 
instances.
The book will be a source of reassur­
ance to medical students, interns and in 
some areas to junior residents. It will 
provide easily readable information about 
the techniques of patient care that are so 
often relegated to that group. Senior res­
idents and consultants having mastered 
the techniques described will find little of 
interest.
J.E. D evitt 
Associate dean,
Department of Continuing Medical 
Education,
University of Ottawa,
Ottawa, Ont.
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